Document:

EX-10.1

 Exhibit 10.1 

$1,000,000,000 

REVOLVING CREDIT AGREEMENT 

DATED AS OF DECEMBER 21, 2018 

AMONG 
 WALGREENS BOOTS
ALLIANCE, INC., 
 THE LENDERS FROM TIME TO TIME PARTIES HERETO, 

BANK OF AMERICA, N.A. 

as Administrative Agent 

and 
 MERRILL LYNCH,
PIERCE, FENNER & SMITH INCORPORATED, 
 as Sole Lead Arranger 

 
  

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	ARTICLE I	  

	DEFINITIONS	  

			
	 Section 1.01
	 	 Certain Defined Terms
	  	 	1	 
	 Section 1.02
	 	 References
	  	 	20	 
	 Section 1.03
	 	 Eurocurrency Rate
	  	 	20	 
	
	ARTICLE II	  

	THE CREDITS	  

			
	 Section 2.01
	 	 Description of Facility; Commitments
	  	 	21	 
	 Section 2.02
	 	 Extension of Maturity Date
	  	 	22	 
	 Section 2.03
	 	 Reserved
	  	 	24	 
	 Section 2.04
	 	 Types of Loans
	  	 	24	 
	 Section 2.05
	 	 Fees; Reductions in Aggregate Commitment
	  	 	24	 
	 Section 2.06
	 	 [Reserved]
	  	 	25	 
	 Section 2.07
	 	 Prepayments and Repayments
	  	 	25	 
	 Section 2.08
	 	 Method of Selecting Types and Interest Periods for New Loans
	  	 	26	 
	 Section 2.09
	 	 Conversion and Continuation of Outstanding Loans
	  	 	27	 
	 Section 2.10
	 	 Interest Rates
	  	 	28	 
	 Section 2.11
	 	 Rates Applicable After Default
	  	 	29	 
	 Section 2.12
	 	 Method of Payment
	  	 	29	 
	 Section 2.13
	 	 Noteless Agreement; Evidence of Indebtedness
	  	 	29	 
	 Section 2.14
	 	 Interest Payment Dates; Interest and Fee Basis
	  	 	30	 
	 Section 2.15
	 	 Notification of Loans, Interest Rates, Prepayments and Commitment Reductions; Availability
of Loans
	  	 	31	 
	 Section 2.16
	 	 Lending Installations
	  	 	31	 
	 Section 2.17
	 	 Payments Generally; Administrative Agent’s Clawback
	  	 	31	 
	 Section 2.18
	 	 Replacement of Lender
	  	 	32	 
	 Section 2.19
	 	 Sharing of Payments by Lenders
	  	 	33	 
	 Section 2.20
	 	 Defaulting Lenders
	  	 	34	 
	
	ARTICLE III	  

	YIELD PROTECTION; TAXES	  

			
	 Section 3.01
	 	 Yield Protection
	  	 	35	 
	 Section 3.02
	 	 Changes in Capital Adequacy Regulations; Certificates for Reimbursement; Delay in
Requests
	  	 	36	 
	 Section 3.03
	 	 Illegality
	  	 	37	 
	 Section 3.04
	 	 Compensation for Losses
	  	 	38	 
	 Section 3.05
	 	 Taxes
	  	 	39	 
	 Section 3.06
	 	 Mitigation Obligations
	  	 	43	 
	 Section 3.07
	 	 Inability to Determine Rates
	  	 	44	 
	 Section 3.08
	 	 Survival
	  	 	45	 

							
	ARTICLE IV	  

	CONDITIONS PRECEDENT	  

			
	 Section 4.01
	 	 Signing Date
	  	 	45	 
	 Section 4.02
	 	 Initial Effectiveness
	  	 	46	 
	 Section 4.03
	 	 Each Borrowing Date
	  	 	47	 
	
	ARTICLE V	  

	REPRESENTATIONS AND WARRANTIES	  

			
	 Section 5.01
	 	 Existence and Standing
	  	 	48	 
	 Section 5.02
	 	 Authorization and Validity
	  	 	48	 
	 Section 5.03
	 	 No Conflict; Government Consent
	  	 	48	 
	 Section 5.04
	 	 Financial Statements
	  	 	49	 
	 Section 5.05
	 	 Material Adverse Effect
	  	 	49	 
	 Section 5.06
	 	 Litigation
	  	 	49	 
	 Section 5.07
	 	 Regulation U
	  	 	49	 
	 Section 5.08
	 	 Investment Company Act
	  	 	50	 
	 Section 5.09
	 	 OFAC, FCPA
	  	 	50	 
	 Section 5.10
	 	 Disclosure
	  	 	50	 
	
	ARTICLE VI	  

	COVENANTS	  

			
	 Section 6.01
	 	 Financial Reporting
	  	 	50	 
	 Section 6.02
	 	 Use of Proceeds
	  	 	52	 
	 Section 6.03
	 	 Notice of Default
	  	 	52	 
	 Section 6.04
	 	 Conduct of Business
	  	 	52	 
	 Section 6.05
	 	 Compliance with Laws
	  	 	53	 
	 Section 6.06
	 	 Inspection; Keeping of Books and Records
	  	 	53	 
	 Section 6.07
	 	 Merger
	  	 	53	 
	 Section 6.08
	 	 Sale of Assets
	  	 	53	 
	 Section 6.09
	 	 Liens
	  	 	54	 
	 Section 6.10
	 	 Financial Covenant
	  	 	55	 
	 Section 6.11
	 	 Sanctions
	  	 	55	 
	
	ARTICLE VII	  

	DEFAULTS	  

			
	 Section 7.01
	 	 Breach of Representations or Warranties
	  	 	56	 
	 Section 7.02
	 	 Failure to Make Payments When Due
	  	 	56	 
	 Section 7.03
	 	 Breach of Covenants
	  	 	56	 

  
 ii 

							
	 Section 7.04
	 	 Cross Default
	  	 	56	 
	 Section 7.05
	 	 Voluntary Bankruptcy; Appointment of Receiver; Etc
	  	 	57	 
	 Section 7.06
	 	 Involuntary Bankruptcy; Appointment of Receiver; Etc
	  	 	57	 
	 Section 7.07
	 	 Judgments
	  	 	57	 
	 Section 7.08
	 	 Unfunded Liabilities
	  	 	57	 
	 Section 7.09
	 	 Reserved
	  	 	57	 
	 Section 7.10
	 	 Other ERISA Liabilities
	  	 	57	 
	 Section 7.11
	 	 Invalidity of Loan Documents
	  	 	58	 
	
	ARTICLE VIII	  

	ACCELERATION, WAIVERS, AMENDMENTS AND REMEDIES	  

			
	 Section 8.01
	 	 Acceleration, Etc
	  	 	58	 
	 Section 8.02
	 	 Amendments
	  	 	58	 
	 Section 8.03
	 	 Preservation of Rights
	  	 	60	 
	
	ARTICLE IX	  

	GENERAL PROVISIONS	  

			
	 Section 9.01
	 	 Survival of Representations
	  	 	60	 
	 Section 9.02
	 	 Governmental Regulation
	  	 	60	 
	 Section 9.03
	 	 Headings
	  	 	60	 
	 Section 9.04
	 	 Entire Agreement
	  	 	60	 
	 Section 9.05
	 	 Several Obligations; Benefits of this Agreement
	  	 	61	 
	 Section 9.06
	 	 Expenses; Indemnification
	  	 	61	 
	 Section 9.07
	 	 Accounting
	  	 	63	 
	 Section 9.08
	 	 Severability of Provisions
	  	 	63	 
	 Section 9.09
	 	 Nonliability of Lenders
	  	 	63	 
	 Section 9.10
	 	 Confidentiality
	  	 	63	 
	 Section 9.11
	 	 Nonreliance
	  	 	65	 
	 Section 9.12
	 	 Disclosure
	  	 	65	 
	
	ARTICLE X	  

	THE ADMINISTRATIVE AGENT	  

			
	 Section 10.01
	 	 Appointment and Authority
	  	 	65	 
	 Section 10.02
	 	 Rights as a Lender
	  	 	66	 
	 Section 10.03
	 	 Reliance by Administrative Agent
	  	 	66	 
	 Section 10.04
	 	 Exculpatory Provisions
	  	 	66	 
	 Section 10.05
	 	 Delegation of Duties
	  	 	67	 
	 Section 10.06
	 	 Resignation of Administrative Agent
	  	 	67	 
	 Section 10.07
	 	 Non-Reliance on Administrative Agent
and Other Lenders
	  	 	68	 
	 Section 10.08
	 	 No Other Duties, Etc.
	  	 	68	 
	 Section 10.09
	 	 Administrative Agent May File Proofs of Claim
	  	 	69	 
	 Section 10.10
	 	 ERISA
	  	 	69	 

  
 iii 

							
	ARTICLE XI	  

	SETOFF	  

			
	 Section 11.01
	 	 Setoff
	  	 	70	 
	
	ARTICLE XII	  

	BENEFIT OF AGREEMENT; ASSIGNMENTS; PARTICIPATIONS	  

			
	 Section 12.01
	 	 Successors and Assigns
	  	 	71	 
	 Section 12.02
	 	 Dissemination of Information
	  	 	75	 
	 Section 12.03
	 	 Tax Treatment
	  	 	75	 
	
	ARTICLE XIII	  

	NOTICES	  

			
	 Section 13.01
	 	 Notices; Effectiveness; Electronic Communication
	  	 	75	 
	
	ARTICLE XIV	  

	COUNTERPARTS; INTEGRATION; EFFECTIVENESS; ELECTRONIC EXECUTION	  

			
	 Section 14.01
	 	 Counterparts; Effectiveness
	  	 	78	 
	 Section 14.02
	 	 Electronic Execution of Assignments
	  	 	78	 
	
	ARTICLE XV	  

	CHOICE OF LAW; CONSENT TO JURISDICTION; WAIVER OF JURY
TRIAL	

 

			
	 Section 15.01
	 	 Choice of Law
	  	 	78	 
	 Section 15.02
	 	 Consent to Jurisdiction
	  	 	78	 
	 Section 15.03
	 	 Waiver of Jury Trial
	  	 	79	 
	 Section 15.04
	 	 U.S. Patriot Act Notice
	  	 	80	 
	 Section 15.05
	 	 No Advisory or Fiduciary Responsibility
	  	 	80	 
	 Section 15.06
	 	 Judgment Currency
	  	 	80	 
	 Section 15.07
	 	 Acknowledgement and Consent to Bail-In of EEA Financial
Institutions
	  	 	81	 

  
 iv 

					
	EXHIBITS
			
	Exhibit A	  	–  	  	Form of Compliance Certificate
	Exhibit B	  	–  	  	Form of Assignment and Assumption
	 Exhibit C
 Exhibit D

Exhibit E
	  	 –  
 –  

–  
	  	 Form of Promissory Note
 Form of Borrowing
Notice
 Form of Conversion/Continuation Notice

	Exhibit F	  	–  	  	Form of Officer’s Certificate
	
	SCHEDULES
			
	Schedule 2.01	  	–  	  	Commitment Schedule
	Schedule 13.01	  	–  	  	Certain Addresses for Notices

  
 v 

 REVOLVING CREDIT AGREEMENT 

This Revolving Credit Agreement, dated as of December 21, 2018, is among WALGREENS BOOTS ALLIANCE, INC., a Delaware corporation (the
“Borrower”), the institutions from time to time parties hereto as Lenders (whether by execution of this Agreement or an assignment pursuant to Section 12.01) and Bank of America, N.A., as Administrative Agent. 

WHEREAS, the Borrower has requested that the Lenders extend revolving credit to the Borrower in the form of Loans in Dollars in an aggregate
principal amount not in excess of $1,000,000,000 for general corporate purposes; and 
 WHEREAS, the Lenders are willing to make such Loans
to the Borrower from to time on the terms and subject to the conditions set forth in this Agreement. Accordingly, the parties hereto agree as follows: 

ARTICLE I 
 DEFINITIONS 

Section 1.01    Certain Defined Terms. As used in this Agreement:

 “Acquisition” means any transaction or series of related concurrent transactions for the purpose of or
resulting, directly or indirectly, in (a) the acquisition by the Borrower or any of its Subsidiaries of all or a material portion of the assets of a Person, or of any business or division of a Person, (b) the acquisition by the Borrower or
any of its Subsidiaries of in excess of 50% of the capital stock, partnership interests, membership interests or equity of any Person (other than a Person that is a Subsidiary), or otherwise causing any Person to become a Subsidiary of the Borrower
or (c) a merger or consolidation or any other combination by the Borrower or any of its Subsidiaries with another Person (other than a Person that is a Subsidiary); provided that the Borrower (or a Person that succeeds to the Borrower
pursuant to Section 6.07 in connection with such transaction or series of related transactions) or a Subsidiary of the Borrower (or a Person that becomes a Subsidiary of the Borrower as a result of such transaction) is the surviving entity;
provided, further that any Person that is a Subsidiary at the time of execution of the definitive agreement related to any such transaction or series of related concurrent transactions (or, in the case of a tender offer or similar
transaction, at the time of filing of the definitive offer document) shall constitute a Subsidiary for purposes of this definition even if in connection with such transaction or series of related transactions, such Person becomes a direct or
indirect holding company of the Borrower. 
 “Acquisition Debt” means any Indebtedness incurred by the Borrower or any of
its Subsidiaries for the purpose of financing, in whole or in part, a Material Acquisition and any related transactions or series of related transactions (including for the purpose of refinancing or replacing all or a portion of any pre-existing Indebtedness of the Borrower, any of its Subsidiaries or the person(s) or assets to be acquired); provided that (a) the release of the proceeds of such Indebtedness to the Borrower and/or
its Subsidiaries is contingent upon the 

  
 1 

 
consummation of such Material Acquisition and, pending such release, such proceeds are held in escrow (and, if the definitive agreement (or, in the case of a tender offer or similar transaction,
the definitive offer document) for such acquisition is terminated prior to the consummation of such Material Acquisition or if such Material Acquisition is otherwise not consummated by the date specified in the definitive documentation relating to
such Indebtedness, such proceeds shall be promptly applied to satisfy and discharge all obligations of the Borrower and/or its Subsidiaries in respect of such Indebtedness) or (b) such Indebtedness contains a “special mandatory
redemption” provision (or other similar provision) or otherwise permits such Indebtedness to be redeemed or prepaid if such Material Acquisition is not consummated by the date specified in the definitive documentation relating to such
Indebtedness (and if the definitive agreement (or, in the case of a tender offer or similar transaction, the definitive offer document) for such Material Acquisition is terminated in accordance with its terms prior to the consummation of such
Material Acquisition or such Material Acquisition is otherwise not consummated by the date specified in the definitive documentation relating to such Indebtedness, such Indebtedness is so redeemed or prepaid within 90 days of such termination or
such specified date, as the case may be). 
 “Actual Unused Commitments” is defined in Section 2.05(a). 

“Administrative Agent” means Bank of America, N.A. in its capacity as contractual representative of the Lenders
pursuant to Article X, and not in its individual capacity as a Lender, and any successor Administrative Agent appointed pursuant to Article X. 

“Administrative Agent’s Office” means the Administrative Agent’s address and, as appropriate, account as set forth
on Schedule 13.01, or such other address or account as the Administrative Agent may from time to time notify to the Borrower and the Lenders. 

“Affiliate” of any Person means any other Person directly or indirectly controlling, controlled by or under common control
with such Person. A Person shall be deemed to control another Person if the controlling Person is the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934) of ten
percent (10%) or more of any class of voting securities (or other voting interests) of the controlled Person or possesses, directly or indirectly, the power to direct or cause the direction of the management or policies of the controlled Person,
whether through ownership of voting securities, by contract or otherwise. 
 “Agent Parties” is defined in
Section 13.01(c). 
 “Aggregate Commitment” means, at any time, the aggregate amount of the Commitments of all the
Lenders, as may be adjusted from time to time pursuant to the terms hereof. The Aggregate Commitment as of the Effective Date is One Billion and 00/100 Dollars ($1,000,000,000). 

“Agreement” means this Revolving Credit Agreement, as it may be amended, restated, supplemented or otherwise modified and as
in effect from time to time. 

  
 2 

 “Agreement Accounting Principles” means GAAP, applied in a manner
consistent with that used in preparing the financial statements of the Borrower referred to in Section 5.04; provided, however, that notwithstanding anything contained in Section 9.07 to the contrary, if the Borrower notifies
the Administrative Agent that the Borrower requests an amendment to any provision hereof to eliminate the effect of any change occurring after the Effective Date in GAAP (or any change in GAAP that occurred on or prior to the Effective Date but was
not reflected in the financial statements included in the Borrower SEC Reports) or in the application thereof on the operation of such provision, regardless of whether any such notice is given before or after such change in GAAP or in the
application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in
accordance herewith. 
 “Agreement Currency” is defined in Section 15.06. 

“Alternate Base Rate” means for any day a fluctuating rate per annum equal to the highest of (a) the Federal Funds Rate
plus 1/2 of 1%, (b) the Prime Rate in effect for such day and (c) the Eurocurrency Base Rate determined in accordance with clause (b) of the definition thereof for a one month Interest Period plus 1.0%. 

“Alternate Base Rate Loan” means a Loan, or portion thereof, which, except as otherwise provided in Section 2.11, bears
interest at the Alternate Base Rate. 
 “Applicable Eurocurrency Margin” means 0.75% per annum. 

“Applicable Margin” means (a) with respect to Eurocurrency Loans (including LIBOR Daily Floating Rate Loans), the
Applicable Eurocurrency Margin and (b) with respect to Alternate Base Rate Loans, 0.00% per annum. 
 “Approved Fund”
means any Fund that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender. 

“Arranger” means Merrill Lynch, Pierce, Fenner & Smith Incorporated (or any other registered broker-dealer
wholly-owned by Bank of America Corporation to which all or substantially all of Bank of America Corporation’s or any of its subsidiaries’ investment banking, commercial lending services or related businesses may be transferred following
the date of this Agreement), in its capacity as the sole lead arranger and sole bookrunner hereunder. 
 “Article” means an
article of this Agreement unless another document is specifically referenced. 
 “Assignee Group” means two or more
Eligible Assignees that are Affiliates of one another or two or more Approved Funds managed by the same investment advisor. 

  
 3 

 “Assignment and Assumption” means an assignment and assumption entered into
by a Lender and an Eligible Assignee (with the consent of any party whose consent is required by Section 12.01), and accepted by the Administrative Agent, in substantially the form of Exhibit B or any other form approved by the
Administrative Agent. 
 “Authorized Officer” means any of the Chief Executive Officer, Global Chief Financial Officer,
Global Chief Administrative Officer and General Counsel, Global Treasurer, Treasury Vice President, Corporate Secretary, Global Controller and Chief Accounting Officer or Financial Controller of the Borrower, acting in accordance with the terms of
the signing authority granted in the incumbency certificate delivered to the Administrative Agent pursuant to Section 4.02(d) (including any supplements thereto delivered to the Administrative Agent from time to time by way of an officers’
certificate jointly executed by two Authorized Officers). 
 “Average Percentage Utilization” means, for any Measurement
Period, an amount, expressed as a percentage, equal to (i) the average aggregate principal amount of the Loans outstanding on each day during such period determined, for any day, after giving effect to any prepayments or repayments of any Loans
occurring during such period divided by (ii) the average of the aggregate Commitments outstanding on each day during such period as adjusted pursuant to Section 2.05(d). 

“Bail-In Action” means the exercise of any Write-Down and Conversion Powers by the
applicable EEA Resolution Authority in respect of any liability of an EEA Financial Institution. 

“Bail-In Legislation” means, with respect to any EEA Member Country implementing
Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country from time to time which is described in the EU Bail-In
Legislation Schedule. 
 “Bank of America” means Bank of America, N.A., a national banking association having its principal
office in Charlotte, North Carolina, in its individual capacity, and its successors. 
 “Benefit Plan” means any of
(a) an “employee benefit plan” (as defined in ERISA) that is subject to Title I of ERISA, (b) a “plan” as defined in and subject to Section 4975 of the Code or (c) any Person whose assets include (for purposes
of ERISA Section 3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such “employee benefit plan” or “plan”. 

“Borrower” is defined in the preamble. 

“Borrower Materials” is defined in Section 6.01. 

“Borrower SEC Reports” means the Borrower’s 2018 Annual Report on Form 10-K.

  
 4 

 “Borrowing” means a borrowing consisting of simultaneous Loans of the same
Type and, in the case of a borrowing of Eurocurrency Loans (other than LIBOR Daily Floating Rate Loans), having the same Interest Period. 

“Borrowing Date” means each date on which a Borrowing is made hereunder, subject to satisfaction (or waiver in accordance
with Section 8.02) of the applicable conditions set forth in Article IV. 
 “Borrowing Notice” is defined in
Section 2.08. 
 “Business Day” means a day (other than a Saturday or Sunday) on which banks are generally open in New
York, New York for the conduct of substantially all of their commercial lending activities and interbank wire transfers can be made on the Fedwire system (or any other equivalent wire system) and if such day relates to any interest rate settings as
to a Eurocurrency Loan, any fundings, disbursements, settlements and payments in respect of any such Eurocurrency Loan, or any other dealings to be carried out pursuant to this Agreement in respect of any such Eurocurrency Loan, means any such day
that is also a London Banking Day. 
 “Capitalized Lease” of a Person means any lease of Property by such Person as lessee
which would be shown as a liability on a balance sheet of such Person prepared in accordance with Agreement Accounting Principles. 

“Change in Law” means the occurrence, after the date of this Agreement, of any of the following: (a) the adoption or
taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation or application thereof by any Governmental Authority or (c) the making or issuance of any
request, guideline or directive (whether or not having the force of law) by any Governmental Authority; provided, that, notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act
and all requests, rules, guidelines or directives promulgated thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on
Banking Supervision (or any successor or similar authority) or the United States regulatory authorities, in each case pursuant to Basel III, shall in the case of clauses (x) and (y) be deemed to be a “Change in Law”, regardless of the
date enacted, adopted, issued, promulgated or implemented. 
 “Code” means the Internal Revenue Code of 1986, as amended,
reformed or otherwise modified from time to time. 
 “Commitment” means, for each Lender, the obligation of such Lender to
make Loans, in an aggregate principal amount at any one time outstanding not to exceed the amount set forth on the Commitment Schedule (which schedule shall set forth each Lender’s Commitment as of the Effective Date) or in an Assignment and
Assumption executed pursuant to Section 12.01, as it may be modified as a result of any assignment that has become effective pursuant to Section 12.01 or as otherwise modified from time to time pursuant to the terms hereof. 

  
 5 

 “Commitment Fee” is defined in Section 2.05(a). 

“Commitment Fee Rate” means 0.11% per annum. 

“Commitment Schedule” means the Schedule attached hereto and identified as such, identifying each Lender’s Commitment as
of the Effective Date. 
 “Consenting Lender” is defined in Section 2.02(a). 

“Consolidated Assets” means, at any date of determination, the total amount, as shown on or reflected in the most recent
consolidated balance sheet of the Borrower and its Subsidiaries as at the end of the Borrower’s fiscal quarter ending prior to such date, of all assets of the Borrower and its consolidated Subsidiaries on a consolidated basis in accordance with
Agreement Accounting Principles (giving pro forma effect to any acquisition or disposition of Property of the Borrower or any of its Subsidiaries with fair value in excess of $100,000,000 that has occurred since the end of such fiscal quarter as if
such acquisition or disposition had occurred on the last day of such fiscal quarter). 
 “Consolidated Debt” means at any
time the consolidated Indebtedness for Borrowed Money of the Borrower and its Subsidiaries calculated on a consolidated basis as of such time in accordance with Agreement Accounting Principles. 

“Consolidated Net Worth” means at any time the consolidated stockholders’ equity of the Borrower and its Subsidiaries
calculated on a consolidated basis as of such time in accordance with Agreement Accounting Principles. 
 “Contingent
Obligation” of a Person means any agreement, undertaking or arrangement by which such Person assumes, guarantees, endorses, contingently agrees to purchase or provide funds for the payment of, or otherwise becomes or is contingently liable
upon, the obligation or liability of any other Person, or agrees to maintain the net worth or working capital or other financial condition of any other Person, or otherwise assures any creditor of such other Person against loss, including, without
limitation, any comfort letter, operating agreement, take-or-pay contract or the obligations of any such Person as general partner of a partnership with respect to the
liabilities of the partnership. 
 “Controlled Group” means all members of a controlled group of corporations or other
business entities and all trades or businesses (whether or not incorporated) under common control which, together with the Borrower or any of its Subsidiaries, are treated as a single employer under Section 414 of the Code. 

“Conversion/Continuation Notice” is defined in Section 2.09. 

“Debtor Relief Laws” means the Bankruptcy Code of the United States, and all other liquidation, conservatorship, bankruptcy,
assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, or similar debtor relief laws of the United States or other applicable jurisdictions from time to time in effect and affecting the rights
of creditors generally. 

  
 6 

 “Declining Lender” is defined in Section 2.02(a). 

“Default” means an event described in Article VII. 

“Defaulting Lender” means, subject to Section 2.20(b), any Lender that (a) has failed to perform any of its funding
obligations hereunder, including in respect of its Loans, within three Business Days of the date required to be funded by it hereunder unless such Lender notifies the Administrative Agent in writing that such failure is the result of such
Lender’s determination that one or more conditions precedent to funding has not been satisfied (which conditions precedent, together with the applicable default, if any, will be specifically identified in such writing), (b) has notified the
Borrower or the Administrative Agent in writing that it does not intend to comply with its funding obligations or has made a public statement to that effect with respect to its funding obligations hereunder, or generally under other agreements in
which it commits to extend credit, unless such notification or public statement relates to such Lender’s obligation to fund a Loan hereunder and states that such position is based on such Lender’s determination that a condition precedent
to funding cannot be satisfied (which conditions precedent, together with the applicable default, if any, will be specifically identified in such writing or public statement), (c) has failed, within three Business Days after written request by the
Administrative Agent or the Borrower, to confirm in a manner satisfactory to the Administrative Agent or the Borrower, as applicable, that it will comply with its funding obligations, which request was made because of a reasonable concern by the
Administrative Agent or the Borrower that such Lender may not be able to comply with its funding obligations hereunder; provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon receipt of such
written confirmation by the Administrative Agent or the Borrower, or (d) has, or has a direct or indirect parent company that has, (i) become the subject of a proceeding under any Debtor Relief Law, (ii) had a receiver, conservator,
trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or a custodian appointed for it, or taken any action in furtherance of, or indicated its consent to, approval
of or acquiescence in any such proceeding or appointment or (iii) become the subject of a Bail-In Action; provided that a Lender shall not be a Defaulting Lender solely by virtue of the ownership
or acquisition of any equity interest in that Lender or any direct or indirect parent company thereof by a Governmental Authority unless such ownership or equity results in or provides such Lender with immunity from the jurisdiction of courts within
the United States or any other nation or from the enforcement of judgments or writs of attachment on its assets or permits such Lender (or such Governmental Authority or instrumentality) to reject, repudiate, disavow or disaffirm any contracts or
agreements made by such Lender. Any determination by the Administrative Agent that a Lender is a Defaulting Lender under any one or more of clauses (a) through (d) above, and of the effective date of such status, shall be conclusive and binding
absent manifest error, and such Lender shall be deemed to be a Defaulting Lender (subject to Section 2.20(b)) as of the date established therefor by the Administrative Agent in a written notice of such determination, which shall be delivered by
the Administrative Agent to the Borrower and each Lender promptly following such determination. 

  
 7 

 “Disqualified Stock” means any capital stock that, by its terms (or by the
terms of any security into which it is convertible or for which it is exchangeable), or upon the happening of any event, matures or is mandatorily redeemable, pursuant to a sinking fund obligation or otherwise, or redeemable at the option of the
holder thereof, in whole or in part, on or prior to the date that is ninety-one (91) days after the Maturity Date. 

“Dollar” and “$” means dollars in the lawful currency of the United States of America. 

“EEA Financial Institution” means (a) any credit institution or investment firm established in any EEA Member Country
which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution
established in an EEA Member Country which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent; 

“EEA Member Country” means any of the member states of the European Union, Iceland, Liechtenstein, and Norway. 

“EEA Resolution Authority” means any public administrative authority or any person entrusted with public administrative
authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution. 

“Effective Date” means the first date on which the conditions set forth in Section 4.02 are satisfied (or waived in
accordance with Section 8.02). 
 “Eligible Assignee” means any Person that meets the requirements to be an assignee
under Section 12.01(b)(v), (vi) and (vii) (subject to such consents, if any, as may be required under Section 12.01(b)(iii)). 

“Environmental Laws” means any and all federal, state, local and foreign statutes, laws, judicial decisions, regulations,
ordinances, rules, judgments, orders, decrees, injunctions, permits, concessions, grants, franchises, licenses and other governmental restrictions relating to (a) the protection of the environment, (b) the effect of the environment on
human health, (c) emissions, discharges or releases of pollutants, contaminants, hazardous substances or wastes into surface water, ground water or land, or (d) the manufacture, processing, distribution, use, treatment, storage, disposal,
transport or handling of pollutants, contaminants, hazardous substances or wastes or the clean-up or other remediation thereof. 

“Environmental Liability” means any liability, contingent or otherwise (including any liability for damages, cost of
environmental remediation, fines, penalties or indemnities), resulting from or based upon (a) violation of any Environmental Law, (b) the generation, use, handling, transportation, storage, treatment or disposal of any Hazardous Materials,
(c) exposure 

  
 8 

 
to any Hazardous Materials, (d) the release or threatened release of any Hazardous Materials into the environment or (e) any contract, agreement or other consensual arrangement pursuant
to which liability is assumed or imposed with respect to any of the foregoing. 
 “ERISA” means the Employee Retirement
Income Security Act of 1974, as amended from time to time, including (unless the context otherwise requires) the rules or regulations promulgated thereunder. 

“EU Bail-In Legislation Schedule” means the EU
Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time. 

“Eurocurrency Base Rate” means, subject to the implementation of a Replacement Rate in accordance with
Section 3.07(b), 
 (a)    for any Interest Period with respect to a Eurocurrency Loan (other than a LIBOR Daily
Floating Rate Loan), the rate per annum equal to the London Interbank Offered Rate administered by the ICE Benchmark Administration (or the successor thereto if the ICE Benchmark Administration is no longer making a London Interbank Offered Rate
available) (“LIBOR”) as published on the applicable Bloomberg screen page (or such other comparable commercially available source providing such quotations as may be designated by the Administrative Agent from time to time in its
reasonable discretion) at approximately 11:00 a.m., London time, two London Banking Days prior to the commencement of such Interest Period, for Dollar deposits (for delivery on the first day of such Interest Period) in the London interbank market
with a term equivalent to such Interest Period; 
 (b)    for any interest calculation with respect to an Alternate Base
Rate Loan on any date, the rate per annum equal to LIBOR, at approximately 11:00 a.m., London time determined two London Banking Days prior to such date for Dollar deposits being delivered in the London interbank market for a term of one month
commencing that day; and 
 (c)    with respect to a LIBOR Daily Floating Rate Loan, a fluctuating rate of interest,
which can change on each Business Day, equal to LIBOR, or a comparable or successor rate which is approved by the Administrative Agent, as published on the applicable Bloomberg screen page (or such other commercially available source providing such
quotations as may be designated by Bank of America from time to time) at or about 11:00 a.m. London time two (2) Business Days prior to the date in question for Dollar deposits with a term equivalent to one (1) month beginning on that
date; provided that to the extent a comparable or successor rate is approved by the Administrative Agent with the consent of the Borrower in connection herewith, the approved rate shall be applied in a manner consistent with market practice
(this clause (c), the “LIBOR Daily Floating Rate”). 
 Unless otherwise specified in any
amendment to this Agreement entered into in accordance with Section 3.07(b), in the event that a Replacement Rate with respect to LIBOR is implemented then all references herein to LIBOR shall be deemed references to such Replacement Rate. 

  
 9 

 “Eurocurrency Loan” means a Loan, or portion thereof, which, except as
otherwise provided in Section 2.11, bears interest at the applicable Eurocurrency Rate requested by the Borrower pursuant to Sections 2.08 and 2.09. 

“Eurocurrency Rate” means with respect to a Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan) for the
relevant Interest Period, the quotient of (i) the Eurocurrency Base Rate determined in accordance with clause (a) of the definition thereof applied to such Interest Period, divided by (ii) one minus the Reserve
Requirement (expressed as a decimal) applicable to such Interest Period. 
 “Excluded Taxes” means, with respect to the
Administrative Agent, any Lender, or any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder, (a) Taxes imposed on or measured by its overall net income (however denominated), franchise Taxes
imposed on it (in lieu of net income Taxes), and branch profits or similar Taxes, in each case, imposed by the jurisdiction (or any political subdivision thereof) (i) under the laws of which such recipient is organized or in which its principal
office is located or, in the case of any Lender, in which its applicable Lending Installation is located, or (ii) where the recipient otherwise has a present or former connection (other than by reason of the activities and transactions
specifically contemplated by this Agreement, including selling or assigning an interest in any Loan or Loan Document or enforcing provisions of any Loan Document), (b) any backup withholding Tax that is required by the Code to be withheld from
amounts payable to a Lender that has failed to comply with Section 3.05(e)(ii), (c) in the case of a Foreign Lender, any U.S. withholding Tax that is required to be imposed on amounts payable to such Foreign Lender (other than an assignee
pursuant to a request by the Borrower under Section 2.18) pursuant to the laws in force at the time such Foreign Lender becomes a party hereto (or designates a new Lending Installation), except to the extent that such Foreign Lender (or its
assignor, if any) was entitled, at the time of designation of a new Lending Installation (or assignment), to receive additional amounts from the Borrower with respect to such withholding Tax pursuant to Section 3.05(a)(i) or (ii), (d) in the
case of a Lender, any withholding Tax that is attributable to such Lender’s failure to comply with Section 3.05(e) and (e) any U.S. federal withholding Taxes imposed under FATCA. 

“Exhibit” refers to an exhibit to this Agreement, unless another document is specifically referenced. 

“Existing Revolving Credit Agreement” means that certain Revolving Credit Agreement, dated as of August 29, 2018, among
the Borrower, the other borrowers party thereto, the lenders and letter of credit issuers from time to time party thereto and Wells Fargo Bank, National Association, as administrative agent (as amended, restated, supplemented or otherwise modified
from time to time). 
 “Extending Lender” is defined in Section 2.02(b). 

  
 10 

 “Extension Date” is defined in Section 2.02(a). 

“Facility Termination Date” means the earlier of (a) the Maturity Date and (b) the date of termination in whole of
the Aggregate Commitment pursuant to Section 2.05 or Section 8.01 hereof. 
 “FATCA” means Sections 1471-1474 of
the Code as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with) and any regulations promulgated thereunder or official interpretations thereof, any
agreements entered into pursuant to Section 1471(b) of the Code, any intergovernmental agreements entered into in connection with the implementation of the foregoing and any laws, rules and regulations adopted by a non-U.S. jurisdiction to effect any such intergovernmental agreement. 
 “Federal Funds
Rate” means, for any day, the rate per annum equal to the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System on such day, as published by the Federal Reserve Bank of New York on
the Business Day next succeeding such day; provided that (a) if such day is not a Business Day, the Federal Funds Rate for such day shall be such rate on such transactions on the next preceding Business Day as so published on the next
succeeding Business Day, and (b) if no such rate is so published on such next succeeding Business Day, the Federal Funds Rate for such day shall be the average rate (rounded upward, if necessary, to a whole multiple of 1/100 of 1%) charged to
the Administrative Agent on such day on such transactions as determined by the Administrative Agent. 
 “Foreign Lender”
means any Lender that is not organized under the laws of the United States, any State thereof or the District of Columbia. 

“Foreign Pension Plan” means any defined benefit plan as described in Section 3(35) of ERISA for which the Borrower or
any Subsidiary is a sponsor or administrator or to which the Borrower or any Subsidiary has any liability, and which (a) is maintained or contributed to for the benefit of employees of the Borrower or any of its respective Subsidiaries,
(b) is not covered by ERISA pursuant to Section 4(b)(4) of ERISA, and (c) under applicable local law, is required to be funded through a trust or other funding vehicle (other than a trust or funding vehicle maintained exclusively by a
Governmental Authority). 
 “Fund” means any Person (other than a natural person) that is (or will be) engaged in making,
purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its business. 

“GAAP” shall mean generally accepted accounting principles in the United States of America, as in effect from time to time,
subject to the Agreement Accounting Principles. 
 “Governmental Authority” means the government of the United States or
any other nation, or of any political subdivision thereof, whether state or local, and any agency, authority, 

  
 11 

 
instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to
government (including any supra-national bodies such as the European Union or the European Central Bank). 
 “Hazardous
Materials” means all explosive or radioactive substances or wastes and all hazardous or toxic substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos-containing materials, polychlorinated
biphenyls, radon gas, infectious or medical wastes and all other substances or wastes of any nature regulated pursuant to any Environmental Law. 

“Increase Date” means the effective date of any increase in the Commitments pursuant to Section 2.01(b). 

“Indebtedness” of a Person means, without duplication, (a) the obligations of such Person (i) for borrowed money,
(ii) under or with respect to notes payable and drafts accepted which represent extensions of credit (whether or not representing obligations for borrowed money) to such Person, (iii) constituting reimbursement obligations with respect to
letters of credit issued for the account of such Person, (iv) for the deferred purchase price of property or services (other than current accounts payable arising in the ordinary course of such Person’s business payable on terms customary
in the trade), (v) for its Contingent Obligations, (vi) for its Net Mark-to-Market Exposure under Rate Management Transactions, (vii) for its Rate Management
Obligations, (viii) for its Receivables Transaction Attributed Indebtedness and (ix) with respect to Disqualified Stock, (b) the obligations of others, whether or not assumed, secured by Liens on property of such Person or payable out
of the proceeds of, or production from, property or assets now or hereafter owned or acquired by such Person and (c) any other obligation or other financial accommodation which in accordance with Agreement Accounting Principles would be shown
as a liability on the consolidated balance sheet of such Person; provided that notwithstanding anything herein to the contrary, Capitalized Leases shall not constitute Indebtedness for any purpose hereunder. 

“Indebtedness for Borrowed Money” of a Person means, without duplication, (a) indebtedness for borrowed money (whether
or not evidenced by bonds, debentures, notes or similar instruments) or for the deferred purchase price of property or services (other than current accounts payable arising in the ordinary course of such Person’s business payable on terms
customary in the trade) and (b) obligations under direct or indirect guaranties in respect of, and obligations (contingent or otherwise) to purchase or otherwise acquire, or otherwise to assure a creditor against loss in respect of,
indebtedness or obligations of any other Person of the kinds referred to in clause (a) above; provided that notwithstanding anything herein to the contrary, neither Capitalized Leases nor any obligations of the type described in clause
(b) above with respect to Capitalized Leases shall constitute Indebtedness for Borrowed Money for any purpose hereunder. 

“Indemnified Taxes” means Taxes (other than Excluded Taxes) imposed on or with respect to any payment made by or on account
of any obligation of the Borrower hereunder. 

  
 12 

 “Indemnitee” is defined in Section 9.06(b). 

“Information” is defined in Section 9.10. 

“Intangible Assets” means, at any date of determination, the value, as shown on or reflected in the most recent consolidated
balance sheet of the Borrower and its Subsidiaries as at the end of the Borrower’s fiscal quarter ending prior to such date, prepared in accordance with Agreement Accounting Principles and giving pro forma effect to any acquisition or
disposition of Property of the Borrower or any of its Subsidiaries with fair value in excess of $100,000,000 that has occurred since the end of such fiscal quarter as if such acquisition or disposition had occurred on the last day of such fiscal
quarter, of all trade names, trademarks, licenses, patents, copyrights, service marks, goodwill and other like intangibles. 

“Interest Period” means, with respect to a Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan), a period of one
week or one, two, three or six months or such other period agreed to by the Lenders and the Borrower, commencing on the Borrowing Date with respect to such Eurocurrency Loan or on the date on which a Eurocurrency Loan is continued or an Alternate
Base Rate Loan is converted into a Eurocurrency Loan. Such Interest Period shall end on but exclude the day which corresponds numerically to such date one, two, three or six months or such other agreed upon period thereafter or, in the case of an
Interest Period of one week, shall end on but exclude the day that is one week thereafter, provided, however, that if there is no such numerically corresponding day in such next, second, third or sixth succeeding month or such other
succeeding period, such Interest Period shall end on the last Business Day of such next, second, third or sixth succeeding month or such other succeeding period. If an Interest Period would otherwise end on a day which is not a Business Day, such
Interest Period shall end on the next succeeding Business Day, provided, however, that if said next succeeding Business Day falls in a new calendar month, such Interest Period shall end on the immediately preceding Business Day. 

“Judgment Currency” is defined in Section 15.06. 

“Lenders” means the Lenders listed on the Commitment Schedule as having a Commitment, any Person that becomes a
“Lender” hereunder pursuant to Section 2.01(b) or Section 2.02 and any other Person that shall have become party hereto with a Commitment pursuant to an Assignment and Assumption, other than any such Person that ceases to be a
party hereto pursuant to an Assignment and Assumption, or if the Commitments have terminated, a Lender with outstanding Loans. 

“Lending Installation” means, with respect to a Lender or the Administrative Agent, the office, branch, subsidiary or
affiliate of such Lender or Administrative Agent listed on the administrative information sheets provided to the Administrative Agent in connection herewith, or otherwise selected by such Lender or Administrative Agent pursuant to Section 2.16.

 “LIBOR” has the meaning specified in the definition of “Eurocurrency Rate”. 

  
 13 

 “LIBOR Daily Floating Rate” means a Loan that bears interest based on
clause (b) of the definition of “Eurocurrency Base Rate”. 
 “LIBOR Daily Floating Rate Loan” means a
Loan that bears interest based on the LIBOR Daily Floating Rate. 
 “LIBOR Successor Amendment” is defined in
Section 3.07(b). 
 “Lien” means any lien (statutory or other), mortgage, pledge, hypothecation, assignment, deposit
arrangement, encumbrance or preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever (including, without limitation, the interest of a vendor or lessor under any conditional sale, Capitalized
Lease or other title retention agreement). 
 “Loan” means, with respect to a Lender, such Lender’s loan made pursuant
to Section 2.01 (and any conversion or continuation thereof pursuant to Section 2.09). All Loans shall be denominated in Dollars. 

“Loan Documents” means this Agreement and any Notes issued pursuant to Section 2.13 (if requested), as the same may be
amended, restated or otherwise modified and in effect from time to time. 
 “London Banking Day” means any day on which
dealings in Dollar deposits are conducted by and between banks in the London interbank eurodollar market. 
 “Major
Subsidiary” means any Subsidiary of the Borrower (a) which is organized and existing under, or has its principal place of business in, the United States or any political subdivision thereof, Canada or any political subdivision thereof,
any country which is a member of the European Union on the Effective Date or any political subdivision thereof, or Switzerland, Norway or Australia or any of their respective political subdivisions, and (b) which has at any time total assets
(after intercompany eliminations) exceeding $7,000,000,000. 
 “Material Acquisition” means any Acquisition the aggregate
consideration therefor (including Indebtedness assumed in connection therewith, all obligations in respect of deferred purchase price (including obligations under any purchase price adjustment but excluding earnout or similar payments) and all other
consideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) exceeds $1,000,000,000. 

“Material Adverse Effect” means a material adverse effect on (a) the financial condition, results of operations,
business or Property of the Borrower and its Subsidiaries taken as a whole or (b) the rights of or remedies available to the Lenders or the Administrative Agent against the Borrower under the Loan Documents, taken as a whole. 

  
 14 

 “Maturity Date” means the date that is eighteen months following the
Effective Date, subject to the extension thereof pursuant to Section 2.02; provided that, if such date shall not be a Business Day, the Maturity Date shall be the immediately preceding Business Day. 

“Maturity Date Extension” is defined in Section 2.02(a). 

“Measurement Period” means, at any date of determination, the most recently completed period commencing on the Effective Date
or any anniversary of the Effective Date and ending on the earlier of (i) the date that is one year after the commencement of such period and (ii) the Facility Termination Date. 

“Minimum Average Percentage Utilization Fee” is defined in Section 2.05(c). 

“Moody’s” means Moody’s Investors Service, Inc. (or any successor thereto). 

“Multiemployer Plan” means a multiemployer plan as defined in Section 3(37) of ERISA that is subject to Title IV of
ERISA and is maintained pursuant to a collective bargaining agreement or any other arrangement to which the Borrower, any Subsidiary or any member of the Controlled Group is a party, and to which plan the Borrower, any Subsidiary or any member of
the Controlled Group is obligated to make contributions. 
 “Net
Mark-to-Market Exposure” of a Person means, as of any date of determination, the excess (if any) of all unrealized losses over all unrealized profits of such
Person arising from Rate Management Transactions. “Unrealized losses” means the fair market value of the cost to such Person of replacing such Rate Management Transaction as of the date of determination (assuming the Rate Management
Transaction were to be terminated as of that date), and “unrealized profits” means the fair market value of the gain to such Person of replacing such Rate Management Transaction as of the date of determination (assuming such Rate
Management Transaction were to be terminated as of that date). 
 “New Lender” is defined in Section 2.02(b). 

“Note” is defined in Section 2.13(d). 

“Obligations” means all Loans, debts, liabilities, obligations, covenants and duties owing by the Borrower to the
Administrative Agent, the Arranger, any Lender, any affiliate of the Administrative Agent, the Arranger or any Lender or any indemnitee under the provisions of Section 9.06 or any other provisions of the Loan Documents, in each case of any kind
or nature, present or future, arising under this Agreement or any other Loan Document, whether or not evidenced by any note, guaranty or other instrument, whether or not for the payment of money, whether arising by reason of an extension of credit,
loan, foreign exchange risk, guaranty, indemnification, or in any other manner, whether direct or indirect (including those acquired by assignment), absolute or contingent, due or to become due, now existing or hereafter arising and however acquired
(including, for the avoidance of doubt, interest accruing after the maturity of the Loans and interest accruing after the filing of any petition in bankruptcy, or the 

  
 15 

 
commencement of any proceeding under any Debtor Relief Law, whether or not a claim for post-filing or post-petition interest is allowed in such proceeding). The term includes, without limitation,
all interest, charges, expenses, fees, attorneys’ fees and disbursements, paralegals’ fees, and any other sum chargeable to the Borrower or any of its Subsidiaries under this Agreement or any other Loan Document. 

“OFAC” means the Office of Foreign Assets Control of the U.S. Department of the Treasury. 

“Other Taxes” means all present or future stamp, documentary, intangible, recording or filing taxes or any similar taxes,
charges or levies arising from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement or any other Loan Document, except any such Taxes that are imposed with respect to an assignment (other than an assignment made
pursuant to Section 2.18). 
 “Overnight Rate” means, for any day, the greater of (i) the Federal Funds Rate and
(ii) an overnight rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation. 

“Participant” is defined in Section 12.01(d). 

“Participant Register” is defined in Section 12.01(d). 

“Payment Date” means the last Business Day of each March, June, September and December and the Facility Termination Date.

 “PBGC” means the Pension Benefit Guaranty Corporation, or any successor thereto. 

“Person” means any natural person, corporation, firm, joint venture, partnership, limited liability company, association,
enterprise, trust or other entity or organization, or any government or political subdivision or any agency, department or instrumentality thereof. 

“Plan” means an employee benefit plan other than a Multiemployer Plan which is covered by Title IV of ERISA or subject to the
minimum funding standards under Section 412 of the Code as to which the Borrower, any Subsidiary or any member of the Controlled Group has liability. 

“Platform” is defined in Section 6.01. 

“Prime Rate” means the rate of interest in effect for such day as publicly announced from time to time by Bank of America as
its “prime rate.” The “prime rate” is a rate set by Bank of America based upon various factors including Bank of America’s costs and desired return, general economic conditions and other factors, and is used as a reference
point for pricing some loans, which may be priced at, above, or below such announced rate. Any change in such rate announced by Bank of America shall take effect at the opening of business on the day specified in the public announcement of such
change. 

  
 16 

 “Pro Rata Share” means, with respect to a Lender, if the Aggregate
Commitment has not been terminated, a portion equal to a fraction the numerator of which is such Lender’s Commitment at such time (in each case, as adjusted from time to time in accordance with the provisions of this Agreement) and the
denominator of which is the Aggregate Commitment at such time, or, if the Aggregate Commitment has been terminated, a portion equal to a fraction the numerator of which is the aggregate outstanding principal amount of such Lender’s Loans at
such time and the denominator of which is the aggregate outstanding principal amount of all Lenders’ Loans at such time. 

“Property” of a Person means any and all property, whether real, personal, tangible, intangible, or mixed, of such Person, or
other assets owned, leased or operated by such Person. 
 “PTE” means a prohibited transaction class exemption issued by
the U.S. Department of Labor, as any such exemption may be amended from time to time. 
 “Public Lender” is defined in
Section 6.01. 
 “Qualified Receivables Transaction” means any transaction or series of transactions that may be
entered into by the Borrower or any Subsidiary pursuant to which the Borrower or any Subsidiary may sell, convey or otherwise transfer to a newly-formed Subsidiary or other special-purpose entity, or any other Person, any accounts or notes
receivable and rights related thereto. 
 “Rate Management Obligations” of a Person means any and all obligations of such
Person, whether absolute or contingent and howsoever and whensoever created, arising, evidenced or acquired (including all renewals, extensions and modifications thereof and substitutions therefor), under (a) any and all Rate Management
Transactions, and (b) any and all cancellations, buy backs, reversals, terminations or assignments of any Rate Management Transactions. 

“Rate Management Transaction” means any transaction (including an agreement with respect thereto) now existing or hereafter
entered into between the Borrower and any Lender or Affiliate thereof which is a rate swap, basis swap, forward rate transaction, commodity swap, commodity option, equity or equity index swap, equity or equity index option, bond option, interest
rate option, foreign exchange transaction, cap transaction, floor transaction, collar transaction, forward transaction, currency swap transaction, cross-currency rate swap transaction, currency option or any other similar transaction (including any
option with respect to any of these transactions) or any combination thereof, whether linked to one or more interest rates, foreign currencies, commodity prices, equity prices or other financial measures. 

“Receivables Transaction Attributed Indebtedness” means the amount of obligations outstanding under the legal documents
entered into as part of any Qualified Receivables 

  
 17 

 
Transaction on any date of determination that would be characterized as principal if such Qualified Receivables Transactions were structured as a secured lending transaction rather than as a
purchase. 
 “Register” is defined in Section 12.01(c). 

“Regulation D” means Regulation D of the Board of Governors of the Federal Reserve System as from time to time in effect and
any successor thereto or other regulation or official interpretation of said Board of Governors. 
 “Regulation U” means
Regulation U of the Board of Governors of the Federal Reserve System as from time to time in effect and any successor or other regulation or official interpretation of said Board of Governors. 

“Regulation X” means Regulation X of the Board of Governors of the Federal Reserve System as from time to time in effect and
any successor or other regulation or official interpretation of said Board of Governors. 
 “Related Parties” means, with
respect to any Person, such Person’s Affiliates and the partners, members, directors, officers, employees, agents and controlling persons of such Person and of such Person’s Affiliates. 

“Replacement Rate” is defined in Section 3.07(b). 

“Reportable Event” means a reportable event, as defined in Section 4043 of ERISA and the regulations issued under such
section, with respect to a Plan, excluding, however, such events as to which the PBGC has by regulation or otherwise waived the requirement of Section 4043(a) of ERISA that it be notified within thirty (30) days of the occurrence of such
event, provided, however, that a failure to meet the minimum funding standard of Section 412 of the Code and of Section 302 of ERISA shall be a Reportable Event regardless of the issuance of any such waiver of the notice
requirement in accordance with either Section 4043(a) of ERISA or Section 412(c) of the Code. 
 “Required
Lenders” means, on any date of determination, Lenders in the aggregate having greater than fifty percent (50%) of the Aggregate Commitment or, if the Aggregate Commitment has been terminated, the aggregate outstanding principal amount of
all Loans on such date; provided that the Commitments of, and the portion of the aggregate outstanding Loans held or deemed held by, any Defaulting Lender shall be excluded for purposes of making a determination of Required Lenders. 

“Requisite Amount” means $250,000,000. 

“Reserve Requirement” means, with respect to an Interest Period, the maximum aggregate reserve requirement (including all
basic, supplemental, marginal and other reserves) which is imposed under Regulation D on “Eurocurrency liabilities” (as defined in Regulation D). 

  
 18 

 “Revolving Facility” means the revolving facility provided hereunder and
evidenced by the Commitments and Loans. 
 “S&P” means Standard & Poor’s Financial Services LLC, a
subsidiary of S&P Global Inc. (or any successor thereto). 
 “Same Day Funds” means immediately available funds.

 “Sanctions” means sanctions administered by OFAC (including by being listed on the list of Specially Designated
Nationals and Blocked Persons issued by OFAC) or the U.S. Department of State. 
 “Schedule” refers to a specific schedule
to this Agreement, unless another document is specifically referenced. 
 “Scheduled Unavailability Date” is defined in
Section 3.07(b). 
 “SEC” means the Securities and Exchange Commission, or any Governmental Authority succeeding to
any of its principal functions. 
 “Section” means a numbered section of this Agreement, unless another document is
specifically referenced. 
 “Signing Date” means the first date on which the conditions set forth in Section 4.01 are
satisfied (or waived in accordance with Section 8.02). 
 “Subsidiary” of a Person means (a) any corporation more
than fifty percent (50%) of the outstanding securities having ordinary voting power of which shall at the time be owned or controlled, directly or indirectly, by such Person or by one or more of its Subsidiaries or by such Person and one or more of
its Subsidiaries, or (b) any partnership, limited liability company, association, joint venture or similar business organization more than fifty percent (50%) of the ownership interests having ordinary voting power of which shall at the time be
so owned or controlled. Unless otherwise expressly provided, all references herein to a “Subsidiary” shall mean a Subsidiary of the Borrower. 

“Substantial Portion” means, on any date of determination, with respect to the Property of the Borrower and its Subsidiaries,
Property which represents more than fifteen percent (15%) of the Consolidated Assets of the Borrower and its Subsidiaries on such date. 

“Taxes” means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding),
assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto. 

“Total Capitalization” means Consolidated Debt plus Consolidated Net Worth. 

  
 19 

 “Total Tangible Assets” means, at any date of determination, Consolidated
Assets less the sum of (i) Intangible Assets and (ii) the amount of Capitalized Leases included as assets on the consolidated balance sheet of the Borrower and its Subsidiaries as at the end of the Borrower’s fiscal
quarter ending prior to such date. 
 “Transferee” is defined in Section 12.02. 

“Type” means, with respect to any Loan, its nature as an Alternate Base Rate Loan or a Eurocurrency Loan (including a LIBOR
Daily Floating Rate Loan), as applicable. 
 “U.S. Patriot Act” means the Uniting and Strengthening America by Providing
Appropriate Tools Required to Intercept and Obstruct Terrorism Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), as amended. 

“Unfunded Liabilities” means the amount (if any) by which the present value of all vested and unvested accrued benefits under
all Plans exceeds the fair market value of all such Plan assets allocable to such benefits, all determined as of the then most recent valuation date for such Plans using PBGC actuarial assumptions for single employer plan terminations. 

“Unmatured Default” means an event which but for the lapse of time or the giving of notice, or both, would constitute a
Default. 
 “Upfront Fee” is defined in Section 2.05(b). 

“Write-Down and Conversion Powers” means, with respect to any EEA Resolution Authority, the write-down and conversion powers
of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule. 
 The foregoing definitions shall be equally applicable to both the
singular and plural forms of the defined terms. 
 Any accounting terms used in this Agreement which are not specifically defined herein
shall have the meanings customarily given them in accordance with Agreement Accounting Principles. 

Section 1.02    References. Any references to the Borrower’s Subsidiaries
shall not in any way be construed as consent by the Administrative Agent or any Lender to the establishment, maintenance or acquisition of any Subsidiary, except as may otherwise be permitted hereunder. 

Section 1.03    Eurocurrency Rate. The Administrative Agent does not
warrant, nor accept responsibility, nor shall the Administrative Agent have any liability with respect to the administration, submission or any other matter related to the rates in the definition of “Eurocurrency Rate” or with respect to
any comparable or successor rate thereto. 

  
 20 

 ARTICLE II 

THE CREDITS 

Section 2.01    Description of Facility; Commitments. (a) From and
including the Effective Date and prior to the Facility Termination Date, upon the satisfaction of the conditions precedent set forth in Section 4.03, each Lender severally and not jointly agrees, on the terms and conditions set forth in this
Agreement, to make Loans in Dollars to the Borrower from time to time in amounts not to exceed in the aggregate at any one time outstanding its Pro Rata Share of the Aggregate Commitment; provided that after giving effect to such Loans,
(a) the aggregate principal amount of all Lenders’ Loans outstanding at such time, after giving effect to any borrowings and prepayments or repayments of any Loans occurring on such date, shall not exceed the Aggregate Commitment at
such time and (b) with respect to any Lender, the aggregate principal amount of such Lender’s Loans outstanding at such time, after giving effect to any borrowings and prepayments or repayments of any Loans occurring on such
date, shall not exceed such Lender’s Commitment at such time. Subject to the terms of this Agreement, the Borrower may borrow, repay and reborrow Loans at any time prior to the Facility Termination Date. Each Borrowing of Loans shall be
in a minimum aggregate amount of $10,000,000 or any integral multiple of $1,000,000 in excess thereof (or, if less, the unused Aggregate Commitment as of such date). The Commitments to lend hereunder shall expire automatically on the Facility
Termination Date. Each Loan shall be made by each Lender in accordance with such Lender’s Pro Rata Share of the Aggregate Commitment. 

(b)    The Borrower may at any time from time to time, upon prior written notice by the Borrower to the Administrative
Agent, increase the Commitments by a maximum aggregate amount of up to Five Hundred Million Dollars ($500,000,000) with additional Commitments from any existing Lenders and/or with new Commitments from any other Person selected by the Borrower and
reasonably acceptable to the Administrative Agent; provided that: 
 (i)    any such increase
shall be in a minimum principal amount of $10,000,000 and in integral multiples of $1,000,000 in excess thereof; 

(ii)    no Default or Unmatured Default shall exist and be continuing at the time of any such increase;

 (iii)    no existing Lender shall be under any obligation to increase its Commitment and any such
decision whether to increase its Commitment shall be in such Lender’s sole and absolute discretion; 

(iv)    (A) any new Lender shall join this Agreement by executing such joinder documents required by the
Administrative Agent and/or (B) any existing Lender electing to increase its Commitment shall have executed a commitment agreement reasonably satisfactory to the Administrative Agent; and 

(v)    as a condition precedent to such increase, the Borrower shall (x) deliver to the Administrative
Agent a certificate dated as of the date of such increase 

  
 21 

 
signed by an Authorized Officer of the Borrower (A) certifying and attaching the resolutions adopted by the Borrower approving or consenting to such increase, and (B) certifying that,
before and after giving effect to such increase, (1) the representations and warranties contained in Article V are true and correct in all material respects (except to the extent such representations and warranties are qualified with
“materiality” or “Material Adverse Effect” or similar terms, in which case such representations and warranties shall be true and correct in all respects) on and as of the date of such increase, except to the extent that such
representations and warranties specifically refer to an earlier date, in which case they are true and correct in all material respects (except to the extent such representations and warranties are qualified with “materiality” or
“Material Adverse Effect” or similar terms, in which case such representations and warranties shall be true and correct in all respects) on and as of such earlier date and (2) no Default or Unmatured Default exists immediately before
or after giving effect to the incurrence of such increase and (y) pay any applicable fee related to such increase (including, without limitation, any applicable arrangement, upfront and/or administrative fee). 

In connection with the effectiveness of any increase under this Section 2.01(b), (x) the Commitment Schedule shall be deemed amended to
reflect such increase and the updated Commitments and Pro Rata Shares of the Lenders, (y) the Administrative Agent shall promptly notify the Borrower and the Lenders of the updated Commitment Schedule and (z) to the extent necessary to
keep any outstanding Loans allocated ratably to the Lenders in accordance with their updated Pro Rata Shares, the Borrower shall (or shall cause the applicable Borrower to) prepay (or, if the Administrative Agent determines in its sole discretion
that a re-allocation of the Loans can be accomplished without any cash prepayments or new cash Loans by the Lenders, be deemed to have prepaid) any Loans owing by it (or such Borrower, as applicable) and
outstanding on the date of any such increase (and pay any additional amounts required pursuant to Section 3.04). The provisions of this Section 2.01(b) involving non-pro rata allocations, prepayments
and Loans shall supersede any provisions in Sections 2.19 or 8.02 to the contrary. 

Section 2.02    Extension of Maturity Date. 

(a)    The Borrower may extend the Maturity Date with respect to the Revolving Facility for an additional period of one
year or eighteen months (a “Maturity Date Extension”) by providing written notice of such request to the Administrative Agent not more than 60 days and not less than 30 days prior to Maturity Date then in effect (such anniversary of
the Maturity Date, the “Extension Date”). The Administrative Agent shall promptly notify each Lender of such request and each Lender shall then, in its sole discretion, notify the Borrower and the Administrative Agent in writing
within 10 Business Days after such request whether such Lender will consent to the extension (each such Lender consenting to the applicable extension, a “Consenting Lender”). The failure of any Lender to notify the Borrower and the
Administrative Agent of its intent to consent to an extension shall be deemed a rejection by such Lender, as applicable. Such extension shall be effective as to Consenting Lenders under the Revolving Facility consenting to such extension if the
Required Lenders approve such Maturity Date Extension; provided, in each case, that (A) the Maturity Date following any such extension shall 

  
 22 

 
not be a date that is more than eighteen months after the applicable Extension Date and (B) at the existing Maturity Date in effect prior to each Maturity Date Extension, (1) the
commitments of Lenders that did not consent to such Maturity Date Extension (each such Lender not consenting to the extension, a “Declining Lender”) will be terminated and the Loans of such Lenders will be repaid (it being
understood that the commitments of the Declining Lenders not consenting to such extension will remain in effect until the Maturity Date originally applicable to such Lenders) and (2) the Borrower shall make such additional prepayments as shall
be necessary in order that the Loans hereunder immediately after such existing Maturity Date will not exceed, respectively, the Aggregate Commitments. 

(b)    The consent of Declining Lenders will not be required provided that Consenting Lenders constituting the Required
Lenders have approved such Maturity Date Extension; provided that the Borrower shall have the right, at any time prior to the existing Maturity Date, to obtain the signatures of the Required Lenders by replacing Declining Lenders with
Consenting Lenders willing (in their sole discretion) to increase their existing commitments (each such Lender, an “Extending Lender”), or other financial institutions willing (in their sole discretion) to become Lenders and extend
new commitments, on terms consistent with Section 2.17 (each such Lender, a “New Lender”), in each case on the existing Maturity Date. If any Lender rejects, or is deemed to have rejected, the Borrower’s request for an
extension, the Borrower may replace Declining Lenders with Extending Lenders or New Lenders, in each case on the existing Maturity Date. In connection with any such replacement pursuant to this clause (b), the Administrative Agent shall enter in the
Register (A) the names of any New Lenders, (B) the Maturity Date applicable to each Lender and (C) the respective allocations of any Declining Lenders, Consenting Lenders, Extending Lenders and New Lenders effective as of the Maturity
Date applicable thereto. No action by or consent of any Declining Lender shall be necessary in connection with such assignment. In connection with any such assignment, the Borrower, Administrative Agent, such Declining Lender and the replacement
Lender shall otherwise comply with Section 12.01; provided that if such Declining Lender does not comply with Section 12.01 within five (5) Business Days after the Borrower’s request, compliance with Section 12.01
(but only on the part of the Declining Lender) shall not be required to effect such assignment. 
 (c)    If any
financial institution or other entity becomes a New Lender or any Extending Lender’s Commitment is increased pursuant to Section 2.02(b), (x) Loans made on or after the existing Maturity Date shall be made in accordance with
Section 2.01(a) or (b), as applicable, based on the respective Commitments in effect on and after the existing Maturity Date and (y) if, on the date of such joinder or increase, there are any Loans outstanding, such Loans shall on or prior
to such date be prepaid from the proceeds of new Loans made hereunder (reflecting such additional Lender or increase), which prepayment shall be accompanied by accrued interest on the applicable Loans being prepaid and any costs incurred by any
Lender in accordance with Section 3.04. 
 (d)    Each such Maturity Date Extension will not be effective as to any
Lender unless (a) no Default or Unmatured Default shall have occurred and be continuing on or as of the date of such extension and (b) all representations and warranties of the Borrower set forth in Article V

  
 23 

 
shall be true and correct in all material respects (except to the extent such representations and warranties are qualified by “materiality” or “Material Adverse Effect” or
similar terms, in which case such representations and warranties shall be true and correct in all respects) as if made on and as of the date of such extension, except to the extent a representation or warranty is stated to relate solely to an
earlier date, in which case the representation or warranty shall be true and correct in all material respects (except to the extent such representations and warranties are qualified with “materiality” or “Material Adverse Effect”
or similar terms, in which case such representations and warranties shall be true and correct in all respects) on and as such earlier date. 

(e)    The Administrative Agent shall promptly notify the Lenders of the effectiveness of each extension pursuant to this
Section 2.02. 
 Section 2.03    Reserved. 

Section 2.04    Types of Loans. The Loans may consist of Alternate
Base Rate Loans or Eurocurrency Loans, or a combination thereof, selected by the Borrower in accordance with Sections 2.08 and 2.09. 

Section 2.05    Fees; Reductions in Aggregate Commitment.
(a) Commitment Fee. The Borrower agrees to pay to the Administrative Agent for the account of each Lender a commitment fee in Dollars (the “Commitment Fee”) at a per annum rate equal to the Commitment Fee Rate on the
daily actual excess of such Lender’s Commitment over the outstanding principal amount of such Lender’s outstanding Loans (such excess, such Lender’s “Actual Unused Commitments”) as adjusted pursuant to
Section 2.05(d), accruing from and including the Effective Date to and including the date on which the Commitments have been terminated in full and all Obligations hereunder have been paid in full pursuant to Section 2.07(b), payable
quarterly in arrears on each Payment Date; provided that no Commitment Fee shall accrue hereunder with respect to the Actual Unused Commitment of a Defaulting Lender so long as such Lender shall be a Defaulting Lender. 

(b)    Upfront Fee. The Borrower agrees to pay to the Administrative Agent for the account of each Lender an
upfront fee (an “Upfront Fee”) in Dollars in an amount equal to [    ]% of the aggregate outstanding Commitments of such Lender then outstanding on the Effective Date immediately prior to giving effect to any
Loans made hereunder on such date. The Upfront Fee shall be earned, due and payable on the Effective Date. 

(c)    Minimum Average Percentage Utilization Fee. The Borrower agrees to pay to the Administrative Agent for the
account of each Lender in accordance with its Pro Rata Share of the Aggregate Commitment (subject to clause (y) of the proviso below), a minimum average percentage utilization fee (a “Minimum Average Percentage Utilization
Fee”) in Dollars in an amount equal to: (i) for any Measurement Period during which the Average Percentage Utilization is greater than or equal to 75%, $0 and (ii) for any Measurement Period during which the Average Percentage
Utilization is less than 75%, a dollar amount equal to the product of (a) the average amount of the aggregate Commitments outstanding on each day during such period 

  
 24 

 
as adjusted pursuant to Section 2.05(d), (b) 75% less the Average Percentage Utilization for such period and (c) the Applicable Eurocurrency Margin minus the Commitment
Fee Rate. The Minimum Average Percentage Utilization Fee shall accrue during each Measurement Period and shall be payable three (3) Business Days after the last day of such Measurement Period (unless such last day is the Facility Termination
Date, in which case they shall be payable on the Facility Termination Date); provided that (x) no Minimum Average Percentage Utilization Fee shall accrue hereunder with respect to a Defaulting Lender so long as such Lender shall be a
Defaulting Lender and (y) if a Commitment increase has occurred during the applicable Measurement Period pursuant to Section 2.01(b) or otherwise, the Administrative Agent shall allocate to each Lender its share of the Minimum Average
Percentage Utilization Fee based on such the weighted average amount of such Lender’s Commitment during the such Measurement Period. 

(d)    Voluntary Reductions in Aggregate Commitment. The Borrower shall have the right, upon same day written
notice to the Administrative Agent delivered prior to 11:00 a.m. (New York time) on any Business Day, to terminate in whole or reduce in part the unused portions of the Commitments of the Lenders at the election of the Borrower. Each partial
reduction of the Commitments shall be in the aggregate amount of $10,000,000 or an integral multiple of $1,000,000 in excess thereof and, once terminated, a Commitment may not be reinstated. The Administrative Agent will promptly notify the Lenders
of any termination or reduction of the Commitments under this Section 2.05(d). Each voluntary reduction of the Commitments pursuant to this Section 2.05(d) will be applied to the outstanding Commitments of each Lender in accordance with
such Lender’s Pro Rata Share of the Revolving Facility. All fees in respect of the Commitments (including any Commitment Fees) accrued until the effective date of any termination of such Commitments shall be paid on the effective date of such
termination. For the avoidance of doubt, the Borrower shall not be permitted to terminate in whole or reduce in part the Commitments to the extent that, after giving effect to such termination, the then outstanding amount of Loans would exceed the
Aggregate Commitment. 
 (e)    Automatic Reductions in Commitments. The Aggregate Commitment shall terminate on
the Facility Termination Date. 
 Section 2.06    [Reserved]. 

Section 2.07    Prepayments and Repayments. 

(a)    Optional Prepayments. The Borrower may from time to time pay, without penalty or premium, all of its
outstanding Alternate Base Rate Loans, or, in a minimum aggregate amount of $10,000,000 or any integral multiple of $1,000,000 in excess thereof, any portion of its outstanding Alternate Base Rate Loans upon prior notice to the Administrative Agent
(which may be in a form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent) (stating the proposed date and aggregate principal amount of the applicable prepayment) at or before 1:00 p.m. (New
York time) on the date of such payment. The Borrower may from time to time pay, subject to the payment of any funding indemnification amounts required by Section 3.04 but without penalty or premium, all of

  
 25 

 
its outstanding Eurocurrency Loans, or, in a minimum aggregate amount of $10,000,000 or any integral multiple of $1,000,000 in excess thereof, any portion of its outstanding Eurocurrency Loans
upon prior notice to the Administrative Agent (stating the proposed date and aggregate principal amount of the applicable prepayment) at or before (i) in the case of LIBOR Daily Floating Rate Loans, 1:00 p.m. (New York time) at least one
(1) Business Day prior to the date of such payment or (ii) in the case of any Eurocurrency Loan other than LIBOR Daily Floating Rate Loans, (a) in the event that Bank of America, N.A. is the sole Lender under the Revolving Facility on
the date of delivery of the applicable notice, at or before 1:00 p.m. (New York time) at least two (2) Business Days prior to the date of such payment and (b) in the event more than one Person is a Lender under the Revolving Facility on
the date of delivery of the applicable notice, with the consent of the Administrative Agent (such consent not the unreasonably withheld or delayed) at or before 1:00 p.m. (New York time) at least two (2) Business Days prior to the date of such
payment, but in no event shall such notice period be longer than three (3) Business Days (or, in each case, subject to the payment of any funding indemnification amounts, if any, required by Section 3.04, such other prior notice as the
Administrative Agent may agree to). Subject to Section 2.20, each such prepayment shall be applied to the Loans outstanding at the direction of the Borrower and will be applied to the outstanding Loans of each Lender in accordance with such
Lender’s Pro Rata Share of the Revolving Facility. 
 (b)    Repayments. The Borrower shall pay any unpaid
principal of and accrued and unpaid Obligations on or relating to the Loans in full on the Facility Termination Date. This Agreement shall terminate on the earlier to occur of (i) the Facility Termination Date and (ii) if the Effective
Date has not occurred by such date, February 15, 2019. Notwithstanding any such termination, until all of the Obligations (other than contingent indemnity obligations) shall have been fully paid and satisfied and all financing arrangements
among the Borrower and the Lenders hereunder and under the other Loan Documents shall have been terminated, all of the rights and remedies under this Agreement and the other Loan Documents shall survive. 

Section 2.08    Method of Selecting Types and Interest Periods for New Loans. The Borrower shall select
the Type of Borrowing and, in the case of each Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan), the Interest Period applicable thereto from time to time. The Borrower shall give the Administrative Agent notice (which notice may be
conditioned on the satisfaction or waiver (in accordance with Section 8.02) of the conditions set forth in Section 4.03) by a borrowing notice substantially in the form of Exhibit D or such other form as may be approved by the Administrative
Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), in each case appropriately completed and signed by an Authorized Officer of the Borrower (a “Borrowing
Notice”); provided that each such Borrowing Notice must be received no later than (i) 11:00 a.m. (New York time) on the date of the proposed borrowing of each Alternate Base Rate Loan or LIBOR Daily Floating Rate Loan,
(ii) in the event that Bank of America, N.A. is the sole Lender under the Revolving Facility on the date of delivery of the applicable Borrowing Notice, 11:00 a.m. (New York time) two (2) Business Days before the date of the proposed
borrowing of each Eurocurrency Loan (other than any LIBOR Daily Floating Rate Loan) and (iii) in the event more than one Person is a Lender under the Revolving Facility on the date of 

  
 26 

 
delivery of the applicable Borrowing Notice, with the consent of the Administrative Agent (such consent not the unreasonably withheld or delayed), 11:00 a.m. (New York time) two (2) Business
Days before the date of the proposed borrowing of each Eurocurrency Loan (other than any LIBOR Daily Floating Rate Loan), but in no event shall such notice period be longer than three (3) Business Days. A Borrowing Notice shall specify: 

(a)    the date of the proposed borrowing, which shall be a Business Day, of such Loans, 

(b)    the aggregate amount of the Loans comprising the proposed borrowing (which Loan shall be in a minimum aggregate
principal amount of $10,000,000 or any integral multiple of $1,000,000 in excess thereof (or, if less, the remaining Aggregate Commitment as of such date)), 

(c)    the Type of Borrowing selected (including whether such Borrowing will consist of LIBOR Daily Floating Rate Loans),
and 
 (d)    in the case of a proposed borrowing comprised of Eurocurrency Loans (other than LIBOR Daily Floating Rate
Loans), the Interest Period applicable thereto. 
 The location and number of the Borrower’s account to which proceeds of the Loans are
to be disbursed shall be set forth in written settlement instructions executed by two Authorized Officers of the Borrower (neither of which shall hold the title of Vice President, Global Treasury) and the Administrative Agent shall have confirmed
such location and number of the Borrower’s account to which proceeds of a Loan are to be disbursed orally by telephone. Any change to the location and number of the Borrower’s account to which proceeds of a Loan are to be disbursed shall
be set forth in written settlement instructions executed by two Authorized Officers of the Borrower (neither of which shall hold the title of Vice President, Global Treasury) and the Administrative Agent shall have confirmed such change to the
location and number of the Borrower’s account to which proceeds of a Loan are to be disbursed orally by telephone. 
 No more than ten
(10) Interest Periods shall be in effect at any time (unless such limit has been waived by the Administrative Agent in its sole discretion). 

Section 2.09    Conversion and Continuation of Outstanding Loans. Alternate Base Rate Loans shall
continue as Alternate Base Rate Loans unless and until such Alternate Base Rate Loans are converted into Eurocurrency Loans pursuant to this Section 2.09 or are prepaid or repaid in accordance with Section 2.07. LIBOR Daily Floating Rate
Loans shall continue as LIBOR Daily Floating Rate Loans unless and until such LIBOR Daily Floating Rate Loans are converted into Alternate Base Rate Loans or Eurocurrency Loans (other than LIBOR Daily Floating Rate Loans) pursuant to this
Section 2.09 or are prepaid or repaid in accordance with Section 2.07. Each Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan) shall continue as a Eurocurrency Loan until the end of the then applicable Interest Period
therefor, at which time such Eurocurrency Loan shall be automatically converted into an Alternate Base 

  
 27 

 
Rate Loan, unless (x) such Eurocurrency Loan is or was repaid in accordance with Section 2.07 or (y) the Borrower shall have given the Administrative Agent a Conversion/Continuation
Notice (as defined below) requesting that, at the end of such Interest Period, such Eurocurrency Loan continue as a Eurocurrency Loan for the same or another Interest Period. The Borrower may elect from time to time to convert all or any part of an
Alternate Base Rate Loan into a Eurocurrency Loan or all or any part of a LIBOR Daily Floating Rate Loan into an Alternate Base Rate Loan or a Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan). Notwithstanding anything to the contrary
contained in this Section 2.09, (except with the consent of the Required Lenders) when any Default has occurred and is continuing each Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan) shall be continued as a Loan with an Interest
Period not longer than one month. The Borrower shall give the Administrative Agent notice by a notice substantially in the form of Exhibit E or such other form as may be approved by the Administrative Agent (including any form on an electronic
platform or electronic transmission system as shall be approved by the Administrative Agent), in each case appropriately completed and signed by an Authorized Officer of the Borrower (a “Conversion/Continuation Notice”) of each
conversion of an Alternate Base Rate Loan into a Eurocurrency Loan, a LIBOR Daily Floating Rate Loan into a Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan), a conversion of a LIBOR Daily Floating Rate Loan into a Eurocurrency Loan
(other than a LIBOR Daily Floating Rate Loan) or a continuation of a Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan), with each such Conversion/Continuation Notice to be received not later than (i) in the event that Bank of
America, N.A. is the sole Lender under the Revolving Facility on the date of delivery of the applicable Conversion/Continuation Notice, 11:00 a.m. (New York time) at least two (2) Business Days prior to the date of the requested conversion or
continuation and (ii) in the event more than one Person is a Lender under the Revolving Facility on the date of delivery of the applicable Conversion/Continuation Notice, with the consent of the Administrative Agent (such consent not the
unreasonably withheld or delayed) 11:00 a.m. (New York time) at least two (2) Business Days prior to the date of the requested conversion or continuation, but in no event shall such notice period be longer than three (3) Business Days,
specifying: 
 (a)    the requested date, which shall be a Business Day, of such conversion or continuation, 

(b)    the aggregate amount and Type (including whether such Loan is a LIBOR Daily Floating Rate Loan) of the Loan which
is to be converted or continued as a Eurocurrency Loan, and 
 (c)    other than with respect to LIBOR Daily Floating
Rate Loans, the duration of the Interest Period applicable thereto. 
 Section 2.10    Interest
Rates. Each Alternate Base Rate Loan and LIBOR Daily Floating Rate Loan shall bear interest on the outstanding principal amount thereof, for each day from and including the date such Loan is made or is converted from a Eurocurrency Loan (other
than a LIBOR Daily Floating Rate Loan) into an Alternate Base Rate Loan or a LIBOR Daily 

  
 28 

 
Floating Rate Loan, as applicable, pursuant to Section 2.09 hereof, to but excluding the date it is paid or is converted into a Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan)
pursuant to Section 2.09 hereof, at a rate per annum equal to (i) in the case of Alternate Base Rate Loans, the Alternate Base Rate plus the Applicable Margin for such day and (ii) in the case of LIBOR Daily Floating Rate Loans, the LIBOR
Daily Floating Rate plus the Applicable Margin. Changes in the rate of interest on that portion of any Loan maintained as an Alternate Base Rate Loan or a LIBOR Daily Floating Rate Loan will take effect simultaneously with each change in the
Alternate Base Rate or the LIBOR Daily Floating Rate, as applicable. Each Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan) shall bear interest on the outstanding principal amount thereof, for each day from and including the first day
of the Interest Period applicable thereto to (but not including) the last day of such Interest Period at the Eurocurrency Rate determined pursuant to clause (a) of the definition thereof for the applicable period plus the Applicable Margin. No
Interest Period may end after the Maturity Date. 
 Section 2.11    Rates Applicable After Default.
During the continuance of a Default under Section 7.02 the Required Lenders may, at their option, by notice to the Borrower (which notice may be revoked at the option of the Required Lenders notwithstanding any provision of Section 8.02
requiring unanimous consent of the Lenders to changes in interest rates, and which election and notice shall not be required after a Default or Unmatured Default under Section 7.05 or 7.06), declare that interest on the overdue amount of the
Loans shall be payable at a rate (after as well as before the commencement of any proceeding under any Debtor Relief Laws) equal to 2% per annum in excess of the rate otherwise payable thereon (and, with respect to any other overdue amounts,
shall bear interest at a rate equal to the Alternate Base Rate plus the Applicable Margin applicable to Alternate Base Rate Loans plus 2% per annum) commencing on the date of such Default and continuing until such Default is cured
or waived. 
 Section 2.12    Method of Payment. Except as otherwise specified herein, all payments
by the Borrower of principal, interest, fees and its other Obligations shall be made in Dollars. All payments of the Obligations hereunder shall be made, without setoff, deduction, or counterclaim, in immediately available funds to the
Administrative Agent at the Administrative Agent’s address specified pursuant to Article XIII, or at any other Lending Installation of the Administrative Agent specified in writing by the Administrative Agent to the Borrower, by 2:00 p.m. (New
York time) on the date when due and shall be applied ratably by the Administrative Agent among the Lenders entitled thereto. Each payment delivered to the Administrative Agent for the account of any Lender shall be delivered promptly by the
Administrative Agent to such Lender in the same type of funds that the Administrative Agent received at such Lender’s address specified pursuant to Article XIII or at any Lending Installation specified in a notice received by the Administrative
Agent from such Lender. 
 Section 2.13    Noteless Agreement; Evidence of Indebtedness.
(a) Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of the Borrower to such Lender resulting from each Loan made by such Lender to the Borrower from time to time, including the
amounts of principal and interest payable and paid to such Lender from time to time hereunder. 

  
 29 

 (b)    The Administrative Agent shall also maintain accounts in which it
will record (A) the date and the amount of each Loan made hereunder, the Type thereof and the Interest Period applicable thereto, (B) the amount of any principal or interest due and payable or to become due and payable from the Borrower to
each Lender hereunder, (C) the effective date and amount of each Assignment and Assumption delivered to and accepted by it and the parties thereto pursuant to Section 12.01, (D) the amount of any sum received by the Administrative Agent
hereunder from the Borrower and each Lender’s share thereof, and (E) all other appropriate debits and credits as provided in this Agreement, including, without limitation, all fees, charges, expenses and interest. In the event of any
conflict between the accounts and records maintained by the Administrative Agent and the accounts and records of any Lender in respect of such matters, the accounts and records of the Administrative Agent shall control absent manifest error. 

(c)    The entries maintained in the accounts maintained pursuant to clauses (a) and (b) above shall be prima
facie evidence of the existence and amounts of the Obligations therein recorded; provided, however, that the failure of the Administrative Agent or any Lender to maintain such accounts or any error therein shall not in any manner
affect the obligation of the Borrower to repay its Obligations in accordance with their terms. 
 (d)    Any Lender may
request that the Loans made or to be made by it be evidenced by a promissory note in substantially the form of Exhibit C (each, a “Note”). In such event, the Borrower shall prepare, execute and deliver to such Lender
such Note or Notes payable to such Lender (or its registered assigns). Thereafter, the Loans evidenced by each such Note and interest thereon shall at all times (including after any assignment pursuant to Section 12.01) be represented by one or more
Notes payable to the payee named therein or any assignee pursuant to Section 12.01, except to the extent that any such Lender or assignee subsequently returns any such Note for cancellation and requests that such Loans once again be evidenced as
described in clauses (a) and (b) above. 
 Section 2.14    Interest Payment Dates; Interest and Fee
Basis. Interest accrued on each Alternate Base Rate Loan and each LIBOR Daily Floating Rate shall be payable in arrears on each Payment Date, commencing with the first such date to occur after the Borrowing Date with respect to such Alternate
Base Rate Loan or LIBOR Daily Floating Rate Loan, as applicable, and on any date on which the Alternate Base Rate Loan or LIBOR Daily Floating Rate Loan, as applicable, is prepaid, whether due to acceleration or otherwise. Interest accrued on each
Eurocurrency Loan (other than LIBOR Daily Floating Rate Loans) shall be payable on the last day of its applicable Interest Period and on any date on which such Eurocurrency Loan is prepaid, whether by acceleration or otherwise, and on the Facility
Termination Date. Interest accrued on each Eurocurrency Loan having an Interest Period longer than three (3) months shall also be payable on the last day of each three-month interval during such Interest Period. Interest accrued pursuant to
Section 2.11 shall be payable on demand. With respect to (a) interest on all Loans (other than Alternate Base Rate Loans where the interest is based on the Alternate Base Rate), Commitment Fees and other fees hereunder, such interest or fees
shall be calculated for actual days elapsed on the basis of a 360-day year and (b) interest on Loans which are Alternate 

  
 30 

 
Base Rate Loans where the interest is based on the Alternate Base Rate, such interest shall be calculated for actual days elapsed on the basis of a 365/366-day year. Interest shall be payable for
the day a Loan is made but not for the day of any payment on the amount paid if payment is received prior to 2:00 p.m. (New York time) at the place of payment. If any payment of principal of or interest on a Loan, any fees or any other amounts
payable to the Administrative Agent or any Lender hereunder shall become due on a day which is not a Business Day, such payment shall be made on the next succeeding Business Day and, in the case of a principal payment, such extension of time shall
be included in computing interest, fees and commissions in connection with such payment. 
 Section
2.15    Notification of Loans, Interest Rates, Prepayments and Commitment Reductions; Availability of Loans. Promptly after receipt thereof, the Administrative Agent will notify each Lender of the contents of each
Commitment reduction notice, Borrowing Notice, Conversion/Continuation Notice and prepayment notice received by it hereunder. The Administrative Agent will notify each Lender of the interest rate applicable to each Loan promptly upon determination
of such interest rate and will give each Lender and the Borrower prompt notice of each change in the Alternate Base Rate. Not later than 1:00 p.m. (New York time) on each Borrowing Date, each Lender shall make available its Loan or Loans in funds
immediately available to the Administrative Agent’s Office. The Administrative Agent will make the funds so received from the Lenders available to the Borrower at the Administrative Agent’s aforesaid address. 

Section 2.16    Lending Installations. Each Lender may book its Loans at any Lending Installation selected
by such Lender and may change its Lending Installation from time to time. All terms of this Agreement shall apply to any such Lending Installation and the Loans and any Notes issued hereunder shall be deemed held by each Lender for the benefit of
any such Lending Installation. Each Lender may, by written notice to the Administrative Agent and the Borrower in accordance with Article XIII, designate replacement or additional Lending Installations through which Loans will be made by it and for
whose account Loan payments are to be made. 
 Section 2.17    Payments Generally; Administrative Agent’s
Clawback. (a) (i) Funding by Lenders; Presumption by Administrative Agent. Unless the Administrative Agent shall have received notice from a Lender prior to the proposed date of any Borrowing of Eurocurrency Loans (or, in
the case of any Alternate Base Rate Loans or LIBOR Daily Floating Rate Loans, prior to 12:00 noon (New York time) on the date of the proposed Borrowing of such Loans) that such Lender will not make available to the Administrative Agent such
Lender’s share of such Loan, the Administrative Agent may assume that such Lender has made such share available on such date in accordance with Section 2.15 and may, in reliance upon such assumption, make available to the Borrower a
corresponding amount. In such event, if a Lender has not in fact made its share of the applicable Loan available to the Administrative Agent, then the applicable Lender and the Borrower severally agree to pay to the Administrative Agent forthwith on
demand such corresponding amount in Same Day Funds with interest thereon, for each day from and including the date such amount is made available to the Borrower to but excluding the date of payment to the Administrative Agent, at (A) in the
case of a payment to be made by such 

  
 31 

 
Lender, the Overnight Rate and (B) in the case of a payment to be made by the Borrower, the interest rate applicable to Alternate Base Rate Loans. If the Borrower and such Lender shall pay
such interest to the Administrative Agent for the same or an overlapping period, the Administrative Agent shall promptly remit to the Borrower the amount of such interest paid by the Borrower for such period. If such Lender pays its share of the
applicable Loan to the Administrative Agent, then the amount so paid shall constitute such Lender’s Loan included in such Loan. Any payment by the Borrower shall be without prejudice to any claim the Borrower may have against a Lender that
shall have failed to make such payment to the Administrative Agent. 
 (ii)    Payments by Borrower;
Presumptions by Administrative Agent. Unless the Administrative Agent shall have received notice from the Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders hereunder that the
Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders the amount due. In such event,
if the Borrower has not in fact made such payment, then each of the Lenders severally agrees to repay to the Administrative Agent forthwith on demand the amount so distributed to such Lender in Same Day Funds with interest thereon, for each day from
and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the Overnight Rate. 
 A notice
of the Administrative Agent to any Lender or the Borrower with respect to any amount owing under this subsection (a) shall be conclusive, absent manifest error. 

(b)    Obligations of Lenders Several. The obligations of the Lenders hereunder to make Loans and to make payments
pursuant to Section 9.06(c) are several and not joint. The failure of any Lender to make any Loan or to make any payment under Section 9.06(c) on any date required hereunder shall not relieve any other Lender of its corresponding obligation to do so
on such date, and no Lender shall be responsible for the failure of any other Lender to so make its Loan or to make its payment under Section 9.06(c). 

Section 2.18    Replacement of Lender. If any Lender requests compensation under Section 3.01 or 3.02,
or if any Lender gives notice to the Borrower pursuant to Section 3.03, or if the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 3.05, or if any Lender
is a Defaulting Lender, or if a Lender fails to consent to an amendment or waiver approved by the Required Lenders as to any matter for which such Lender’s consent is needed, or if any Lender is a Declining Lender under Section 2.02, then
the Borrower may, at its sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in, and consents
required by, Section 12.01), all of its interests, rights and obligations under this Agreement and the related Loan Documents to an assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such
assignment), provided that: 
 (a)    the Borrower shall have paid to the Administrative Agent the assignment fee
specified in Section 12.01(b)(iv); 

  
 32 

 (b)    such Lender shall have received payment of an amount equal to the
outstanding principal of its Loans, accrued interest thereon, accrued fees and all other amounts payable to it hereunder and under the other Loan Documents (including any amounts under Section 3.04) from the assignee (to the extent of such
outstanding principal and accrued interest and fees) or the Borrower (in the case of all other amounts); 
 (c)    in
the case of any such assignment resulting from a claim for compensation under Section 3.01 or payments required to be made pursuant to Section 3.05, such assignment will result in a reduction in such compensation or payments thereafter; 

(d)    such assignment does not conflict with applicable laws; 

(e)    in the case of any such assignment resulting from a failure to consent to an amendment or waiver approved by the
Required Lenders, such assignee shall have consented to the relevant amendment or waiver; and 
 (f)    in the case of
any such assignment by a Declining Lender, such assignee shall have consented to the applicable Maturity Date Extension and shall, for all purposes, constitute a Consenting Lender. 

A Lender shall not be required to make any such assignment or delegation if, prior thereto, as a result of a waiver by such Lender or
otherwise, the circumstances entitling the Borrower to require such assignment and delegation cease to apply. 

Section 2.19    Sharing of Payments by Lenders. Except as otherwise specified herein, if any Lender
shall, by exercising any right of setoff or counterclaim or otherwise, obtain payment in respect of any principal of or interest on any of the Loans made by it resulting in such Lender’s receiving payment of a proportion of the aggregate amount
of such Loans and accrued interest thereon greater than its Pro Rata Share of the Revolving Facility to which it is entitled pursuant hereto, then the Lender receiving such greater proportion shall (a) notify the Administrative Agent of such
fact, and (b) purchase (for cash at face value) participations in the Loans of the other Lenders or make such other adjustments as shall be equitable, so that the benefit of all such payments shall be shared by the Lenders ratably in accordance
with the aggregate amount of principal of and accrued interest on their respective Loans and other amounts owing them, provided that: 

(i)    if any such participations are purchased and all or any portion of the payment giving rise thereto
is recovered, such participations shall be rescinded and the purchase price restored to the extent of such recovery, without interest; and 

(ii)    the provisions of this Section shall not be construed to apply to (x) any payment made by the
Borrower pursuant to and in accordance with the express terms of 

  
 33 

 
this Agreement (including the application of funds arising from the existence of a Defaulting Lender) or (y) any payment obtained by a Lender as consideration for the assignment of or sale
of a participation in any of its Loans to any assignee or participant, other than to the Borrower or any Subsidiary thereof (as to which the provisions of this Section shall apply). 

The Borrower for itself and solely with respect to its Obligations consents to the foregoing and agrees, to the extent it may effectively do so under
applicable law, that any Lender acquiring a participation pursuant to the foregoing arrangements may exercise against the Borrower rights of setoff and counterclaim with respect to such participation as fully as if such Lender were a direct creditor
of the Borrower in the amount of such participation. 
 Section 2.20    Defaulting Lenders.
(a) Adjustments. Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting Lender, then, until such time as that Lender is no longer a Defaulting Lender, to the extent permitted by
applicable law: 
 (i)    Waivers and Amendments. That Defaulting Lender’s right to approve
or disapprove any amendment, waiver or consent with respect to this Agreement shall be restricted as set forth in Section 8.02 and the definition of Required Lender. 

(ii)    Reallocation of Payments. Any payment of principal, interest, fees or other amounts received
by the Administrative Agent for the account of that Defaulting Lender under this Agreement or the other Loan Documents (whether voluntary or mandatory, at maturity, pursuant to Section 8.01 or otherwise, and including any amounts made available
to the Administrative Agent by that Defaulting Lender pursuant to Section 11.01), shall be applied at such time or times as may be determined by the Administrative Agent as follows: first, to the payment of any amounts owing by that
Defaulting Lender to the Administrative Agent hereunder; second, as the Borrower may request (so long as no Default or Unmatured Default exists), to the funding of any Loan in respect of which that Defaulting Lender has failed to fund its
portion thereof as required by this Agreement, as determined by the Administrative Agent; third, if so determined by the Administrative Agent and the Borrower, to be held in a non-interest bearing deposit account (other than any interest
earned on the investment of such deposits, which investments shall be made at the option and sole discretion of the Administrative Agent (provided that such cash collateral shall be invested solely in investments that provide for preservation of
capital)) and released in order to satisfy obligations of that Defaulting Lender to fund Loans under this Agreement; fourth, to the payment of any amounts owing to the Lenders as a result of any judgment of a court of competent jurisdiction
obtained by any Lender against that Defaulting Lender as a result of that Defaulting Lender’s breach of its obligations under this Agreement; fifth, so long as no Default or Unmatured Default exists, to the payment of any amounts owing
to the Borrower as a result of any judgment of a court of competent jurisdiction obtained by the Borrower against that Defaulting Lender as a result of that Defaulting Lender’s breach of 

  
 34 

 
its obligations under this Agreement; and sixth, to that Defaulting Lender or as otherwise directed by a court of competent jurisdiction; provided that if (x) such payment is a
payment of the principal amount of any Loans in respect of which that Defaulting Lender has not fully funded its appropriate share and (y) such Loans were made at a time when the conditions set forth in Section 4.03 were satisfied or
waived, such payment shall be applied first to pay the Loans of all non-Defaulting Lenders on a pro rata basis prior to being applied as set forth above in this sub-clause (ii). Any payments, prepayments or other amounts paid or payable to a
Defaulting Lender that are applied (or held) to pay amounts owed by a Defaulting Lender pursuant to this Section 2.20(a)(ii) shall be deemed paid to and redirected by that Defaulting Lender, and each Lender irrevocably consents hereto. 

(iii)    Certain Fees. The Defaulting Lender shall not be entitled to receive any Commitment Fee or
any Minimum Average Percentage Utilization Fee pursuant to Section 2.05(a) and 2.05(c), respectively, for any period during which that Lender is a Defaulting Lender. 

(b)    Defaulting Lender Cure. If the Borrower and the Administrative Agent agree in writing in their sole
discretion that a Defaulting Lender should no longer be deemed to be a Defaulting Lender, the Administrative Agent will so notify the parties hereto, whereupon as of the effective date specified in such notice and subject to any conditions set forth
therein, that Lender will, to the extent applicable, purchase that portion of outstanding Loans of the other Lenders or take such other actions as the Administrative Agent may determine to be necessary to cause the Loans to be held on a pro rata
basis by the Lenders in accordance with their Pro Rata Shares of the Revolving Facility, whereupon that Lender will cease to be a Defaulting Lender; provided that no adjustments will be made retroactively with respect to fees accrued or
payments made by or on behalf of the Borrower while that Lender was a Defaulting Lender; and provided further, that except to the extent otherwise expressly agreed by the affected parties, no change hereunder from Defaulting Lender to Lender
will constitute a waiver or release of any claim of any party hereunder arising from that Lender’s having been a Defaulting Lender. 

ARTICLE III 
 YIELD
PROTECTION; TAXES 
 Section 3.01    Yield Protection. If, after the date of this Agreement, any Change in
Law: 
 (a)    imposes, modifies or deems applicable any reserve, special deposit, compulsory loan, insurance charge or
similar requirement against assets of, deposits with or for the account of, or credit extended or participated in by, any Lender (except any reserve requirement reflected in the Eurocurrency Rate); 

(b)    subjects any Lender to any Tax of any kind whatsoever (except for (i) Indemnified Taxes or Other Taxes covered
by Section 3.05 and (ii) Excluded Taxes) on its loans, loan principal, letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto; or 

  
 35 

 (c)    imposes on any Lender or the London interbank market any other
condition, cost or expense affecting this Agreement or Loans made by such Lender; 
 and the result of any of the foregoing shall be to increase the cost to
such Lender of making, continuing, converting to or maintaining any Eurocurrency Loans or of maintaining its obligation to make any such Eurocurrency Loan, or to reduce the amount of any sum received or receivable by such Lender hereunder (whether
of principal, interest or any other amount) then, upon request of such Lender, the Borrower shall pay to such Lender such additional amount or amounts as will compensate such Lender for such additional costs incurred or reduction suffered.
Notwithstanding the foregoing, no Lender shall be entitled to seek compensation under this Section 3.01 based on the occurrence of a Change in Law arising solely from (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and
all requests, rules, guidelines or directives promulgated thereunder or issued in connection therewith or (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking
Supervision (or any successor or similar authority) or the United States regulatory authorities, in each case pursuant to Basel III, unless such Lender is generally seeking compensation from other borrowers that are similarly situated to and of
similar creditworthiness with respect to its similarly affected commitments, loans and/or participations under agreements with such borrowers having provisions similar to this Section 3.01. 

Section 3.02    Changes in Capital Adequacy Regulations; Certificates for Reimbursement; Delay in
Requests. (a) Changes in Capital Adequacy. If any Lender determines that any Change in Law after the date of this Agreement affecting such Lender or any Lending Installation of such Lender or such Lender’s holding company, if
any, regarding capital or liquidity requirements has or would have the effect of reducing the rate of return on such Lender’s capital or on the capital of such Lender’s holding company, if any, as a consequence of this Agreement, the
Commitments of such Lender or the Loans made by such Lender, to a level below that which such Lender or such Lender’s holding company could have achieved but for such Change in Law (taking into consideration such Lender’s policies and the
policies of such Lender’s holding company with respect to capital adequacy), then from time to time the Borrower will pay to such Lender such additional amount or amounts as will compensate such Lender or such Lender’s holding company for
any such reduction suffered. Notwithstanding the foregoing, no Lender shall be entitled to seek compensation under this Section 3.02 based on the occurrence of a Change in Law arising solely from (x) the Dodd-Frank Wall Street Reform and
Consumer Protection Act and all requests, rules, guidelines or directives promulgated thereunder or issued in connection therewith or (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the
Basel Committee on Banking Supervision (or any successor or similar authority) or the United States regulatory authorities, in each case pursuant to Basel III, unless such Lender is generally seeking compensation from other borrowers that are
similarly situated to and of similar creditworthiness with respect to its similarly affected commitments, loans and/or participations under agreements with such borrowers having provisions similar to this Section 3.02. 

  
 36 

 (b)    Certificates for Reimbursement. A certificate of a Lender
setting forth the amount or amounts necessary to compensate such Lender or its holding company, as the case may be, as specified in Section 3.01 or subsection (a) of this Section and delivered to the Borrower shall be conclusive absent manifest
error. The Borrower shall pay to such Lender the amount shown as due on any such certificate within fifteen (15) days after receipt thereof. 

(c)    Delay in Requests. Failure or delay on the part of any Lender to demand compensation pursuant to the
foregoing provisions of this Section or Section 3.01 shall not constitute a waiver of such Lender’s right to demand such compensation, provided that the Borrower shall not be required to compensate a Lender pursuant to the foregoing
provisions of this Section or Section 3.01 for any increased costs incurred or reductions suffered more than nine months prior to the date that such Lender notifies the Borrower of the Change in Law giving rise to such increased costs or
reductions and of such Lender’s intention to claim compensation therefor (except that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the nine-month period referred to above shall be extended to
include the period of retroactive effect thereof). 
 (d)    Additional Reserve Requirements. The Borrower shall
pay to each Lender, as long as such Lender shall be required to comply with any reserve ratio requirement or analogous requirement of any central banking or financial regulatory authority imposed in respect of the maintenance of the Commitments or
the funding of the Loans, such additional costs (expressed as a percentage per annum and rounded upwards, if necessary, to the nearest five decimal places) equal to the actual costs allocated to such Commitment or Loan by such Lender (as determined
by such Lender in good faith, which determination shall be conclusive), which shall be due and payable on each date on which interest is payable on such Loan, provided the Borrower shall have received at least 30 days’ prior notice (with
a copy to the Administrative Agent) of such additional costs from such Lender. Such Lender shall deliver a certificate to the Borrower setting forth in reasonable detail a calculation of such actual costs incurred by such Lender and shall certify
that it is generally charging such costs to similarly situated customers of similar creditworthiness of the applicable Lender under agreements having provisions similar to this Section 3.02(d) after consideration of such factors as such Lender
then reasonably determines to be relevant (which determination shall be made in good faith). If a Lender fails to give notice 30 days prior to the relevant Payment Date, such additional costs shall be due and payable 30 days from receipt of such
notice. For the avoidance of doubt, any amounts paid under this Section 3.02(d) shall be without duplication of eurocurrency adjustments in the definition of “Eurocurrency Rate”. 

Section 3.03    Illegality. If any Lender determines that any law has made it unlawful, or that any
Governmental Authority has asserted that it is unlawful, for any Lender or its applicable Lending Installation to make, maintain or fund Eurocurrency Loans, or to determine or charge interest rates based upon the Eurocurrency Rate, or any
Governmental Authority has 

  
 37 

 
imposed material restrictions on the authority of such Lender to purchase or sell, or to take deposits of, Dollars in the London interbank market, then, on notice thereof by such Lender to the
Borrower through the Administrative Agent, any obligation of such Lender to make or continue Eurocurrency Loans or to convert Alternate Base Rate Loans to Eurocurrency Loans shall be suspended until such Lender notifies the Administrative Agent and
the Borrower that the circumstances giving rise to such determination no longer exist. Upon receipt of such notice, the Borrower shall, upon demand from such Lender (with a copy to the Administrative Agent), prepay or convert all Eurocurrency Loans
of such Lender to Alternate Base Rate Loans, either on the last day of the Interest Period therefor, if such Lender may lawfully continue to maintain such Eurocurrency Loans to such day, or immediately, if such Lender may not lawfully continue to
maintain such Eurocurrency Loans. Upon any such prepayment or conversion, the Borrower shall also pay accrued interest on the amount so prepaid or converted. 

Section 3.04    Compensation for Losses. Upon demand of any Lender (with a copy to the Administrative Agent)
from time to time, the Borrower shall, promptly compensate such Lender for and hold such Lender harmless from any loss, cost or expense incurred by it as a result of: 

(a)    any continuation, conversion, payment or prepayment of any Loan other than an Alternate Base Rate Loan or a LIBOR
Daily Floating Rate Loan on a day other than the last day of the Interest Period for such Loan or other than upon prior notice (i) in the event that Bank of America, N.A. is the sole Lender under the Revolving Facility on the date of delivery
of the applicable notice, at least two (2) Business Days in advance and (ii) in the event more than one Person is a Lender under the Revolving Facility on the date of delivery of the applicable notice, with the consent of the
Administrative Agent (such consent not the unreasonably withheld or delayed) at least two (2) Business Days in advance, but in no event shall such notice period be longer than three (3) Business Days to the Administrative Agent (whether
voluntary, mandatory, automatic, by reason of acceleration, or otherwise, but excluding any prepayment or conversion required pursuant to Section 3.03); 

(b)    any failure by the Borrower (for a reason other than the failure of such Lender to make a Loan) to prepay, borrow,
continue or convert any Loan other than an Alternate Base Rate Loan or a LIBOR Daily Floating Rate Loan on the date or in the amount notified by the Borrower; or 

(c)    any assignment of a Eurocurrency Loan (other than a LIBOR Daily Floating Rate Loan) on a day other than the last
day of the Interest Period therefor as a result of a request by the Borrower pursuant to Section 2.18; 
 including any foreign exchange losses and loss or
expense arising from the liquidation or reemployment of funds obtained by it to maintain such Loan or from fees payable to terminate the deposits from which such funds were obtained or from the performance of any foreign exchange contract. The
Borrower shall also pay any customary administrative fees charged by such Lender in connection with the foregoing. 

  
 38 

 For purposes of calculating amounts payable by the Borrower to the Lenders under this
Section 3.04, each Lender shall be deemed to have funded each Eurocurrency Loan made by it at the Eurocurrency Rate for such Loan by a matching deposit or other borrowing in the London interbank eurodollar market and for a comparable amount and for
a comparable period, whether or not such Eurocurrency Loan was in fact so funded. 

Section 3.05    Taxes. (a) Payments Free of Taxes; Obligation to Withhold; Payments on Account
of Taxes. (i) Any and all payments by or on account of any obligation of the Borrower hereunder or under any other Loan Document shall to the extent permitted by applicable laws be made free and clear of and without reduction or withholding
for any Taxes. If, however, applicable laws require the Borrower or the Administrative Agent (as determined in the good faith discretion of the Administrative Agent) to withhold or deduct any Tax, such Tax shall be withheld or deducted in accordance
with such laws as determined by the Borrower or the Administrative Agent, as the case may be, upon the basis of the information and documentation to be delivered pursuant to subsection (e) below. 

(ii)    If the Borrower or the Administrative Agent shall be required by applicable law to withhold or
deduct any Taxes from any payment, then (A) the Borrower or the Administrative Agent, as applicable, shall withhold or make such deductions as are determined by the Borrower or the Administrative Agent, as applicable, to be required based upon
the information and documentation it, or the applicable taxing authority, has received pursuant to subsection (e) below (for the avoidance of doubt, in the case of any such information and documentation received by an applicable taxing
authority, solely to the extent the Borrower or the Administrative Agent has been provided with a copy of such information and documentation or otherwise has actual knowledge of such information and documentation and, in each case, is entitled to
rely thereon), (B) the Borrower or the Administrative Agent, as applicable, shall timely pay the full amount withheld or deducted to the relevant Governmental Authority in accordance with applicable law, and (C) to the extent that the
withholding or deduction is made on account of Indemnified Taxes or Other Taxes, the sum payable by the Borrower shall be increased as necessary so that after any required withholding or the making of all required deductions (including deductions
applicable to additional sums payable under this Section) the Administrative Agent or any Lender receives an amount equal to the sum it would have received had no such withholding or deduction been made. 

(b)    Payment of Other Taxes. Without limiting the provisions of subsection (a) above, the Borrower shall
timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable laws. 

(c)    Indemnification. (i) Without limiting the provisions of subsection (a) or (b) above, the Borrower
shall indemnify the Administrative Agent and each Lender, and shall make payment in respect thereof within thirty (30) days after written demand therefor, for the full amount of any Indemnified Taxes or Other Taxes (including Indemnified Taxes
or Other Taxes imposed or asserted on or attributable to amounts payable under this Section) withheld or 

  
 39 

 
deducted by the Borrower or the Administrative Agent or paid by the Administrative Agent or such Lender, and any reasonable expenses arising therefrom or with respect thereto, whether or not such
Indemnified Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. The Borrower shall also indemnify the Administrative Agent and shall make payment in respect thereof within thirty (30) days
after demand therefor, for any amount which a Lender for any reason fails to pay indefeasibly to the Administrative Agent as required by clause (ii)(x)(1) of this subsection. A certificate as to the amount of any such payment or liability delivered
to the Borrower by a Lender (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender, shall be conclusive absent manifest error. 

(ii)     Without limiting the provisions of subsection (a) or (b) above, each Lender shall, and
does hereby, indemnify (x) the Borrower and the Administrative Agent, and shall make payment in respect thereof within thirty (30) days after demand therefor, against any and all Taxes and any and all related losses, claims, liabilities,
penalties, interest and expenses (including the fees, charges and disbursements of any counsel for the Borrower or the Administrative Agent) incurred by or asserted against the Borrower or the Administrative Agent by any Governmental Authority as a
result of (1) the failure by such Lender to deliver, or as a result of the inaccuracy, inadequacy or deficiency of, any documentation required to be delivered by such Lender to the Borrower or the Administrative Agent pursuant to subsection
(e) or (2) the failure of such Lender to comply with the provisions of Section 12.01(d) relating to the maintenance of a Participant Register and (y) the Administrative Agent against any Indemnified Taxes or Other Taxes attributable
to such Lender (but only to the extent the Borrower has not already indemnified the Administrative Agent for such Indemnified Taxes or Other Taxes and without limiting the obligation of the Borrower to do so) or Excluded Taxes attributable to such
Lender, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. Each Lender hereby authorizes the Administrative Agent to
set off and apply any and all amounts at any time owing to such Lender under this Agreement or any other Loan Document against any amount due to the Administrative Agent under this clause (ii). The agreements in this clause (ii) shall survive the
resignation and/or replacement of the Administrative Agent, any assignment of rights by, or the replacement of, a Lender, the termination of this Agreement or the Aggregate Commitment and the repayment, satisfaction or discharge of all other
Obligations. 
 (d)    Evidence of Payments. Upon request by the Borrower or the Administrative Agent, as the
case may be, after any payment of Taxes by the Borrower or the Administrative Agent to a Governmental Authority as provided in this Section 3.05, the Borrower shall deliver to the Administrative Agent or the Administrative Agent shall deliver to the
Borrower, as the case may be, the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of any return required by law to report such payment or other evidence of such payment reasonably
satisfactory to the Borrower or the Administrative Agent, as the case may be. 

  
 40 

 (e)    Status of Lenders; Tax Documentation. (i) Each Lender
shall deliver to the Borrower and the Administrative Agent, at the time or times prescribed by applicable laws or when reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation prescribed by
applicable laws or by the taxing authorities of any jurisdiction and such other reasonably requested information (A) to secure any applicable exemption from, or reduction in the rate of, deduction or withholding imposed by any jurisdiction in
respect of any payments to be made by the Borrower to such Lender, and (B) as will permit the Borrower or the Administrative Agent, as the case may be, to determine (1) whether or not payments made hereunder or under any other Loan
Document are subject to Taxes, (2) if applicable, the required rate of withholding or deduction, and (3) such Lender’s entitlement to any available exemption from, or reduction of, applicable Taxes in respect of all payments to be
made to such Lender by the Borrower pursuant to this Agreement or otherwise to establish such Lender’s status for withholding tax purposes in the applicable jurisdiction. 

(ii)    Without limiting the generality of the foregoing, if the Borrower (or, if the Borrower is
disregarded as an entity separate from its owner for U.S. federal income tax purposes, the Person treated as its owner for U.S. federal income tax purposes) is a “United States person” within the meaning of Section 7701(a)(30) of the
Code, 
 (A)    any Lender (or, if such Lender is disregarded as an entity separate from its owner for
U.S. federal income tax purposes, the Person treated as its owner for U.S. federal income tax purposes) that is a “United States person” within the meaning of Section 7701(a)(30) of the Code shall deliver to the Borrower and the
Administrative Agent on or prior to the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the request of the Borrower or the Administrative Agent) executed originals of Internal Revenue Service
Form W-9 or such other documentation or information prescribed by applicable laws or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent, as the case may be, to determine whether
or not such Lender is subject to backup withholding or information reporting requirements; 
 (B)    each
Foreign Lender (or, if such Foreign Lender is disregarded as an entity separate from its owner for U.S. federal income tax purposes, the Person treated as its owner for U.S. federal income tax purposes) that is entitled under the Code or any
applicable treaty to an exemption from or reduction of withholding tax with respect to payments hereunder or under any other Loan Document shall deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by
the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the request of the Borrower or the Administrative Agent, but only

  
 41 

 
if such Foreign Lender (or, if such Foreign Lender is disregarded as an entity separate from its owner for U.S. federal income tax purposes, the Person treated as its owner for U.S. federal
income tax purposes) is legally entitled to do so), whichever of the following is applicable: 

(1)    executed originals of Internal Revenue Service Form W-8BEN or W-BEN-E, as applicable, claiming
eligibility for benefits of an income tax treaty to which the United States is a party, 

(2)    executed originals of Internal Revenue Service Form W-8ECI, 

(3)    executed originals of Internal Revenue Service Form W-8IMY and all required supporting
documentation, 
 (4)    in the case of a Foreign Lender (or, if such Foreign Lender is disregarded as
an entity separate from its owner for U.S. federal income tax purposes, the Person treated as its owner for U.S. federal income tax purposes) claiming the benefits of the exemption for portfolio interest under section 881(c) of the Code, (x) a
certificate to the effect that such Foreign Lender (or such other Person) is not (A) a “bank” within the meaning of section 881(c)(3)(A) of the Code, (B) a “10 percent shareholder” of the Borrower within the meaning of
section 881(c)(3)(B) of the Code, or (C) a “controlled foreign corporation” described in section 881(c)(3)(C) of the Code and (y) executed originals of Internal Revenue Service Form W-8BEN or W-8BEN-E, as applicable, or 

(5)    executed originals of any other form prescribed by applicable laws as a basis for claiming
exemption from or a reduction in U.S. federal withholding tax together with such supplementary documentation as may be prescribed by applicable laws to permit the Borrower or the Administrative Agent to determine the withholding or deduction
required to be made. 
 (C)    each Lender shall deliver to the Administrative Agent and the Borrower
such documentation reasonably requested by the Administrative Agent or the Borrower sufficient for the Administrative Agent and the Borrower to comply with their obligations under FATCA and to determine whether payments to such Lender are subject to
withholding tax under FATCA. Solely for purposes of this sub-clause (C), “FATCA” shall include any amendments made to FATCA after the date of this Agreement. 

(iii)    Each Lender shall promptly (A) notify the Borrower and the Administrative Agent of any change
in circumstances which would modify or render invalid any claimed exemption or reduction and (B) take such steps as shall not be 

  
 42 

 
materially disadvantageous to it, in the reasonable judgment of such Lender and as may be reasonably necessary (including the re-designation of its Lending Installation), to avoid any requirement
of applicable laws of any jurisdiction that the Borrower or the Administrative Agent make any withholding or deduction for taxes from amounts payable to such Lender. 

(f)    Treatment of Certain Refunds. Unless required by applicable laws, at no time shall the Administrative Agent
have any obligation to file for or otherwise pursue on behalf of a Lender, or have any obligation to pay to any Lender, any refund of Taxes withheld or deducted from funds paid for the account of such Lender. If the Administrative Agent or any
Lender determines, in its sole discretion, exercised in good faith that it has received a refund of any Taxes or Other Taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower has paid additional amounts
pursuant to this Section, it shall pay to the Borrower an amount equal to such refund (but only to the extent of indemnity payments made, or additional amounts paid, by the Borrower under this Section with respect to the Taxes or Other Taxes giving
rise to such refund), net of all out-of-pocket expenses incurred by the Administrative Agent or such Lender and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund), provided that
the Borrower, upon the request of the Administrative Agent or such Lender, as the case may be, agrees to repay the amount paid over to the Borrower (plus any penalties, interest (to the extent accrued from the date such refund is paid over to the
Borrower) or other charges imposed by the relevant Governmental Authority), to the Administrative Agent or such Lender in the event the Administrative Agent or such Lender is required to repay such refund to such Governmental Authority. This
subsection shall not be construed to require the Administrative Agent or any Lender to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the Borrower or any other Person. 

Section 3.06    Mitigation Obligations. If any Lender requests compensation under Section 3.01 or
Section 3.02, or the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 3.05, or if any Lender gives a notice pursuant to Section 3.03, then such Lender
shall use reasonable efforts to designate a different Lending Installation for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or affiliates, if, in the judgment of such
Lender, such designation or assignment (i) would eliminate or reduce amounts payable pursuant to Section 3.01, 3.02 or 3.05, as the case may be, in the future, or eliminate the need for the notice pursuant to Section 3.03, as applicable, and
(ii) in each case, would not subject such Lender to any unreimbursed cost or expense and would not otherwise be materially disadvantageous to such Lender. The Borrower hereby agrees to pay all reasonable costs and expenses incurred by any
Lender in connection with any such designation or assignment. 

  
 43 

 Section 3.07    Inability to Determine Rates. 

(a)    If the Required Lenders determine that for any reason in connection with any request for a Eurocurrency Loan or a
conversion to or continuation thereof that (i) deposits are not being offered to banks in the London interbank eurodollar market for the applicable amount and Interest Period of such Eurocurrency Loan, (ii) adequate and reasonable means do
not exist for determining the Eurocurrency Base Rate for any requested Interest Period with respect to a proposed Eurocurrency Loan, or (iii) the Eurocurrency Base Rate for any requested Interest Period with respect to a proposed Eurocurrency
Loan does not adequately and fairly reflect the cost to such Lenders of funding such Loan, the Administrative Agent will promptly so notify the Borrower and each Lender. Thereafter, the obligation of the Lenders to make or maintain Eurocurrency
Loans shall be suspended until the Administrative Agent (upon the instruction of the Required Lenders) revokes such notice. Upon receipt of such notice, the Borrower may revoke any pending request for the making of, conversion to, or continuation
of, Eurocurrency Loans or, failing that, will be deemed to have converted such request into a request for Alternate Base Rate Loans in the amount specified therein. 

(b)    Notwithstanding anything to the contrary in this Agreement or any other Loan Documents, if the Administrative Agent
determines (which determination shall be made by notice to the Borrower and shall be conclusive absent manifest error), or the Borrower or Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to
Borrower) that the Borrower or Required Lenders (as applicable) have determined, that: 
 (i)    (A)
Dollar deposits are not being offered to banks in the London interbank eurodollar market for the applicable amount and Interest Period of any applicable Eurocurrency Loan or (B) adequate and reasonable means do not exist for ascertaining LIBOR
for Dollars for any requested Interest Period, including, without limitation, because the Eurocurrency Base Rate is not available or published on a current basis, and in each case such circumstances are unlikely to be temporary, or 

(ii)    the administrator of the Eurocurrency Base Rate for the applicable currency or a Governmental
Authority having jurisdiction over the Administrative Agent has made a public statement identifying a specific date after which LIBOR for Dollars or the Eurocurrency Base Rate for Dollars shall no longer be made available, or used for determining
the interest rate of loans (such specific date, the “Scheduled Unavailability Date”), or 

(iii)    syndicated loans in the U.S. market denominated in Dollars being executed at the time, or that
include language similar to that contained in this Section 3.07, are being generally executed or amended, as applicable, to incorporate or adopt, as applicable, a new benchmark interest rate to replace LIBOR for the applicable currency, 

then, reasonably promptly after such determination by the Administrative Agent or receipt by the Administrative Agent of such notice, as
applicable, the Administrative Agent and the Borrower may amend this Agreement (a “LIBOR Successor Amendment”) to replace the Eurocurrency Base Rate with respect to the applicable currency with an alternate benchmark

  
 44 

 
rate, giving due consideration to any evolving or then existing convention for similar syndicated credit facilities in the U.S. market denominated in Dollars for such alternative benchmarks (any
such proposed rate, a “Replacement Rate”) and any such amendment shall become effective at 5:00 p.m. (New York time) on the fifth Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders
and the Borrower unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders do not accept such amendment. 

If no Replacement Rate has been determined and the circumstances under clause (i) above exist or the Scheduled Unavailability Date has
occurred (as applicable), the Administrative Agent will promptly so notify the Borrower and each Lender. Thereafter, (x) the obligation of the Lenders to make or maintain Eurocurrency Loans shall be suspended (to the extent of the affected
Eurocurrency Loans or Interest Periods), and (y) the Eurocurrency Rate component shall no longer be utilized in determining the Alternate Base Rate. Upon receipt of such notice, the Borrower may revoke any pending request for a Borrowing of,
conversion to or continuation of Eurocurrency Loans (to the extent of the affected Eurocurrency Loans or Interest Periods) or, failing that, will be deemed to have converted such request into a request for a Borrowing of Alternate Base Rate Loans
(subject to the foregoing clause (y)) in the amount specified therein. 
 Section 3.08    Survival.
All of the Borrower’s obligations under this Article III shall survive termination of this Agreement or the Aggregate Commitment, repayment of all other Obligations hereunder and resignation of the Administrative Agent. 

ARTICLE IV 
 CONDITIONS
PRECEDENT 
 Section 4.01    Signing Date. This Agreement (but not the Lenders’ Commitments
hereunder) shall become effective and shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns on and as of the first date (the “Signing Date”) on which the Borrower has
furnished to the Administrative Agent the following: 
 (a)    From each party hereto either (i) a counterpart of
this Agreement signed on behalf of such party or (ii) customary written evidence reasonably satisfactory to the Administrative Agent (which may include telecopy or electronic transmission of a signed signature page of this Agreement) that such
party has signed a counterpart of this Agreement; and 
 (b)    An officer’s certificate, substantially in the form
of Exhibit F, dated as of the Signing Date, signed by an Authorized Officer of the Borrower, certifying that (x) on the Signing Date, no Default or Unmatured Default has occurred and is continuing and (y) the representations and warranties
contained in Sections 5.01, 5.02 and 5.03 are true and correct in all material respects (except to the extent such representations and warranties are qualified by “materiality” or “Material Adverse Effect” or similar terms, in
which case such representations and warranties shall be true and correct in all respects) as of the Signing Date, except to the extent any such representation or warranty is stated to relate solely to an earlier date, in which

  
 45 

 
case such representation or warranty shall have been true and correct in all material respects (except to the extent such representations and warranties are qualified with “materiality”
or “Material Adverse Effect” or similar terms, in which case such representations and warranties shall be true and correct in all respects) on and as of such earlier date. 

Section 4.02    Initial Effectiveness. The Lenders’ Commitments shall become effective hereunder
on and as of the first date, which shall be no later than February 15, 2019 (the “Effective Date”), on which the Borrower has furnished to the Administrative Agent (or, in the case of Section 4.02(g), the Borrower shall have
paid) the following (it being understood that the Commitments of the Lender shall never become effective if the Effective Date has not occurred on or before February 15, 2019): 

(a)    The Signing Date shall have occurred; 

(b)    Copies of the articles of incorporation of the Borrower, together with all amendments thereto, and a certificate of
good standing for the Borrower, each certified by the appropriate governmental officer in its jurisdiction of incorporation; 

(c)    Copies, certified by the Secretary, Assistant Secretary or General Counsel of the Borrower, of the Borrower’s
by-laws and of its Board of Directors’ resolutions and of resolutions or actions of any other body authorizing the execution of the Loan Documents to which it is a party and a certification that there have been no changes to its articles of
incorporation provided pursuant to Section 4.02(b); 
 (d)    An incumbency certificate, executed by the Secretary,
Assistant Secretary or General Counsel of the Borrower, which shall identify by name and title and bear the signatures of the Authorized Officers and any other officers or employees of the Borrower authorized to sign the Loan Documents to which the
Borrower is a party and to request Loans hereunder, upon which certificate the Administrative Agent and the Lenders shall be entitled to rely until informed of any change in writing by the Borrower; 

(e)    An officer’s certificate, substantially in the form of Exhibit F, dated as of the Effective Date, signed by an
Authorized Officer of the Borrower, certifying that (x) on the Effective Date, no Default or Unmatured Default has occurred and is continuing and (y) the representations and warranties contained in Article V are true and correct in
all material respects (except to the extent such representations and warranties are qualified by “materiality” or “Material Adverse Effect” or similar terms, in which case such representations and warranties shall be true and
correct in all respects) as of the Effective Date, except to the extent any such representation or warranty is stated to relate solely to an earlier date, in which case such representation or warranty shall have been true and correct in all material
respects (except to the extent such representations and warranties are qualified with “materiality” or “Material Adverse Effect” or similar terms, in which case such representations and warranties shall be true and correct in all
respects) on and as of such earlier date; 

  
 46 

 (f)    A written opinion (addressed to the Administrative Agent and the
Lenders and dated the Effective Date) of Davis Polk & Wardwell LLP in form and substance reasonably acceptable to the Administrative Agent; 

(g)    All fees (including the Upfront Fee), costs and expenses due and payable to the Arranger or the Administrative
Agent, for itself and on behalf of the Lenders, or its counsel on the Effective Date and (in the case of expenses) for which the Borrower has received an invoice at least three (3) Business Days prior to the Effective Date; 

(h)    At least three (3) Business Days prior to the Effective Date, the Borrower shall have provided the
documentation and other information to the Administrative Agent that is required by bank regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including, without limitation, the U.S.
Patriot Act, to the extent such information was reasonably requested by the Arranger (including on behalf of any Lender) in writing at least ten (10) days prior to the Effective Date. 

Without limiting the generality of the provisions of Section 8.02, for purposes of determining compliance with the conditions specified in
this Section 4.02, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or
satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Effective Date specifying its objection thereto. 

Section 4.03    Each Borrowing Date. Each Lender’s obligations to make any Loan hereunder shall
become effective upon the satisfaction or waiver (in accordance with Section 8.02) of the following conditions on or after the Effective Date: 

(a)    The Effective Date shall have occurred; 

(b)    No Default or Unmatured Default has occurred and is continuing, or would result from such Borrowing; 

(c)    Each of the representations and warranties contained in Article V (other than the representations and warranties
contained in Sections 5.05 and 5.06 in the case of any Borrowings made after the Effective Date other than on any Borrowing made on an Extension Date or Increase Date) are, in each case, true and correct in all material respects (except to the
extent such representations and warranties are qualified by “materiality” or “Material Adverse Effect” or similar terms, in which case such representations and warranties shall be true and correct in all respects) as of such
Borrowing Date, except to the extent any such representation or warranty is stated to relate solely to an earlier date, in which case such representation or warranty shall have been true and correct in all material respects (except to the extent
such representations and warranties are qualified by “materiality” or “Material Adverse Effect” or similar terms, in which case such representations and warranties shall be true and correct in all respects) on and as of such
earlier date; 

  
 47 

 (d)    The Administrative Agent shall have received a Borrowing Notice
in accordance with Section 2.08. 
 Each Borrowing Notice shall constitute a representation and warranty by the Borrower as to the
matters specified in paragraphs (b) and (c) of this Section. 
 ARTICLE V 

REPRESENTATIONS AND WARRANTIES 

The Borrower represents and warrants as follows to each Lender and the Administrative Agent as of the Effective Date and thereafter on each
date as required by Section 2.01(b) and 2.02 and Section 4.03 (it being agreed that the representations and warranties contained in Sections 5.05 and 5.06 shall be made only as of the Effective Date, each Extension Date and each Increase
Date): 
 Section 5.01    Existence and Standing. The Borrower (a) is a corporation,
partnership, limited liability company or other entity duly and properly incorporated or organized, as the case may be, validly existing and (to the extent such concept applies to such entity) in good standing under the laws of its jurisdiction of
incorporation or organization and (b) has all requisite authority to conduct its business in each jurisdiction in which its business is conducted, except to the extent that the failure to have such authority would not reasonably be expected to
have a Material Adverse Effect. 
 Section 5.02    Authorization and Validity. The Borrower has the
power and authority and legal right to execute and deliver the Loan Documents and to perform its obligations thereunder. The execution and delivery by the Borrower of the Loan Documents and the performance of its obligations thereunder have been
duly authorized by proper proceedings, and the Loan Documents constitute legal, valid and binding obligations of the Borrower enforceable against it in accordance with their terms, except as may be limited by bankruptcy, insolvency or similar laws
relating to or affecting creditors’ rights generally and by general principles of equity, regardless of whether considered in a proceeding in equity or at law. 

Section 5.03    No Conflict; Government Consent. (a) Neither the execution and delivery by the
Borrower of the Loan Documents, nor the consummation of the transactions therein contemplated, nor compliance with the provisions thereof will violate (i) any law, rule, regulation, order, writ, judgment, injunction, decree or award binding on
the Borrower, (ii) the Borrower’s bylaws, articles or certificate of incorporation, partnership agreement, certificate of partnership, operating agreement or other management agreement, articles or certificate of organization or other
similar formation, organizational or governing documents, instruments and agreements, as the case may be, or (iii) the provisions of any indenture, instrument or agreement to which the Borrower is a party or is subject, or by which it, or its
Property, is bound, except in the case of clauses (i) and (iii) where such violation would not reasonably be expected to have a Material Adverse Effect. 

  
 48 

 (b)    No order, consent, adjudication, approval, license,
authorization, or validation of, or filing, recording or registration with, or exemption by, or other action in respect of any governmental or public body or authority, or any subdivision thereof, which has not been obtained by the Borrower, is
required to be obtained by the Borrower in connection with the execution and delivery of the Loan Documents, the borrowings under the Loan Documents, the payment and performance by the Borrower of its Obligations or the legality, validity, binding
effect or enforceability of the Loan Documents. 
 Section 5.04    Financial Statements. (i) The
August 31, 2018 audited consolidated financial statements of the Borrower and its Subsidiaries heretofore delivered to the Administrative Agent and the Lenders, copies of which are included in the Borrower’s Annual Report on Form 10-K as
filed with the SEC, and, if applicable, the audited consolidated financial statements of the Borrower and its Subsidiaries as of the last day of the fiscal year for which the Borrower has most recently filed an annual report on Form 10-K, and
(ii) if applicable, commencing with the fiscal quarter ending November 30, 2018, the unaudited consolidated financial statements of the Borrower and its Subsidiaries as of the last day of the most recent fiscal quarter for which the
Borrower has most recently filed a quarterly report on Form 10-Q, (a) were prepared in accordance with GAAP, (b) fairly present in all material respects the consolidated financial condition and operations of the Borrower and its
Subsidiaries at such dates and the consolidated results of their operations and cash flows for the period then ended and (c) show all material indebtedness and other liabilities, direct or contingent, of the Borrower and its Subsidiaries as of
the date thereof that are required under Agreement Accounting Principles to be reflected thereon. 

Section 5.05    Material Adverse Effect. Except as disclosed in the Borrower SEC Reports (excluding any
disclosures set forth in any risk factor section and in any section relating to forward-looking or safe harbor statements), since August 31, 2018 there has been no material adverse effect on the financial condition, results of operations,
business or Property of the Borrower and its Subsidiaries taken as a whole. 

Section 5.06    Litigation. As of the Effective Date, there is no litigation, arbitration, governmental
investigation, proceeding or inquiry pending or, to the knowledge of any of their officers, threatened against or affecting the Borrower or any of its Subsidiaries which has not been disclosed in the Borrower SEC Reports (a) that would
reasonably be expected to have a Material Adverse Effect or (b) which seeks to prevent, enjoin or delay the making of any Loan or otherwise calls into question the validity of any Loan Document and as to which there is a reasonable possibility
of an adverse decision. 
 Section 5.07    Regulation U. The Borrower is not engaged principally, or
as one of its important activities, in the business of extending credit for the purpose, whether immediate, incidental or ultimate of buying or carrying margin stock (within the meaning of Regulation U or Regulation X); and after applying the
proceeds of the Loans, margin stock (as defined in Regulation U) constitutes not more than twenty-five percent (25%) of the value of those assets of the Borrower which are subject to any limitation on sale or pledge, or any other restriction
hereunder. 

  
 49 

 Section 5.08    Investment Company Act. The Borrower
is not an “investment company”, a company “controlled by” an “investment company” or a company required to register as an “investment company,” each as defined in the Investment Company Act of 1940, as
amended. 
 Section 5.09    OFAC, FCPA. None of the Borrower, any of its Subsidiaries, or, to the
knowledge of the Borrower, any directors or officers of the Borrower or any of its Subsidiaries, is the subject of Sanctions. None of the Borrower or its Subsidiaries is located, organized or resident in a country or territory that is the subject of
Sanctions. No part of the proceeds of the Loans shall be used by the Borrower in violation of the United States Foreign Corrupt Practices Act of 1977, as amended or Sanctions. 

Section 5.10    Disclosure. All information (other than financial projections and other forward-looking
information and information of a general economic or industry nature) (as used in this Section 5.10, the “Information”) provided by or on behalf of the Borrower or its representatives to the Administrative Agent or the Lenders
in written form in connection with the transactions contemplated hereby does not, when taken as a whole, and will not, when furnished and when taken as a whole, contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements contained therein, when taken as a whole, not materially misleading when taken as a whole and in light of the circumstances under which such statements were made (giving effect to any supplements then or theretofore
furnished). 
 ARTICLE VI 

COVENANTS 
 From the Effective
Date, so long as any Lender shall have any Commitment hereunder, or any Loan or other Obligation hereunder (other than any contingent indemnification obligations for which no claim has been made) shall remain unpaid or unsatisfied: 

Section 6.01    Financial Reporting. The Borrower will maintain, for itself and each Subsidiary, a
system of accounting established and administered in accordance with GAAP, and furnish to the Administrative Agent for the Administrative Agent’s distribution to the Lenders: 

(a)    As soon as available, but in any event on or prior to the earlier of (i) the 90th day after the close of each
of its fiscal years and (ii) the day that is five (5) Business Days after the date the Borrower’s annual report on Form 10-K is required to be filed with the SEC after giving effect to any extensions permitted by the SEC (commencing
with the first fiscal year of the Borrower ending after the Effective Date), a consolidated balance sheet as of the end of such period, related statements of earnings, statements of equity and cash flows prepared in accordance with GAAP on a
consolidated basis for itself and its Subsidiaries together with an audit report certified by independent certified public accountants of recognized standing whose opinion shall not be qualified as to the scope of the audit or as to the status of
the Borrower and its consolidated Subsidiaries as a going concern, accompanied by any management letter prepared by said accountants. 

  
 50 

 (b)    As soon as available, but in any event on or prior to the earlier
of (i) the 45th day after the close of the first three quarterly periods of each of its fiscal years and (ii) the day that is five (5) Business Days after the date the Borrower’s quarterly report on Form 10-Q is required to be
filed with the SEC after giving effect to any extensions permitted by the SEC (commencing with the first fiscal quarter of the Borrower ending after the Effective Date), for itself and its Subsidiaries, a consolidated unaudited balance sheet as at
the close of each such period and consolidated unaudited statements of earnings, statements of equity and cash flows for the period from the beginning of such fiscal year to the end of such quarter, all certified by its chief financial officer,
chief accounting officer or treasurer. 
 (c)    Together with the financial statements required under Sections 6.01(a)
and (b), a compliance certificate in substantially the form of Exhibit A signed by its chief financial officer, chief accounting officer or treasurer showing the calculations necessary to determine compliance with the financial covenant set
forth in Section 6.10 and stating that no Default or Unmatured Default exists, or if any Default or Unmatured Default exists, stating the nature and status thereof, it being understood and agreed that in the event the Borrower delivers a notice
to the Administrative Agent pursuant to the proviso to the definition of “Agreement Accounting Principles” the Borrower shall deliver an additional calculation of compliance with the financial covenant set forth in Section 6.10
demonstrating that notwithstanding GAAP in effect at such time, the Borrower has complied with Section 6.10 under GAAP as in effect and applied immediately before such change in GAAP (in the case of such a notice under “Agreement
Accounting Principles); provided that in no event shall the Borrower be required to furnish the Administrative Agent with more than one version of financial statements pursuant to Section 6.01(a) or Section 6.01(b) prepared in
accordance with different versions of GAAP as a result of any such notice. 
 (d)    Such other information with respect
to the business, condition or operations, financial or otherwise, and Properties of the Borrower and its Subsidiaries as the Administrative Agent, including at the request of any Lender, may from time to time reasonably request. 

Documents required to be delivered pursuant to Section 6.01(a) or (b) may be delivered electronically and if so delivered, shall be deemed to
have been delivered on the date (i) on which the Borrower posts such documents, or provides a link thereto on the Borrower’s website on the Internet at http://investor.walgreensbootsalliance.com or such other website with respect to which
the Borrower may from time to time notify the Administrative Agent and to which the Lenders have access; or (ii) on which such documents are posted on the Borrower’s behalf by the Administrative Agent on SyndTrak or another relevant
website, if any, to which each Lender and the Administrative Agent have access (whether a commercial, third-party website or whether sponsored by the Administrative Agent) or filed electronically through EDGAR and available on the Internet at
www.sec.gov; provided that the Borrower shall notify (which may be by facsimile or electronic mail) the Administrative Agent of the posting or filing of any such documents and 

  
 51 

 
provide to the Administrative Agent by electronic mail electronic versions (i.e., soft copies) of such documents. The Administrative Agent shall have no obligation to request the delivery or to
maintain copies of the documents referred to above, and in any event shall have no responsibility to monitor compliance by the Borrower with any such request for delivery. 

The Borrower hereby acknowledges that (a) the Administrative Agent and/or the Arranger may make available to the Lenders materials and/or
information provided by or on behalf of the Borrower hereunder (collectively, “Borrower Materials”) by posting the Borrower Materials on SyndTrak or another similar electronic system (the “Platform”) and
(b) certain of the Lenders (each a “Public Lender”) may have personnel who do not wish to receive material non-public information with respect to the Borrower or its Affiliates, or the respective securities of any of the
foregoing, and who may be engaged in investment and other market-related activities with respect to such Persons’ securities. The Borrower hereby agrees that (w) all Borrower Materials that are to be made available to Public Lenders shall
be clearly and conspicuously marked “PUBLIC” which, at a minimum, shall mean that the word “PUBLIC” shall appear prominently on the first page thereof; (x) by marking Borrower Materials “PUBLIC,” the Borrower shall
be deemed to have authorized the Administrative Agent, the Arranger and the Lenders to treat the Borrower Materials as not containing any material non-public information with respect to the Borrower or its securities for purposes of United States
Federal and state securities laws (provided, however, that to the extent the Borrower Materials constitute Information, they shall be treated as set forth in Section 9.10); (y) all Borrower Materials marked “PUBLIC” are
permitted to be made available through a portion of the Platform designated “Public Side Information;” and (z) the Administrative Agent and the Arranger shall be entitled to treat the Borrower Materials that are not marked
“PUBLIC” as being suitable only for posting on a portion of the Platform that is not designated “Public Side Information.” 

Section 6.02    Use of Proceeds. The Borrower will, and will cause each of
its Subsidiaries to, use the proceeds of the Loans for general corporate purposes. The Borrower shall use the proceeds of the Loans in compliance with all applicable legal and regulatory requirements and any such use shall not result in a violation
of any such requirements, including, without limitation, Regulation U and Regulation X, the Securities Act of 1933 and the Securities Exchange Act of 1934 and the regulations promulgated thereunder. 

Section 6.03    Notice of Default. The Borrower will give
prompt notice in writing to the Lenders of the occurrence of any Default or Unmatured Default after an Authorized Officer becomes aware of such Default or Unmatured Default. 

Section 6.04    Conduct of Business. The Borrower will, and will cause each of its Major Subsidiaries
to, except as otherwise permitted by Section 6.07, do all things necessary to remain duly incorporated or organized, validly existing and (to the extent such concept applies to such entity) in good standing as a corporation, partnership, limited
liability company or other entity in its jurisdiction of incorporation or organization, as the case may be, and maintain all requisite authority to conduct its business in each jurisdiction in which its business is conducted, except in each case
(other than valid existence of the Borrower) where the failure to do so would not reasonably be expected to have a Material Adverse Effect. 

  
 52 

 Section 6.05    Compliance with Laws. The Borrower
will, and will cause each of its Major Subsidiaries to, comply in all material respects with all applicable laws, rules, regulations and orders (such compliance to include, without limitation, compliance with ERISA and Environmental Laws and paying
before the same become delinquent all taxes, assessments and governmental charges imposed upon it or upon its property except to the extent contested in good faith), except to the extent such noncompliance would not have a Material Adverse Effect.

 Section 6.06    Inspection; Keeping of Books and Records. Subject to applicable law and third
party confidentiality agreements entered into by the Borrower or any Subsidiary in the ordinary course of business, the Borrower will, and will cause each Subsidiary to, permit the Administrative Agent, during the continuance of a Default or
Unmatured Default, by its representatives and agents, to inspect any of the Property, books and financial records of the Borrower and each Subsidiary, to examine and make copies of the books of accounts and other financial records of the Borrower
and each Subsidiary, and to discuss the affairs, finances and accounts of the Borrower and each Subsidiary with their respective officers at such reasonable times and intervals as the Administrative Agent may designate but in all events upon
reasonable prior notice to the Borrower’s Finance Department, Attention: Chief Accounting Officer, with a copy to Vice President, Global Treasury. The Borrower shall keep and maintain, and cause each of its Subsidiaries to keep and maintain, in
all material respects, proper books of record and account in which entries in conformity with GAAP shall be made of all dealings and transactions in relation to their respective businesses and activities. 

Section 6.07    Merger. (a) The Borrower will not merge into or consolidate with any other Person,
unless (i) the Person formed by such consolidation or into which the Borrower is merged shall be a Person organized and existing under the laws of the United States of America, any State thereof or the District of Columbia and shall expressly
assume pursuant to an instrument executed and delivered to the Administrative Agent, and in form and substance reasonably satisfactory to the Administrative Agent, the Borrower’s obligations for the due and punctual payment of the Obligations
and the performance of every covenant of this Agreement on the part of the Borrower to be performed; and (ii) immediately after giving effect to such transaction, no Default or Unmatured Default shall have occurred and be continuing. For the
avoidance of doubt, this Section 6.07 shall only apply to a merger or consolidation in which the Borrower is not the surviving Person. 

(b)    Upon any consolidation by the Borrower with or merger by the Borrower into any other Person, the successor Person
formed by such consolidation or into which the Borrower is merged shall succeed to, and be substituted for, and may exercise every right and power of, the Borrower under this Agreement with the same effect as if such successor Person had been named
as the Borrower herein. 
 Section 6.08    Sale of Assets. The Borrower will not lease, sell or
otherwise dispose of, or permit one or more Subsidiaries to lease, sell or otherwise dispose of, all or substantially all of the Property of the Borrower and the Subsidiaries, taken as a whole, to any Person, unless, immediately before and after
giving effect thereto, no Default or Unmatured Default would exist. 

  
 53 

 Section 6.09    Liens. The Borrower will not, and
will not permit any Major Subsidiary to, create or suffer to exist any Lien in, of or on any of its Property, in each case to secure or provide for the payment of any Indebtedness for Borrowed Money, except: 

(a)    Liens for taxes, assessments or governmental charges or levies on its Property if the same shall not at the time be
delinquent or thereafter can be paid without penalty, or are being contested in good faith and by appropriate proceedings and for which adequate reserves in accordance with Agreement Accounting Principles shall have been set aside on its books. 

(b)    Liens for taxes, assessments or governmental charges or levies on its Property regardless of their delinquency or
whether they can be paid without penalty provided such taxes, assessments, charges or levies do not in the aggregate at any one time exceed $10,000,000. 

(c)    Liens imposed by law, such as carriers’, warehousemen’s and mechanics’ liens and other similar liens
arising in the ordinary course of business which secure payment of obligations not more than sixty (60) days past due or which are being contested in good faith by appropriate proceedings and for which adequate reserves in accordance with
Agreement Accounting Principles shall have been set aside on its books. 
 (d)    Liens arising out of pledges or
deposits under worker’s compensation laws, unemployment insurance, old age pensions, or other social security or retirement benefits, or similar legislation. 

(e)    Utility easements, building restrictions and such other encumbrances or charges against real property as the
Borrower reasonably deems necessary or desirable consistent with past practices. 
 (f)    Precautionary Liens provided
by the Borrower or any Major Subsidiary in connection with the sale, assignment, transfer or other disposition of assets by the Borrower or any Major Subsidiary which transaction is determined by the Board of Directors of the Borrower or such Major
Subsidiary to constitute a “sale” under accounting principles generally accepted in the United States. 

(g)    Liens existing on the date hereof securing Indebtedness for Borrowed Money (and the replacement, extension or
renewal thereof upon or in the same property). 
 (h)    Liens securing Indebtedness for Borrowed Money in an aggregate
amount, immediately after giving effect to the incurrence of such Indebtedness for Borrowed Money, not to exceed 15% of Total Tangible Assets. 

  
 54 

 (i)    Liens on deposits, cash or cash equivalents, if any, in favor of
any issuer of one or more letters of credit issued under the Existing Revolving Credit Agreement to cash collateralize or otherwise secure the obligations of a defaulting lender to fund risk participations thereunder. 

(j)    Usual and customary set off rights with respect to bank accounts and brokerage accounts in the ordinary course of
business. 
 (k)    Usual and customary deposits in favor of lessors and similar deposits in the ordinary course of
business. 
 (l)    Liens existing on property of any Person acquired by the Borrower or Major Subsidiary, other than
any such Lien or security interest created in contemplation of such acquisition (and the replacement, extension or renewal thereof upon or in the same property). 

Section 6.10    Financial Covenant. As of the last day of each fiscal quarter of the Borrower,
commencing with the first full fiscal quarter-end date occurring after the Effective Date, the ratio of Consolidated Debt to Total Capitalization shall not be greater than 0.60:1.00; provided that upon the consummation of any Material
Acquisition and the written election of the Borrower to the Administrative Agent (which shall promptly notify the Lenders) no later than thirty days following the consummation of a Material Acquisition, the maximum permitted ratio of Consolidated
Debt to Total Capitalization set forth above shall increase to 0.70 to 1.00 with respect to the last day of the fiscal quarter during which such Material Acquisition shall have been consummated and the last day of each of the immediately following
three consecutive fiscal quarters; provided further that (i) the Borrower may only make an election pursuant to the immediately preceding proviso on two separate occasions prior to the Maturity Date and (ii) from the period beginning on
the date the definitive documentation relating to any Material Acquisition is entered into (or, in the case of a Material Acquisition in the form of a tender offer or similar transaction, after the offer shall have been launched) prior to the date
such Material Acquisition is consummated (or such definitive documentation is terminated), any Acquisition Debt and the proceeds thereof shall be excluded from the calculation of the ratio of Consolidated Debt to Total Capitalization. 

Section 6.11    Sanctions. The Borrower and its Subsidiaries will not, directly or, to the knowledge of
the Borrower, indirectly, (a) use the proceeds of the Loans, or (b) lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or other individual or entity, in each case, to fund any activities or
business (x) of or with any individual or entity named on the most current list of Specially Designated Nationals or Blocked Persons maintained by OFAC or the U.S. Department of State, or (y) in any country or territory, that, at the time
of such funding, is, or whose government is, the subject of Sanctions, except in the case of (a) or (b) to the extent licensed by OFAC or otherwise permissible under U.S. law. 

  
 55 

 ARTICLE VII 

DEFAULTS 
 The occurrence of any
one or more of the following events shall constitute a Default: 
 Section 7.01    Breach of
Representations or Warranties. Any representation or warranty made by the Borrower to the Lenders or the Administrative Agent under this Agreement, or any certificate or information delivered in connection with this Agreement, shall be false in
any material respect when made or deemed made. 
 Section 7.02    Failure to Make Payments When Due.
Nonpayment of (a) principal of any Loan when due, or (b) interest upon any Loan, any Commitment Fee, any Minimum Average Percentage Utilization Fee or other payment Obligations under any of the Loan Documents within five (5) Business
Days after such interest, fee or other Obligation becomes due. 
 Section 7.03    Breach of
Covenants. The breach by the Borrower of (a) any of the terms or provisions of Section 6.03, 6.07, 6.08, 6.09 or 6.10 or (b) any of the other terms or provisions of this Agreement which is not remedied within thirty (30) days
after an Authorized Officer of the Borrower knows of the occurrence thereof. 
 Section 7.04    Cross
Default. (a) The Borrower or any Major Subsidiary shall fail to pay any principal of or premium or interest on (x) any Indebtedness for Borrowed Money which is outstanding in a principal amount of at least the Requisite Amount in the
aggregate (but excluding indebtedness arising hereunder) or (y) a Capitalized Lease in respect of any single Property in an amount equal to at least $500,000,000, in each case, of the Borrower or such Major Subsidiary (as the case may be), when
the same becomes due and payable (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise), and such failure shall continue after the applicable grace period, if any, specified in the agreement or instrument relating to
such Indebtedness for Borrowed Money or Capitalized Lease, as applicable, unless adequate provision for any such payment has been made in form and substance satisfactory to the Required Lenders. 

(b)    Any (x) Indebtedness for Borrowed Money of the Borrower or any Major Subsidiary which is outstanding in a
principal amount of at least the Requisite Amount in the aggregate or (y) Capitalized Lease in respect of any single Property in an amount equal to at least $500,000,000, in each case, shall be declared to be due and payable, or required to be
prepaid (other than by a scheduled required prepayment), redeemed, purchased or defeased, or an offer to prepay, redeem, purchase or defease such Indebtedness for Borrowed Money or Capitalized Lease, as applicable, shall be required to be made, in
each case prior to the stated maturity thereof as a result of a breach by the Borrower or such Major Subsidiary (as the case may be) of the agreement or instrument relating to such Indebtedness for Borrowed Money or Capitalized Lease, as applicable,
and such failure shall continue after the applicable grace period, if any, specified in the agreement or instrument relating to such Indebtedness for Borrowed Money or Capitalized Lease, as applicable, unless adequate provision for the payment of
such Indebtedness for Borrowed Money or Capitalized Lease, as applicable, has been made in form and substance satisfactory to the Required Lenders. 

(c)    The Borrower or any of its Major Subsidiaries shall admit in writing its inability to pay its debts generally as
they become due. 

  
 56 

 Section 7.05    Voluntary Bankruptcy; Appointment of
Receiver; Etc. The Borrower or any of its Major Subsidiaries shall (a) have an order for relief entered with respect to it under the Federal bankruptcy laws as now or hereafter in effect, (b) make an assignment for the benefit of
creditors, (c) apply for, seek, consent to, or acquiesce in, the appointment of a receiver, custodian, trustee, examiner, liquidator or similar official for it or any Substantial Portion of its Property, (d) institute any proceeding
seeking an order for relief under the Federal bankruptcy laws as now or hereafter in effect or seeking to adjudicate it bankrupt or insolvent, or seeking dissolution, winding up, liquidation, reorganization, arrangement, adjustment or composition of
it or its debts under any law relating to bankruptcy, insolvency or reorganization or relief of debtors or fail to file an answer or other pleading denying the material allegations of any such proceeding filed against it, (e) take any corporate
or partnership action to authorize or effect any of the foregoing actions set forth in this Section 7.05, or (f) fail to contest in good faith any appointment or proceeding described in Section 7.06 

Section 7.06    Involuntary Bankruptcy; Appointment of Receiver; Etc. Without the application, approval
or consent of the Borrower or any of its Major Subsidiaries, a receiver, trustee, custodian, examiner, liquidator or similar official shall be appointed for the Borrower or any of its Major Subsidiaries or any Substantial Portion of its Property, or
a proceeding described in Section 7.05(d) shall be instituted against the Borrower or any of its Major Subsidiaries, and such appointment continues undischarged, or such proceeding continues undismissed or unstayed, in each case, for a period
of sixty (60) consecutive days. 
 Section 7.07    Judgments. The Borrower or any of its Major
Subsidiaries shall fail within sixty (60) days to pay, bond or otherwise discharge one or more judgments or orders for the payment of money (except to the extent covered by independent third party insurance and as to which the insurer has not
disclaimed coverage) in excess of the Requisite Amount (or the equivalent thereof in currencies other than Dollars) in the aggregate, which judgment(s), in any such case, is/are not stayed on appeal or otherwise being appropriately contested in good
faith. 
 Section 7.08    Unfunded Liabilities. (i) The aggregate Unfunded Liabilities of all
Plans would reasonably be expected to result in a material adverse effect on the financial condition, results of operations, business or Property of the Borrower and its Subsidiaries taken as a whole; (ii) the present value of the unfunded
liabilities to provide the accrued benefits under all Foreign Pension Plans in the aggregate would reasonably be expected to result in a material adverse effect on the financial condition, results of operations, business or Property of the Borrower
and its Subsidiaries taken as a whole; or (iii) any Reportable Event shall occur in connection with any Plan and such Reportable Event would reasonably be expected to result in a material adverse effect on the financial condition, results of
operations, business or Property of the Borrower and its Subsidiaries taken as a whole. 

Section 7.09    Reserved. 

Section 7.10    Other ERISA Liabilities. The Borrower, any Subsidiary or any other member of the
Controlled Group shall have been notified by the sponsor of a Multiemployer Plan that it has incurred withdrawal liability or become obligated to make contributions to a 

  
 57 

 
Multiemployer Plan in an amount which, when aggregated with all other amounts required to be paid to Multiemployer Plans by the Borrower, any Subsidiary or any other member of the Controlled
Group as withdrawal liability (determined as of the date of such notification), would reasonably be expected to result in a material adverse effect on the financial condition, results of operations, business or Property of the Borrower and its
Subsidiaries taken as a whole. 
 Section 7.11    Invalidity of Loan Documents. Any material
provision of any Loan Document, at any time after its execution and delivery and for any reason other than as expressly permitted hereunder or thereunder or satisfaction in full of all the Obligations (other than contingent indemnification
obligations that survive the termination of this Agreement), ceases to be in full force and effect; or the Borrower contests in any manner the validity or enforceability of any Loan Document; or the Borrower denies that it has any or further
liability or obligation under any Loan Document, or purports to revoke, terminate or rescind any Loan Document for any reason other than as expressly permitted hereunder or thereunder. 

ARTICLE VIII 
 ACCELERATION,
WAIVERS, AMENDMENTS AND REMEDIES 
 Section 8.01    Acceleration, Etc. If any Default described in
Section 7.05 or 7.06 occurs, the obligations of the Lenders to make Loans shall automatically terminate and the Obligations of the Borrower shall immediately become due and payable without any election or action on the part of the Administrative
Agent or any Lender. If any other Default occurs, the Required Lenders (or the Administrative Agent with the consent of the Required Lenders) may terminate or suspend (in whole or in part) the obligations of the Lenders to make Loans or declare the
Obligations of the Borrower to be due and payable (in whole or in part), whereupon such Obligations shall become immediately due and payable, without presentment, demand, protest or notice of any kind, all of which the Borrower hereby expressly
waives. Promptly upon any acceleration of the Obligations, the Administrative Agent will provide the Borrower with notice of such acceleration. 

If, within thirty (30) days after acceleration of the maturity of the Obligations of the Borrower or termination of the obligations of
the Lenders to make Loans hereunder as a result of any Default (other than any Default as described in Section 7.05 or 7.06) and before any judgment or decree for the payment of the Obligations due shall have been obtained or entered, the Required
Lenders (in their sole discretion) shall so direct, the Administrative Agent shall, by notice to the Borrower, rescind and annul such acceleration and/or termination. 

Section 8.02    Amendments. Subject to the provisions of this Article VIII and except as otherwise
specified herein (including pursuant to a LIBOR Successor Amendment), the Required Lenders (or the Administrative Agent with the consent in writing of the Required Lenders) and the Borrower may enter into agreements supplemental hereto for the
purpose of adding or modifying any provisions to the Loan Documents or changing in any manner the rights of the 

  
 58 

 
Lenders or the Borrower hereunder or thereunder or waiving any Default hereunder or thereunder; provided, however, that no such supplemental agreement shall: 

(a)    Extend the final maturity of any of the Loans of any Lender or forgive all or any portion of the principal amount
thereof payable to any Lender, or reduce the rate or extend the scheduled time of payment of interest or fees thereon (other than a waiver of the application of the default rate of interest pursuant to Section 2.11 hereof) payable to any Lender,
without the consent of each Lender affected thereby. 
 (b)    Reduce the percentage specified in the definition of
Required Lenders or any other percentage of Lenders specified to be the applicable percentage in this Agreement to act on specified matters or amend Section 2.19 or the definition of “Pro Rata Share”, without the consent of all Lenders
affected thereby. For the sake of clarity, the addition of one or more term loan facilities or the increase or addition of one or more revolving credit facilities or an extension of the maturity of a portion of the Revolving Facility and similar
modifications shall be permitted with the consent of the Required Lenders and the Lenders agreeing to participate in the new facility or to increase the amount of their commitment or extend the maturity of their Loans. 

(c)    Extend the Maturity Date or the Facility Termination Date as it applies to any Lender (other than as expressly
permitted by the terms of Section 2.02(a)), or increase the amount or otherwise extend the term of the Commitment of any Lender hereunder (other than as expressly permitted by the terms of Section 2.01(b)) without the consent of each
Lender affected thereby. 
 (d)    Permit the Borrower to assign its rights or obligations under this Agreement except
as provided in Section 6.07 without the consent of all Lenders. 
 (e)    Amend this Section 8.02 without the
consent of all Lenders. 
 provided further, that (i) no amendment of any provision of this Agreement relating to the Administrative Agent shall
be effective without the written consent of the Administrative Agent; (ii) no amendment, waiver or consent shall, unless in writing and signed by the Administrative Agent in addition to the Lenders required above, affect the rights or duties of
the Administrative Agent under this Agreement or any other Loan Document; (iii) any provision of this Agreement or any other Loan Document may be amended by an agreement in writing entered into by the Borrower and the Administrative Agent to
cure any ambiguity, omission, defect or inconsistency (including, without limitation, amendments, supplements or waivers to any of documents executed by the Borrower or any Subsidiary in connection with this Agreement if such amendment, supplement
or waiver is delivered in order to cause such related documents to be consistent with this Agreement and the other Loan Documents) and (iv) the Administrative Agent and the Borrower may enter into amendments or modifications to this Agreement
or enter into additional documentation as the Administrative Agent reasonably deems appropriate in order to implement any Replacement Rate or otherwise effectuate the terms of Section 3.07(b) in accordance with the terms of
Section 3.07(b). Notwithstanding anything to the contrary herein, no Defaulting Lender shall have any right to approve or disapprove any amendment, waiver or consent hereunder, (it being specifically understood and agreed that any amendment,
waiver or consent which by its terms requires the consent of all Lenders or each affected Lender may be effected with the consent of the applicable Lenders other than Defaulting Lenders), except that

  
 59 

 
(A) the Commitment of such Lender may not be increased or extended without the consent of such Lender and (B) any waiver, amendment or modification requiring the consent of all Lenders or
each affected Lender that by its terms affects any Defaulting Lender more adversely than other affected Lenders shall require the consent of such Defaulting Lender. 

Section 8.03    Preservation of Rights. No delay or omission of the Lenders or the Administrative Agent
to exercise any right under the Loan Documents shall impair such right or be construed to be a waiver of any Default or an acquiescence therein, and the making of a Loan notwithstanding the existence of a Default or Unmatured Default or the
inability of the Borrower to satisfy the conditions precedent to such Loan shall not constitute any waiver or acquiescence. Any single or partial exercise of any such right shall not preclude other or further exercise thereof or the exercise of any
other right, and no waiver, amendment or other variation of the terms, conditions or provisions of the Loan Documents whatsoever shall be valid unless in writing signed by, or by the Administrative Agent with the consent of, the requisite number of
Lenders required pursuant to Section 8.02, and then only to the extent in such writing specifically set forth. All remedies contained in the Loan Documents or by law afforded shall be cumulative and all shall be available to the Administrative Agent
and the Lenders until all of the Obligations have been paid in full. 
 ARTICLE IX 

GENERAL PROVISIONS 

Section 9.01    Survival of Representations. All representations and warranties made hereunder and in
any other Loan Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and thereof. Such representations and warranties have been or will be relied upon
by the Administrative Agent and each Lender, regardless of any investigation made by the Administrative Agent, any Lender or on their behalf and notwithstanding that the Administrative Agent, any Lender may have had notice or knowledge of any
Default at the time of any Loan, and shall continue in full force and effect as long as any Loan or any other Obligation hereunder (other than any contingent indemnification obligations for which no claim has been made) shall remain unpaid or
unsatisfied. 
 Section 9.02    Governmental Regulation. Anything contained in this Agreement to the
contrary notwithstanding, no Lender shall be obligated to extend credit to the Borrower in violation of any limitation or prohibition provided by any applicable statute or regulation. 

Section 9.03    Headings. Section headings in the Loan Documents are for convenience of reference only,
and shall not govern the interpretation of any of the provisions of the Loan Documents. 

Section 9.04    Entire Agreement. The Loan Documents embody the entire agreement and understanding
among the Borrower, the Administrative Agent, the Arranger and the Lenders party thereto and supersede all prior agreements and understandings among the Borrower, the Administrative Agent, the Arranger and the Lenders, as applicable, relating to the
subject matter thereof. 

  
 60 

 Section 9.05    Several Obligations; Benefits of this
Agreement. The respective obligations of the Lenders hereunder are several and not joint and no Lender shall be the partner or agent of any other (except to the extent to which the Administrative Agent is authorized to act as such). The failure
of any Lender to perform any of its obligations hereunder shall not relieve any other Lender from any of its obligations hereunder. Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties
hereto, their respective successors and assigns permitted hereby, Participants to the extent provided in Section 12.01(d) and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent and the Lenders) any
legal or equitable right, remedy or claim under or by reason of this Agreement; provided, however, that the parties hereto expressly agree that each Arranger shall enjoy the benefits of the provisions of Sections 9.06, 9.09 and 10.07
to the extent specifically set forth therein and shall have the right to enforce such provisions on its own behalf and in its own name to the same extent as if it were a party to this Agreement. 

Section 9.06    Expenses; Indemnification. (a) Costs and Expenses. The Borrower shall
reimburse (i) all reasonable and documented out-of-pocket expenses incurred by, without duplication, the Administrative Agent, the Arranger and their respective Affiliates (including the reasonable fees, charges and disbursements of Sidley
Austin LLP), in connection with the syndication of the credit facilities provided for herein, the preparation, negotiation, execution, delivery and administration of this Agreement and the other Loan Documents or any amendments, modifications or
waivers of the provisions hereof or thereof (whether or not the transactions contemplated hereby or thereby shall be consummated) and (ii) all reasonable and documented out-of-pocket expenses incurred by the Administrative Agent and the Lenders
(including the reasonable fees, charges and disbursements of one primary counsel (and to the extent reasonably determined to be necessary, one local counsel and one regulatory counsel in any applicable jurisdiction) for the Administrative Agent, the
Arranger and the Lenders) in connection with the enforcement or protection of its rights (A) in connection with this Agreement and the other Loan Documents, including its rights under this Section, or (B) in connection with the Loans made
hereunder, including all such reasonable and documented out-of-pocket expenses incurred during any workout, restructuring or negotiations in respect of such Loans. 

(b)    Indemnification by the Borrower. The Borrower shall indemnify the Administrative Agent (and any sub-agent
thereof) and each Lender, and each Related Party of any of the foregoing Persons (each such Person being called an “Indemnitee”) against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and
the reasonable and documented out-of-pocket legal and other related expenses (including the reasonable fees, charges and disbursements of any counsel for any Indemnitee), in each case to the extent arising out of any investigation, litigation, claim
or proceeding in connection with or as a result of (i) the execution or delivery of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto

  
 61 

 
of their respective obligations hereunder or thereunder, the consummation of the transactions contemplated hereby or thereby, or, in the case of the Administrative Agent (and any sub-agent
thereof) and its Related Parties only, the administration of this Agreement and the other Loan Documents (including in respect of any matters addressed in Section 3.05), (ii) any Loan or the use or proposed use of the proceeds therefrom,
(iii) any actual or alleged presence or release of Hazardous Materials on or from any property owned, leased or operated by the Borrower or any of its Subsidiaries, or any Environmental Liability related in any way to the Borrower or any of its
Subsidiaries or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by the Borrower, and
regardless of whether any Indemnitee is a party thereto; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of
competent jurisdiction by final and nonappealable judgment to have resulted from (x) the bad faith, gross negligence or willful misconduct of such Indemnitee or its Related Parties, (y) a material breach of such Indemnitee’s or its
Related Parties’ obligations hereunder or under any other Loan Document or (z) a dispute among two or more Indemnitees not arising from any act or omission of the Borrower or its Subsidiaries hereunder (but not including any such dispute
that involves a Lender to the extent such Lender is acting in a different capacity (i.e., the Administrative Agent or the Arranger) under any Loan Document). This Section 9.06(b) shall not apply with respect to Taxes other than any Taxes that
represent losses, claims, damages, etc. arising from any non-Tax claim. 
 (c)    Reimbursement by Lenders. To
the extent that the Borrower for any reason fails to indefeasibly pay any amount required under subsection (a) of this Section or the Borrower for any reason fail to indefeasibly pay or cause to be paid any amount required under subsection
(b) of this Section, in each case, to be paid to the Administrative Agent (or any sub-agent thereof) or any Related Party of any of the foregoing, each Lender severally agrees to pay to the Administrative Agent (or any such sub-agent) or such
Related Party, as the case may be, such Lender’s ratable share (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount, provided that the unreimbursed expense or
indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent (or any such sub-agent) in its capacity as such, or against any Related Party of any of the foregoing
acting for the Administrative Agent (or any such sub-agent) in connection with such capacity. The obligations of the Lenders under this subsection (c) are subject to the provisions of Section 2.17(b). 

(d)    Waiver of Consequential Damages, Etc. To the fullest extent permitted by applicable law, each party hereto
shall not assert, and hereby waives, any claim against any other party hereto, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a
result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby, the transactions contemplated hereby or thereby, any Loan or the use of the proceeds thereof (it being agreed that the Borrower’s indemnity
and contribution obligations set forth in this Section 9.06 shall apply in respect of any special, indirect, consequential or punitive damages that may 

  
 62 

 
be awarded against any Indemnitee in connection with a claim by a third party unaffiliated with the Indemnitee). No Indemnitee referred to in subsection (b) above shall be liable for any
damages arising from the use by unintended recipients of any information or other materials distributed to such unintended recipients by such Indemnitee through telecommunications, electronic or other information transmission systems in connection
with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby other than for direct or actual damages resulting from the gross negligence, bad faith or willful misconduct of such Indemnitee or its Related Parties
or a material breach of such Indemnitee’s or its Related Parties’ obligations hereunder or under any other Loan Document, in each case, as determined by a final and nonappealable judgment of a court of competent jurisdiction. 

(e)    Payments. All amounts due under this Section shall be payable not later than ten (10) Business Days
after written demand therefor. 
 (f)    Survival. The agreements in this Section shall survive the resignation
of the Administrative Agent, the replacement of any Lender, the termination of this Agreement or the Aggregate Commitment and the repayment, satisfaction or discharge of all the other Obligations. 

Section 9.07    Accounting. Except as provided to the contrary herein, all accounting terms used herein
shall be interpreted and all accounting determinations hereunder shall be made in accordance with the Agreement Accounting Principles. 

Section 9.08    Severability of Provisions. Any provision in any Loan Document that is held to be
inoperative, unenforceable, or invalid in any jurisdiction shall, as to that jurisdiction, be inoperative, unenforceable, or invalid without affecting the remaining provisions in that jurisdiction or the operation, enforceability, or validity of
that provision in any other jurisdiction, and to this end the provisions of all Loan Documents are declared to be severable. Without limiting the foregoing provisions of this Section 9.08, if and to the extent that the enforceability of any
provisions in this Agreement relating to Defaulting Lenders shall be limited by Debtor Relief Laws, as determined in good faith by the Administrative Agent, then such provisions shall be deemed to be in effect only to the extent not so limited. 

Section 9.09    Nonliability of Lenders. The relationship between the Borrower on the one hand and the
Lenders, the Arranger and the Administrative Agent on the other hand shall be solely that of borrower and lender. None of the Administrative Agent, the Arranger or any Lender shall have any fiduciary responsibilities to the Borrower. None of the
Administrative Agent, the Arranger or any Lender undertakes any responsibility to the Borrower to review or inform the Borrower of any matter in connection with any phase of the Borrower’s business or operations. 

Section 9.10    Confidentiality. Each of the Administrative Agent and the Lenders agrees to maintain
the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its Affiliates and to its and its Affiliates’ respective partners, directors, officers, employees, agents, trustees, advisors and
representatives on a confidential basis (it being understood that the Persons to whom such disclosure is made will be informed of 

  
 63 

 
the confidential nature of such Information and instructed to keep such Information confidential and with the Person, to the extent such compliance is within its control, disclosing such
information being responsible for such compliance), (b) to the extent requested by any state, federal or foreign authority or examiner regulating banks or banking or otherwise purporting to have jurisdiction over it or its Affiliates (including
any self-regulatory authority, such as the National Association of Insurance Commissioners); provided that the Administrative Agent and the Lenders, as applicable, shall, to the extent practicable and not prohibited by applicable law, give
the Borrower reasonable notice thereof before complying therewith, except to the extent in connection with an audit or examination conducted by a regulatory authority having jurisdiction over it or its affiliates, (c) as may be compelled in a
judicial or administrative proceeding or as otherwise required by applicable laws or regulations or by any subpoena or similar legal process, provided that the Administrative Agent and the Lenders, as applicable, shall, except with respect to
regulatory audit or examination conducted by accountants or any governmental or regulatory authority exercising examination or regulatory authority, to the extent practicable and not prohibited by applicable law, give the Borrower reasonable notice
thereof before complying therewith, except to the extent in connection with an audit or examination conducted by a regulatory authority having jurisdiction over it or its affiliates, (d) to any other party hereto, (e) in connection with
the exercise of any remedies or the enforcement of rights hereunder or under any other Loan Document in any suit, action or proceeding relating thereto to the extent such disclosure is reasonably necessary in connection with such suit, action or
proceeding (provided that the Borrower shall be given notice thereof and a reasonable opportunity, in each case to the extent reasonably practicable and to the extent permitted by applicable law, to seek a protective court order with respect to such
Information prior to such disclosure (it being understood that the refusal by a court to grant such a protective order shall not prevent the disclosure of such Information thereafter)), (f) subject to the acknowledgment and acceptance by any
such party that such information is being disseminated on a confidential basis in accordance with the standard syndication process of the Arranger or customary market standards for dissemination of such types of information, subject to customary
confidentiality restrictions that are no less restrictive in any material respect than those in this Section, which shall in any event require “click through” or other affirmative actions on the part of recipient to access such
information, to (i) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (ii) any actual or prospective counterparty (or its advisors) to any swap or
derivative transaction relating to the Borrower and its obligations, (g) with the consent of the Borrower, (h) in connection with obtaining CUSIP numbers, (i) to the extent such Information (x) is or becomes publicly available
other than as a result of a breach of this Section or (y) becomes available to the Administrative Agent, any Lender or any of their respective Affiliates from a source, other than the Borrower or its Affiliates, that is not to such
Person’s knowledge subject to any confidentiality or fiduciary obligation to the Borrower with respect to such Information or (j) to the extent that such information is independently developed by the Administrative Agent or Lender, as
applicable other than as a result of a breach of this Section. 
 In addition, on a confidential basis (except to the extent publicly
available other than as a result of a breach of this Section), the Administrative Agent and each Lender may disclose the 

  
 64 

 
existence of this Agreement and the information about this Agreement to market data collectors, similar services providers to the lending industry, and service providers to the Administrative
Agent and the Lenders in connection with the administration and management of this Agreement and the other Loan Documents. 
 For purposes
of this Section, “Information” means all information received from the Borrower or any Subsidiary relating to the Borrower or any Subsidiary or any of their respective businesses, other than any such information that is available to
the Administrative Agent or any Lender on a nonconfidential basis prior to disclosure by the Borrower or any Subsidiary. Any Person required to maintain the confidentiality of Information as provided in this Section shall be considered to have
complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information. 

Each of the Administrative Agent and the Lenders acknowledges that (a) the Information may include material non-public information
concerning the Borrower or a Subsidiary, as the case may be, (b) it has developed compliance procedures regarding the use of material non-public information and (c) it will handle such material non-public information in accordance with
applicable law, including United States Federal and state securities laws. 

Section 9.11    Nonreliance. Each of the Lenders hereby represents that it is not relying on or looking
to any margin stock (as defined in Regulation U) as collateral in the extension or maintenance of the credit provided for herein. 

Section 9.12    Disclosure. The Borrower and each Lender hereby acknowledge and agree that the
Administrative Agent and/or its respective Affiliates and certain of the other Lenders and/or their respective Affiliates from time to time may hold investments in, make other loans to or have other relationships with the Borrower and its
Affiliates. 
 ARTICLE X 

THE ADMINISTRATIVE AGENT 

Section 10.01    Appointment and Authority. Each of the Lenders hereby irrevocably appoints Bank of
America to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such actions on its behalf and to exercise such powers as are delegated to the Administrative Agent
by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto. The provisions of this Article, other than Section 10.06 below, are solely for the benefit of the Administrative Agent and the Lenders, and
the Borrower shall not have rights as a third party beneficiary of any of such provisions (other than as provided in Section 10.06 below). It is understood and agreed that the use of the term “agent” herein or in any other Loan Documents
(or any other similar term) with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable law. Instead such term is used as a matter of
market custom, and is intended to create or reflect only an administrative relationship between contracting parties. 

  
 65 

 Section 10.02    Rights as a Lender. The Person
serving as the Administrative Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not the Administrative Agent and the term “Lender” or
“Lenders” shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits
from, lend money to, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with the Borrower or any Subsidiary or other Affiliate thereof as if such Person were not the Administrative Agent
hereunder and without any duty to account therefor to the Lenders. 
 Section 10.03    Reliance by
Administrative Agent. The Administrative Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any
electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person; provided that the foregoing shall not relieve the
Administrative Agent of its obligations to comply with the procedures set forth in Section 2.08, including the requirement to orally confirm the location and number of the Borrower’s account to which proceeds of Loans are to be disbursed. The
Administrative Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. In determining compliance with any condition
hereunder to the making of a Loan that by its terms must be fulfilled to the satisfaction of a Lender, the Administrative Agent may presume that such condition is satisfactory to such Lender unless the Administrative Agent shall have received notice
to the contrary from such Lender prior to the making of such Loan. The Administrative Agent may consult with legal counsel (who may be counsel for the Borrower), independent accountants and other experts selected by it, and shall not be liable for
any action taken or not taken by it in good faith in accordance with the advice of any such counsel, accountants or experts. 

Section 10.04    Exculpatory Provisions. The Administrative Agent shall not have any duties or
obligations except those expressly set forth herein and in the other Loan Documents. Without limiting the generality of the foregoing, the Administrative Agent: 

(a)    shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is
continuing; 
 (b)    shall not have any duty to take any discretionary action or exercise any discretionary powers,
except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that the Administrative Agent is required to exercise as directed in writing by the Required Lenders (or such other number or percentage of the
Lenders as shall be expressly provided for herein or in the other Loan Documents), provided that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the
Administrative Agent to liability or that is contrary to any Loan Document or applicable law, including for the avoidance of doubt any action that may be in violation of the automatic stay under any Debtor Relief Law or that may effect a forfeiture,
modification or termination of property of a Defaulting Lender in violation of any Debtor Relief Law; and 

  
 66 

 (c)    shall not, except as expressly set forth herein and in the other
Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to the Borrower or any of its Affiliates that is communicated to or obtained by the Person serving as the Administrative Agent
or any of its Affiliates in any capacity. 
 The Administrative Agent shall not be liable for any action taken or not taken by it
(i) with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith shall be necessary, under the circumstances as
provided in Article VIII) or (ii) in the absence of its own gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and nonappealable judgment. The Administrative Agent shall be deemed not to have
knowledge of any Default unless and until written notice describing such Default is given to the Administrative Agent by the Borrower or a Lender. 

The Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or
representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the
performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any
other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set forth in Article IV or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the
Administrative Agent. 
 Section 10.05    Delegation of Duties. The Administrative Agent may perform
any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent. The Administrative Agent and any such sub-agent may perform any
and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Article shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such
sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as Administrative Agent. The Administrative Agent shall not be responsible for the
negligence or misconduct of any sub-agents except to the extent that a court of competent jurisdiction determines in a final and non-appealable judgment that the Administrative Agent acted with gross negligence or willful misconduct (or breached its
material obligations under the Loan Documents) in the selection of such sub-agents. 

Section 10.06    Resignation of Administrative Agent. The Administrative Agent may at any time give
notice of its resignation to the Lenders and the Borrower. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, subject to, so long as no 

  
 67 

 
Default has occurred and is continuing, the consent of the Borrower (such consent not to be unreasonably withheld or delayed), to appoint a successor, which shall be a bank with an office in the
United States, or an Affiliate of any such bank with an office in the United States. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30 days after the retiring Administrative
Agent gives notice of its resignation, then the retiring Administrative Agent may on behalf of the Lenders, appoint a successor Administrative Agent meeting the qualifications set forth above, subject to, so long as no Default has occurred and is
continuing, the consent of the Borrower (such consent not to be unreasonably withheld or delayed); provided that if the Administrative Agent shall notify the Borrower and the Lenders that no qualifying Person has accepted such appointment,
then such resignation shall nonetheless become effective in accordance with such notice and (1) the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents and
(2) except for any indemnity payments or other amounts then owed to the retiring Administrative Agent, all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to
each Lender directly, until such time as the Required Lenders appoint a successor Administrative Agent as provided for above in this Section. Upon the acceptance of a successor’s appointment as Administrative Agent hereunder, such successor
shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Administrative Agent (other than as provided in Section 3.08 and other than any rights to indemnity payments or other amounts owed
to the retiring Administrative Agent as of the effective date of its resignation), and the retiring Administrative Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already
discharged therefrom as provided above in this Section). The fees payable by the Borrower to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrower and such successor.
After the retiring Administrative Agent’s resignation hereunder and under the other Loan Documents, the provisions of this Article and Section 9.06 shall continue in effect for the benefit of such retiring Administrative Agent, its sub-agents
and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while the retiring Administrative Agent was acting as Administrative Agent. 

Section 10.07    Non-Reliance on Administrative Agent and Other Lenders. Each of the Lenders
acknowledges that it has, independently and without reliance upon the Administrative Agent or any other Lender or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and
decision to enter into this Agreement. Each of the Lenders also acknowledges that it will, independently and without reliance upon the Administrative Agent or any other Lender or any of their Related Parties and based on such documents and
information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or
thereunder. 
 Section 10.08    No Other Duties, Etc.. Anything herein to the contrary
notwithstanding, the Arranger listed on the cover page hereof shall not have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent or a
Lender hereunder. 

  
 68 

 Section 10.09    Administrative Agent May File Proofs of
Claim. In case of the pendency of any proceeding under any Debtor Relief Law or any other judicial proceeding relative to the Borrower, the Administrative Agent (irrespective of whether the principal of any Loan shall then be due and payable as
herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on the Borrower) shall be entitled and empowered (but not obligated), by intervention in such proceeding or otherwise:

 (a)    to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of
the Loans and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders and the Administrative Agent (including any claim for the reasonable
compensation, expenses, disbursements and advances of the Lenders and the Administrative Agent and their respective agents and counsel and all other amounts due the Lenders and the Administrative Agent) allowed in such judicial proceeding; and 

(b)    to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the
same; 
 and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby
authorized by each Lender to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders, to pay to the Administrative Agent any amount due for
the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due to the Administrative Agent. 

Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of any
Lender any plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender to authorize the Administrative Agent to vote in respect of the claim of any Lender in any such proceeding. 

Section 10.10    ERISA. 

(a)    Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and
(y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, that at least one of the following is and will be true: 

(i)    such Lender is not using “plan assets” (within the meaning of Section 3(42) of ERISA
or otherwise) of one or more Benefit Plans in connection with the Loans or the Commitments, 

  
 69 

 (ii)    the transaction exemption set forth in one or
more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1
(a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain
transactions determined by in-house asset managers), is applicable with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement, 

(iii)    (A) such Lender is an investment fund managed by a “Qualified Professional Asset
Manager” (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Commitments and
this Agreement, (C) the entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and
(D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the
Commitments and this Agreement, or 
 (iv)    such other representation, warranty and covenant as may be
agreed in writing between the Administrative Agent, in its sole discretion, and such Lender. 
 (b)    In addition,
unless either (1) sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with sub-clause (iv) in the
immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such
Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent, the Arranger and their respective Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Borrower, that none of the Administrative Agent,
the Arranger or any of their respective Affiliates is a fiduciary with respect to the assets of such Lender involved in the Loans, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the
Administrative Agent under this Agreement, any Loan Document or any documents related to hereto or thereto). 
 ARTICLE XI 

SETOFF 

Section 11.01    Setoff. In addition to, and without limitation of, any rights of the Lenders under
applicable law, if any Default occurs, any and all deposits (including all account balances, whether provisional or final and whether or not collected or available) and any other Indebtedness at any time held or owing by any Lender or any Affiliate
of any Lender to or for the credit or account of the Borrower may be offset and applied toward the payment of the 

  
 70 

 
Obligations of the Borrower then owing to such Lender to the extent the Obligations shall then be due; provided, that in the event that any Defaulting Lender shall exercise any such right
of setoff, (x) all amounts so set off shall be paid over immediately to the Administrative Agent for further application in accordance with the provisions of Section 2.20(a)(ii) and, pending such payment, shall be segregated by such
Defaulting Lender from its other funds and deemed held in trust for the benefit of the Administrative Agent and the Lenders, and (y) the Defaulting Lender shall provide promptly to the Administrative Agent a statement describing in reasonable
detail the Obligations owing to such Defaulting Lender as to which it exercised such right of setoff. 
 ARTICLE XII 

BENEFIT OF AGREEMENT; ASSIGNMENTS; PARTICIPATIONS 

Section 12.01    Successors and Assigns. (a) Successors and Assigns Generally. The
provisions of this Agreement and the other Loan Documents shall be binding upon and inure to the benefit of the parties hereto and thereto and their respective successors and assigns permitted hereby, except that the Borrower may not assign or
otherwise transfer any of its rights or obligations hereunder or thereunder without the prior written consent of the Administrative Agent and each Lender and no Lender may assign or otherwise transfer any of its rights or obligations hereunder
except (i) to an assignee in accordance with the provisions of subsection (b) of this Section, (ii) by way of participation in accordance with the provisions of subsection (d) of this Section or (iii) by way of pledge or
assignment of a security interest subject to the restrictions of subsection (f) of this Section (and any other attempted assignment or transfer by any party hereto shall be null and void). 

(b)    Assignments by Lenders. Any Lender may at any time assign to one or more assignees all or a portion of its
rights and obligations under this Agreement and the other Loan Documents (including all or a portion of its Commitment and the Loans at the time owing to it); provided that any such assignment shall be subject to the following conditions:

 (i)    Minimum Amounts. 

(A)    in the case of an assignment of the entire remaining amount of the assigning Lender’s
Commitment and the Loans at the time owing to it or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned; and 

(B)    in any case not described in subsection (b)(i)(A) of this Section, the aggregate amount of the
Commitment (which for this purpose includes Loans outstanding thereunder) or, if the Commitment is not then in effect, the principal outstanding balance of the Loans of the assigning Lender subject to each such assignment, determined as of the date
the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent or, if “Trade Date” is specified in the Assignment and Assumption, as of the Trade Date, shall not be less than $10,000,000 unless each
of the Administrative Agent and, so long as no Default under Sections 7.02, 7.05 or 7.06 has occurred and is continuing, 

  
 71 

 
the Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed); provided, however, that concurrent assignments to members of an Assignee Group and
concurrent assignments from members of an Assignee Group to a single Eligible Assignee (or to an Eligible Assignee and members of its Assignee Group) will be treated as a single assignment for purposes of determining whether such minimum amount has
been met. 
 (ii)    Proportionate Amounts. Each partial assignment shall be made as an assignment
of a proportionate part of all the assigning Lender’s rights and obligations under this Agreement with respect to the Loans or the Commitment assigned. 

(iii)    Required Consents. No consent shall be required for any assignment except to the extent
required by subsection (b)(i)(B) of this Section and, in addition: 
 (A)    the prior written consent of
the Borrower (such consent to be provided in the Borrower’s sole discretion) shall be required unless (i) a Default under Sections 7.02, 7.05 or 7.06 has occurred and is continuing at the time of such assignment or (ii) such
assignment is to a Person that is a Lender (as defined under the Existing Revolving Credit Agreement as in effect on the Signing Date) on the Signing Date and, as a result of such assignment, the assignee’s Commitment is equal to or less than
such assignee’s Commitment (as defined under the Existing Revolving Credit Agreement as in effect on the Signing Date) under the Existing Revolving Credit Agreement as in effect on the Signing Date; and 

(B)    the prior written consent of the Administrative Agent (such consent not to be unreasonably withheld
or delayed) shall be required if such assignment is to a Person that is not a Lender, an Affiliate of such Lender or an Approved Fund with respect to such Lender. 

(iv)    Assignment and Assumption. The parties to each assignment shall execute and deliver to the
Administrative Agent an Assignment and Assumption, together with a processing and recordation fee in the amount of $3,500; provided, however, that the Administrative Agent may, in its sole discretion, elect to waive such processing and
recordation fee in the case of any assignment. The assignee, if it is not a Lender, shall deliver to the Administrative Agent an administrative questionnaire. 

(v)    No Assignment to Borrower. No such assignment shall be made to the Borrower or any of its
Affiliates or Subsidiaries. 
 (vi)    No Assignment to Natural Persons. No such assignment shall
be made to a natural person. 
 (vii)    No Assignment to Defaulting Lenders. No such assignment
shall be made to a Defaulting Lender. 

  
 72 

 (viii)    Certain Additional Payments. In
connection with any assignment of rights and obligations of any Defaulting Lender hereunder, no such assignment shall be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to the assignment shall
make such additional payments to the Administrative Agent in an aggregate amount sufficient, upon distribution thereof as appropriate (which may be outright payment, purchases by the assignee of participations or subparticipations, or other
compensating actions, including funding, with the consent of the Borrower and the Administrative Agent, the Pro Rata Share of Loans previously requested but not funded by the Defaulting Lender, to each of which the applicable assignee and assignor
hereby irrevocably consent), to (x) pay and satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent or any Lender hereunder (and interest accrued thereon) and (y) acquire (and fund as
appropriate) its full Pro Rata Share of all Loans. Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become effective under applicable law without compliance with the
provisions of this paragraph, then the assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs. 

Subject to acceptance and recording thereof by the Administrative Agent pursuant to subsection (c) of this Section, from and after the
effective date specified in each Assignment and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under
this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all
of the assigning Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto) but shall continue to be entitled to the benefits of Sections 3.01, 3.03, 3.04, 3.05, and 9.06 with respect to facts and
circumstances occurring prior to the effective date of such assignment. Upon request, the Borrower (at its expense) shall execute and deliver a Note to the assignee Lender. Any assignment or transfer by a Lender of rights or obligations under this
Agreement that does not comply with this subsection shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with subsection (d) of this Section. 

(c)    Register. The Administrative Agent, acting solely for this purpose as a non-fiduciary agent of the Borrower,
shall maintain at the Administrative Agent’s Office a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated
interest) of the Loans owing to, each Lender pursuant to the terms hereof from time to time (the “Register”). The entries in the Register shall be conclusive, absent manifest error, and the Borrower, the Administrative Agent and the
Lenders may treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. In addition, the Administrative Agent shall maintain
on the Register information regarding the designation, and revocation of 

  
 73 

 
designation, of any Lender as a Defaulting Lender. The Register shall be available for inspection by the Borrower at any reasonable time and from time to time upon reasonable prior notice. In
addition, at any time that a request for a consent for a material or substantive change to the Loan Documents is pending, any Lender may request and receive from the Administrative Agent a copy of the Register. 

(d)    Participations. Any Lender may, with the prior written consent of the Borrower ((i) such consent to be
provided in the Borrower’s sole discretion, (ii) such consent not to be required if a Default under Sections 7.02, 7.05 or 7.06 has occurred and is continuing at the time of the sale of the applicable participation and (iii) such
consent not to be required for a participation to a Person that is a Lender (as defined under the Existing Revolving Credit Agreement as in effect on the Signing Date) on the Signing Date), sell participations to any Person (other than a natural
person, Defaulting Lender or the Borrower or any of its Affiliates or Subsidiaries) (each, a “Participant”), in all or a portion of such Lender’s rights and/or obligations under this Agreement (including all or a portion of its
Commitment and/or the Loans); provided that (i) such Lender’s obligations under this Agreement shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such
obligations and (iii) the Borrower, the Administrative Agent and the Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement. 

Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right
to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement; provided that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree
to any amendment, waiver or other modification described in the first proviso to Section 8.02 that affects such Participant. Subject to subsection (e) of this Section, the Borrower agrees that each Participant shall be entitled to the benefits
of Sections 3.01, 3.03, 3.04 and 3.05 to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to subsection (b) of this Section. To the extent permitted by law, each Participant also shall be entitled to
the benefits of Section 11.01 as though it were a Lender, provided that such Participant agrees to be subject to Section 2.19 as though it were a Lender. 

Each Lender that sells a participation shall, acting solely for this purpose as a nonfiduciary agent of the Borrower, maintain a register on
which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant’s interest in the Loans or other Obligations under the Loan Documents (the “Participant Register”);
provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant’s interest in any Commitments, Loans or
its other Obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such Commitment, Loan or other Obligation is in registered form under Section 5f.103-1(c) of the United States
Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register 

  
 74 

 
as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its capacity as
Administrative Agent) shall have no responsibility for maintaining a Participant Register. 
 (e)    Limitations upon
Participant Rights. A Participant shall not be entitled to receive any greater payment under Section 3.01, 3.03, 3.04 or 3.05 than the applicable Lender would have been entitled to receive with respect to the participation sold to such
Participant, unless the sale of the participation to such Participant is made with the Borrower’s prior written consent. A Participant shall not be entitled to the benefits of Section 3.05 unless such Participant agrees to comply with Section
3.05 as though it were a Lender (it being understood that the documentation required under Section 3.05(e) shall be delivered to the Lender who sells the participation). 

(f)    Certain Pledges. Any Lender may at any time pledge or assign a security interest in all or any portion of
its rights under this Agreement (including under its Note, if any) to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or other central banking authority having jurisdiction over
such Lender; provided that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto. 

Section 12.02    Dissemination of Information. The Borrower authorizes each of the Lenders to disclose
to any Participant or any other Person acquiring an interest in the Loan Documents by operation of law (each a “Transferee”) and any prospective Transferee any and all information in such Lender’s possession concerning the
creditworthiness of the Borrower and its Subsidiaries, including without limitation any information contained in any reports or other information delivered by the Borrower pursuant to Section 6.01; provided that each Transferee and
prospective Transferee agrees to be bound by Section 9.10 of this Agreement or other provisions at least as restrictive as Section 9.10 including making the acknowledgments set forth therein. 

Section 12.03    Tax Treatment. If any interest in any Loan Document is transferred to any Transferee
which is organized under the laws of any jurisdiction other than the United States or any State thereof, the transferor Lender shall cause such Transferee, concurrently with the effectiveness of such transfer, to comply with the provisions of
Section 3.05(e); provided, that damages for any breach of this Section 12.03 shall in no event exceed the reasonable out-of-pocket expenses incurred by the Borrower in collecting or attempting to collect from the Transferee any forms it
reasonably requires in order to determine its withholding and reporting obligations in accordance with Section 3.05(e) herein. 

ARTICLE XIII 
 NOTICES 

Section 13.01    Notices; Effectiveness; Electronic Communication. (a) Notices Generally. Except
in the case of notices and other communications expressly permitted to be given by telephone (and except as provided in subsection (b) below), all notices and other communications provided for herein shall be in writing and shall be delivered by
hand or 

  
 75 

 
overnight courier service, mailed by certified or registered mail or sent by telecopier as follows, and all notices and other communications expressly permitted hereunder to be given by telephone
shall be made to the applicable telephone number, as follows: 
 (i)    if to the Borrower or the
Administrative Agent, to the address, telecopier number, electronic mail address or telephone number set forth on Schedule 13.01; and 

(ii)    if to any other Lender, to the address, telecopier number, electronic mail address or telephone
number specified in its administrative questionnaire. 
 Notices and other communications sent by hand or overnight courier service, or mailed by certified
or registered mail, shall be deemed to have been given when received; notices and other communications sent by telecopier shall be deemed to have been given when sent (except that, if not given during normal business hours for the recipient, shall
be deemed to have been given at the opening of business on the next Business Day for the recipient). Notices and other communications delivered through electronic communications to the extent provided in paragraph (b) below, shall be effective
as provided in said paragraph (b). 
 (b)    Electronic Communications. Notices and other communications to the
Lenders hereunder may be delivered or furnished by electronic communication (including e-mail and internet or intranet websites) pursuant to procedures approved by the Administrative Agent or as otherwise determined by the Administrative Agent,
provided that the foregoing shall not apply to notices to any Lender pursuant to Article II if such Lender has notified the Administrative Agent that it is incapable of receiving notices under such Article by electronic communication. The
Administrative Agent or the Borrower may, in its respective discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it or as it otherwise determines,
provided that such determination or approval may be limited to particular notices or communications. 
 Unless the Administrative
Agent otherwise prescribes, (i) notices and other communications sent to an e-mail address shall be deemed received upon the sender’s receipt of an acknowledgement from the intended recipient (such as by the “return receipt
requested” function, as available, return e-mail or other written acknowledgement), provided that if such notice or other communication is not given during the normal business hours of the recipient, such notice or communication shall be
deemed to have been given at the opening of business on the next Business Day for the recipient, and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended
recipient at its e-mail address as described in the foregoing clause (i) of notification that such notice or communication is available and identifying the website address therefor. 

(c)    The Platform. THE PLATFORM (IF ANY) IS PROVIDED “AS IS” AND “AS AVAILABLE.” THE AGENT
PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS. NO WARRANTY

  
 76 

 
OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER
CODE DEFECTS, IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER MATERIALS OR THE PLATFORM. In no event shall the Administrative Agent or any of its Related Parties (collectively, the “Agent Parties”) have any liability to
the Borrower, any Lender, or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of the Borrower’s or the Administrative Agent’s transmission of Borrower
Materials through the Internet, except to the extent that such losses, claims, damages, liabilities or expenses are determined by a court of competent jurisdiction by a final and nonappealable judgment to have resulted from the gross negligence or
willful misconduct of such Agent Party; provided, however, that in no event shall any Agent Party have any liability to the Borrower, any Lender, or any other Person for indirect, special, incidental, consequential or punitive damages
(as opposed to direct or actual damages). 
 (d)    Change of Address, Etc. Each of the Borrower and the
Administrative Agent may change its address, telecopier or telephone number for notices and other communications hereunder by written notice to the other parties hereto. Each other Lender may change its address, telecopier or telephone number for
notices and other communications hereunder by written notice to the Borrower and the Administrative Agent. In addition, each Lender agrees to notify the Administrative Agent from time to time to ensure that the Administrative Agent has on record
(i) an effective address, contact name, telephone number, telecopier number and electronic mail address to which notices and other communications may be sent and (ii) accurate wire instructions for such Lender. Furthermore, each Public
Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all times have selected the “Private Side Information” or similar designation on the content declaration screen of the Platform in order to enable
such Public Lender or its delegate, in accordance with such Public Lender’s compliance procedures and applicable law, including United States Federal and state securities laws, to make reference to Borrower Materials that are not made available
through the “Public Side Information” portion of the Platform and that may contain material non-public information with respect to the Borrower or its securities for purposes of United States Federal or state securities laws. 

(e)    Reliance by Administrative Agent and Lenders. The Administrative Agent and the Lenders shall be entitled to
rely and act upon any notices purportedly given by or on behalf of the Borrower so long as such notices appear on their face to be authentic even if (i) such notices were not made in a manner specified herein, were incomplete or were not
preceded or followed by any other form of notice specified herein, or (ii) the terms thereof, as understood by the recipient, varied from any confirmation thereof. The Borrower shall indemnify the Administrative Agent, each Lender and the
Related Parties of each of them from all losses, costs, expenses and liabilities resulting from the reliance by such Person on each notice purportedly given by or on behalf of the Borrower. All telephonic communications with the Administrative Agent
may be recorded by the Administrative Agent, and each of the parties hereto hereby consents to such recording. 

  
 77 

 ARTICLE XIV 

COUNTERPARTS; INTEGRATION; EFFECTIVENESS; ELECTRONIC EXECUTION 

Section 14.01    Counterparts; Effectiveness. This Agreement may be executed in counterparts (and by
different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Except as provided in Article IV, this Agreement shall become effective when it
shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof which, when taken together, bear the signatures of each of the parties hereto, and thereafter shall be binding upon and
inure to the benefit of the parties hereto and their respective successors and assigns. Delivery of an executed counterpart of a signature page of this Agreement by telecopy or email shall be effective as delivery of a manually executed counterpart
of this Agreement. 
 Section 14.02    Electronic Execution of Assignments. The words
“execute,” “execution,” “signed,” “signature,” and words of like import in or related to any document to be signed in connection with this Agreement and the transactions contemplated hereby (including without
limitation Assignment and Assumptions, amendments or other modifications, Borrowing Notices, waivers and consents) shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic
platforms approved by the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping
system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar
state laws based on the Uniform Electronic Transactions Act; provided that notwithstanding anything contained herein to the contrary, the Administrative Agent is under no obligation to agree to accept electronic signatures in any form or in
any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved by it. 
 ARTICLE XV 

CHOICE OF LAW; CONSENT TO JURISDICTION; WAIVER OF JURY TRIAL 

Section 15.01    Choice of Law. THE LOAN DOCUMENTS AND OBLIGATIONS OF THE PARTIES THEREUNDER
(INCLUDING, WITHOUT LIMITATION, ANY CLAIMS SOUNDING IN CONTRACT LAW OR TORT LAW ARISING OUT OF THE SUBJECT MATTER THEREOF AND ANY DETERMINATIONS WITH RESPECT TO POST-JUDGMENT INTEREST) SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES THEREOF THAT WOULD REQUIRE THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION. 

Section 15.02    Consent to Jurisdiction. EACH OF THE BORROWER, THE ADMINISTRATIVE AGENT, THE ARRANGER
AND THE LENDERS HEREBY IRREVOCABLY SUBMITS TO JURISDICTION OF any Federal COURT OF THE UNITED 

  
 78 

 
STATES OF AMERICA SITTING IN THE BOROUGH OF MANHATTAN OR, IF THAT COURT DOES NOT HAVE SUBJECT MATTER JURISDICTION, IN ANY STATE COURT LOCATED IN THE CITY AND COUNTY OF NEW YORK IN ANY ACTION OR
PROCEEDING ARISING OUT OF OR RELATING TO ANY LOAN DOCUMENTS AND HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH COURT AND IRREVOCABLY WAIVES ANY OBJECTION IT MAY NOW OR
HEREAFTER HAVE AS TO THE VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN SUCH A COURT OR THAT SUCH COURT IS AN INCONVENIENT FORUM. NOTHING HEREIN SHALL LIMIT THE RIGHT OF THE ADMINISTRATIVE AGENT, THE ARRANGER OR ANY LENDER TO BRING
PROCEEDINGS AGAINST THE BORROWER IN THE COURTS OF ANY OTHER JURISDICTION. ANY JUDICIAL PROCEEDING BROUGHT BY THE BORROWER, DIRECTLY OR INDIRECTLY, IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH ANY LOAN DOCUMENT SHALL BE BROUGHT ONLY IN A
COURT IN ANY FEDERAL COURT OF THE UNITED STATES OF AMERICA SITTING IN THE BOROUGH OF MANHATTAN OR, IF THAT COURT DOES NOT HAVE SUBJECT MATTER JURISDICTION, IN ANY STATE COURT LOCATED IN THE CITY AND COUNTY OF NEW YORK. 

EACH OF THE BORROWER, THE ADMINISTRATIVE AGENT, THE ARRANGER AND THE LENDERS HEREBY AGREES FURTHER THAT SERVICE OF ALL PROCESS IN ANY SUCH
PROCEEDING IN ANY SUCH COURT MAY BE MADE BY REGISTERED OR CERTIFIED MAIL, RETURN RECEIPT REQUESTED, TO THE APPLICABLE PERSON AT ITS ADDRESS PROVIDED IN ACCORDANCE WITH SECTION 13.01 AND AGREES THAT SUCH SERVICE IS SUFFICIENT TO CONFER PERSONAL
JURISDICTION OVER THE APPLICABLE PERSON IN ANY SUCH PROCEEDING IN ANY SUCH COURT, AND OTHERWISE CONSTITUTES EFFECTIVE AND BINDING SERVICE IN EVERY RESPECT. NOTHING HEREIN SHALL LIMIT THE RIGHT OF THE ADMINISTRATIVE AGENT, THE ARRANGER OR LENDERS TO
SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY LAW. 
 Section 15.03    Waiver of Jury Trial. EACH
PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN
DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR
OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 

  
 79 

 Section 15.04    U.S. Patriot Act Notice. Each Lender
that is subject to the U.S. Patriot Act and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that pursuant to the requirements of the U.S. Patriot Act, it is required to obtain, verify and record
information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrower in accordance with the
U.S. Patriot Act. The Borrower shall, promptly following a request by the Administrative Agent or any Lender, provide all documentation and other information that the Administrative Agent or such Lender requests in order to comply with its ongoing
obligations under applicable “know your customer” and anti-money laundering rules and regulations, including the U.S. Patriot Act. 

Section 15.05    No Advisory or Fiduciary Responsibility. In connection with all aspects of each
transaction contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document), the Borrower acknowledges and agrees, and acknowledges its Affiliates’ understanding, that:
(i) (A) the arranging and other services regarding this Agreement provided by the Administrative Agent, the Arranger and the Lenders are arm’s-length commercial transactions between the Borrower and its Affiliates, on the one hand,
and the Administrative Agent, the Arranger and the Lenders, on the other hand, (B) the Borrower has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, and (C) the Borrower is capable
of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other Loan Documents; (ii) (A) each of the Administrative Agent, the Arranger and the Lenders is and has been
acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for the Borrower or any of its Affiliates, or any other Person and
(B) neither the Administrative Agent nor the Arranger nor any of the Lenders has any obligation to the Borrower or any of its Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein
and in the other Loan Documents; and (iii) the Administrative Agent, the Arranger, the Lenders and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Borrower and its
Affiliates, and neither the Administrative Agent nor the Arranger nor any of the Lenders has any obligation to disclose any of such interests to the Borrower or its Affiliates. To the fullest extent permitted by law, the Borrower hereby agrees and
covenants that it will not make any claims that it may have against the Administrative Agent, the Arranger and the Lenders with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction
contemplated hereby. 
 Section 15.06    Judgment Currency. If, for the purposes of obtaining
judgment in any court, it is necessary to convert a sum due hereunder or any other Loan Document in one currency into another currency, the rate of exchange used shall be that at which in accordance with normal banking procedures the Administrative
Agent could purchase the first currency with 

  
 80 

 
such other currency on the Business Day preceding that on which final judgment is given. The obligation of the Borrower in respect of any such sum due from it to the Administrative Agent or any
Lender hereunder or under the other Loan Documents shall, notwithstanding any judgment in a currency (the “Judgment Currency”) other than that in which such sum is denominated in accordance with the applicable provisions of this Agreement
(the “Agreement Currency”), be discharged only to the extent that on the Business Day following receipt by the Administrative Agent or such Lender, as the case may be, of any sum adjudged to be so due in the Judgment Currency, the
Administrative Agent or such Lender, as the case may be, may in accordance with normal banking procedures purchase the Agreement Currency with the Judgment Currency. If the amount of the Agreement Currency so purchased is less than the sum
originally due to the Administrative Agent or any Lender from the Borrower in the Agreement Currency, the Borrower agrees, as a separate obligation and notwithstanding any such judgment, to indemnify the Administrative Agent or such Lender, as the
case may be, against such loss. If the amount of the Agreement Currency so purchased is greater than the sum originally due to the Administrative Agent or any Lender in such currency, the Administrative Agent or such Lender, as the case may be,
agrees to return the amount of any excess to the Borrower (or to any other Person who may be entitled thereto under applicable law). 

Section 15.07    Acknowledgement and Consent to Bail-In of EEA Financial Institutions. Notwithstanding
anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any EEA Financial Institution arising under any Loan Document, to the
extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of an EEA Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by: 

(a)    the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities
arising hereunder which may be payable to it by any party hereto that is an EEA Financial Institution; 
 (b)    the
effects of any Bail-In Action on any such liability, including, if applicable: 
 (i) a reduction in full or in part or cancellation of any
such liability; 
 (ii) a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA
Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any
such liability under this Agreement or any other Loan Document; or 
 (iii) the variation of the terms of such liability in connection with
the exercise of the Write-Down and Conversion Powers of any EEA Resolution Authority. 
 [Signature Pages Follow] 

  
 81 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above. 
  

			
	 WALGREENS BOOTS ALLIANCE, INC.,

as the Borrower

		
	By:	 	 /s/ Aidan Clare

	Name:	 	Aidan Clare
	Title:	 	Senior Vice President and Global Treasurer
		
	By:	 	 /s/ John Devlin

	Name:	 	John Devlin
	Title:	 	Vice President, Global Treasury

  
 [Signature Page
to Credit Agreement] 

 ADMINISTRATIVE AGENT: 

 

			
	 BANK OF AMERICA, N.A.,
 as
the Administrative Agent

		
	By:	 	 /s/ J. Casey Cosgrove

	Name:	 	J. Casey Cosgrove
	Title:	 	Director

 LENDERS: 
  

			
	 BANK OF AMERICA, N.A.,
 as a
Lender

		
	By:	 	 /s/ J. Casey Cosgrove

	Name:	 	J. Casey Cosgrove
	Title:	 	Director

  
 [Signature Page
to Credit Agreement] 

 Schedule 2.01 

COMMITMENT SCHEDULE 
 TO
REVOLVING CREDIT AGREEMENT 
 [On file with Administrative Agent] 

 Schedule 13.01 

CERTAIN ADDRESSES FOR NOTICES 
  

	1.	 Address of the Borrower: 

Attention: 
 Aidan Clare; Senior
Vice President and Global Treasurer 
 108 Wilmot Road 

Deerfield, IL 60015 
 Phone:
(847) 315-3593 
 Fax: (847) 315-3652 

Email: Aidan.Clare@wba.com 

With a copy to: 
 Attention:

 Marco Pagni; Executive Vice President, Global Chief Administrative Officer and General Counsel 

108 Wilmot Road 
 Deerfield, IL
60015 
 Phone: (847) 315-2665 

Fax: (847) 315-3652 
 Email:
Marco.Pagni@wba.com 
 With copies to: 

Attention: 
 Gráinne
Kelly; Vice President, Global Treasury 
 108 Wilmot Road 

Deerfield, IL 60015 
 Phone:
(847) 315-2634 
 Fax: (847) 315-3652 

Email: Grainne.Kelly@wba.com 

Sara La Berg; Senior Manager, Global Treasury 

108 Wilmot Road 
 Deerfield, IL
60015 
 Phone: (847) 527-4084 

Fax: (847) 315-3652 
 Email:
Sara.Laberg@Wba.com 

	2.	 Address for the Administrative Agent: 

Bank of America, N.A. 
 540 W.
Madison St. 
 Chicago, IL 60601 

Mailcode: IL4-540-22-23 

Telephone: (312) 828-3092 

Fax: (415) 503-5113 
 Attn:
Casey Cosgrove 
 E-Mail: casey.cosgrove@baml.com 
  

	3.	 Wiring Instructions for the Administrative Agent 

To: Bank of America N.A. 
 ABA
Number: [                    ] 
 Acct
Name: [                    ] 
 Account
No: [                    ] 
 Reference:
Walgreens Booth Alliance 
 Bank of America Address 

100 N. Tryon Street 
 Charlotte,
NC 28255 
 Ongoing Servicing: 

CHRISTINA MELCHIOR 
 Phone:
(980) 386-4590 
 Fax: (704) 409-0111 

Email: christina.melchior@baml.comEX-10.1

 Exhibit 10.1 

[***] Text omitted and filed separately with the Securities and Exchange 

Commission/Confidential Treatment Requested under 17 C.F.R. Section 240.24b-2 

THIS DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (this “Agreement”) is entered into and effective as of
December 18, 2018 (the “Effective Date”) by and between Endo Ventures Limited, an Irish company, with offices located at First Floor, Minerva House, Simmonscourt Road, Ballsbridge, Dublin 4, Ireland (“EVL”),
and Catalyst Pharmaceuticals, Inc., a Delaware corporation, with offices located at 355 Alhambra Circle Suite 1250, Coral Gables, FL, USA (“Catalyst”). 

W I T N E S S E T H 

WHEREAS, Catalyst has undertaken certain development activities relating to the preparation of a generic pharmaceutical formulation of
the Product [***]; and 
 WHEREAS, Catalyst desires to (a) continue development activities with respect to the Product together
with EVL and (b) [***] to enable EVL to manufacture or have manufactured, and market and distribute, a generic version of the Brand Product (as defined below) in the Territory, subject to the terms and provisions hereof. 

NOW, THEREFORE, in consideration of the mutual covenants and agreements of the Parties contained herein and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: 
 ARTICLE 1.
DEFINITIONS 
 Capitalized terms used in this Agreement shall have the following definitions: 

“Acquisition Cost” means the cost of manufacturing or acquiring the Product by EVL and/or its Affiliates, calculated in
accordance with GAAP, as applicable, but without any duplication of any such costs, as follows: 
 (a)    if the Product
is manufactured by EVL (or its Affiliates) (x) [***], plus (y) [***], or 
 (b)    if the Product is
manufactured by a Third Party Manufacturer, (x) [***], plus (y) [***]. 
 “Affiliate(s)” means, with
respect to a Party, any Person that is directly or indirectly controlled by, controlling, or is under common control with such Party. For purposes of this definition only, the term “control” (including, with correlative meaning, the terms
“controlling”, “controlled by”, and “under common control with”), as used with respect to the applicable Party, means the possession, directly or indirectly, of the power to direct or cause the direction of the
management and policies of the applicable Person, whether through ownership of interests 

  
 1 

 
representing equity, securities, or partnership interests or by contract, or otherwise. Ownership of more than fifty percent (50%) of such equity, securities or partnership interests in a Person,
or greater than fifth percent (50%) interests in the income of such Person shall, without limitation, be deemed to be control for purposes of this definition. 

“Agreement” has the meaning given to such term in the introductory paragraph of this Agreement. 

“ANDA” means an Abbreviated New Drug Application pursuant to 21 U.S.C. § 355(j) et seq., and the regulations
promulgated thereunder, as such application may be amended or supplemented from time to time. 
 “ANDA Transfer” has the
meaning set forth in Section 4.1.2. 
 “Anti-Corruption Laws” has the meaning set forth in
Section 9.3.1. 
 “API” means, with respect to the Product, the active pharmaceutical
ingredient(s) in such Product. 
 “Applicable Laws” means all laws, rules, regulations and guidelines of any Governmental
Authority with jurisdiction over the development, manufacturing, exportation, importation, promotion, marketing, sale or distribution of the API or the Product and/or the performance of a Party’s obligations under this Agreement, to the extent
applicable and relevant, and including specifically all cGMP or similar standards or guidelines of the FDA and other applicable Regulatory Authorities and compendial guidelines (e.g., United States Pharmacopeia or European Pharmacopeia), as
well as Export Control Laws, and the FCPA and other Anti-Corruption Laws, in each case to the extent applicable to the performance of a Party’s obligations under this Agreement. 

“Bioequivalence Studies” means any bioequivalence study conducted by or on behalf of Catalyst or its Affiliates which is
undertaken to satisfy the FDA’s requirements for bioequivalence in connection with establishing that a Drug Product subject to an ANDA is a Therapeutic Equivalent of the Brand Product referenced in such ANDA. 

“Brand Product” means the reference listed drug product, Sabril®,
that is the subject of NDA No. 020427, as may be amended or supplemented from time to time. 
 “Business Day” means any
day (other than a Saturday or Sunday) on which banking institutions in New York, New York, United States, and in Dublin, Ireland are open for business. 

“Calendar Quarter” means a three (3) consecutive month period ending on March 31, June 30, September 30 or
December 31. 
 “Catalyst” has the meaning given to such term in the introductory paragraph of this Agreement. 

“Catalyst Indemnitee” has the meaning set forth in Section 10.2. 

  
 2 

 “Catalyst Intellectual Property” means Intellectual Property that
(i) is Controlled by Catalyst and/or its Affiliates and (ii) covers the Product. 
 “cGMP” means all current good
manufacturing practices as may be applicable, including: (a) as required by the provisions of 21 C.F.R., parts 210 and 211 and all applicable rules, regulations, orders and guidances of the FDA and other applicable Regulatory Authorities; and
(b) ICH, Guidance for Industry Q7a Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients. 

“Code” has the meaning set forth in Section 12.6.2. 

“Commercial Launch” means the first commercial sale in the Territory of the Product by EVL, its Affiliate or sublicensee, as
the case may be, to a Third Party. 
 “Commercialize” or “Commercialization” means the marketing,
promotion, sale (and offer for sale or contract to sell), distribution, importation or other commercial exploitation of the Product. Commercialization shall include commercial activities conducted in preparation for Commercial Launch. 

“Commercially Reasonable Efforts” means (a) with respect to product development efforts, the carrying out of such
obligations or tasks with the level of effort and resources consistent with commercially reasonable practices normally devoted by a pharmaceutical company to their research, development or manufacturer of a similar pharmaceutical product owned by it
(or to which it has exclusive rights) at a similar stage of development, a similar market potential, a similar profit potential and strategic value, and (b) with respect to Commercialization, the carrying out of such obligations or tasks with a
level of effort and resources consistent with commercially reasonable practices normally devoted by a pharmaceutical company based on conditions then prevailing including issues of safety and efficacy, product profile, competiveness of alternative
products in the market place, pricing and reimbursement for the Product, the likely timing of the Product’s entry into the market and other relevant technical and commercial factors. 

“Competitive Product” has the meaning set forth in Section 2.2.1. 

“Compliance Event” has the meaning set forth in Section 9.3.4. 

“Confidential Information” means, with respect to a Disclosing Party, all non-public
information of any kind whatsoever (including data, materials, compilations, formulae, models, patent disclosures, procedures, processes, projections, protocols, results of experimentation and testing, specifications, strategies, techniques and all non-public Intellectual Property as defined herein), and all tangible and intangible embodiments thereof of any kind whatsoever (including materials, samples, compositions, documents, drawings, patent applications,
records and reports) of the Disclosing Party and/or its Affiliates, which are disclosed by the Disclosing Party and/or its Affiliate to the Receiving Party and/or its Affiliate, including any and all copies, replication or embodiments thereof.
Confidential Information of both Parties includes the terms, conditions and provisions of this Agreement and Protected Personal Information. 

Notwithstanding the foregoing, and except for Protected Personal Information, Confidential Information of a Disclosing Party shall not include
information that the Receiving 

  
 3 

 
Party can establish by competent proof to have (a) been publicly known prior to disclosure of such information by the Disclosing Party and/or its Affiliate to the Receiving Party and/or its
Affiliate, (b) become publicly known, without fault on the part of the Receiving Party and/or its Affiliate, subsequent to disclosure of such information by the Disclosing Party and/or its Affiliate to the Receiving Party and/or its Affiliate,
(c) been received by the Receiving Party and/or its Affiliate from a source rightfully having possession of, and the right to disclose, such information free of an obligation of confidentiality, (d) been otherwise rightfully known by the
Receiving Party and/or its Affiliate prior to disclosure of such information by the Disclosing Party and/or its Affiliate to the Receiving Party and/or its Affiliate, or (e) been independently developed by employees or agents of the Receiving
Party and/or its Affiliate without the use of Confidential Information of the Disclosing Party and/or its Affiliate. 

“Controlled” means the legal or regulatory right (whether by ownership, license or otherwise) to grant access, right, title, a
license or a sublicense to Intellectual Property without violating the terms of any Third Party agreement, court order, or other arrangement or legal obligation. 

“Cost of Goods Sold” means [***]. 

“Data Protection Laws” has the meaning set forth in Section 9.3.2. 

“Disclosing Party” means the Party disclosing Confidential Information hereunder to the other Party. 

[***] 
 [***] 

“DMF” means a drug master file for the API to be used in the Product, which has been filed by [***] with the FDA
pursuant to 21 C.F.R. § 314.420 (or, if applicable, any other Applicable Laws outside of the United States). 
 “Drug
Product” means a drug product, as defined in 21 C.F.R. § 314.3, for administration to human subjects. 
 “Effective
Date” has the meaning given to such term in the introductory paragraph of this Agreement. 
 “EVL” has the meaning
given to such term in the introductory paragraph of this Agreement. 
 “EVL Facility” means the facility of EVL or its
Affiliate designated in writing by EVL to Catalyst. 
 “EVL Indemnitee” has the meaning set forth in
Section 10.1. 
 “Export Control Laws” means all applicable U.S. laws and regulations relating to
(a) economic and trade sanctions and embargoes imposed by the Office of Foreign Assets Control of 

  
 4 

 
the U.S. Department of Treasury or (b) the export or re-export of commodities, technologies, or services, including the Export Administration Act of
1979, 24 U.S.C. §§ 2401-2420, the International Emergency Economic Powers Act, 50 U.S.C. §§ 1701-1706, the International Traffic in Arms Regulations, 22 C.F.R. parts 120-130, the Trading
with the Enemy Act, 50 U.S.C. §§ 1 et. seq., the Arms Export Control Act, 22 U.S.C. §§ 2778 and 2779, and the International Boycott Provisions of Section 999 of the U.S. Internal Revenue Code of 1986 (as amended).

 “FCPA” means U.S. Foreign Corrupt Practices Act (15 U.S.C. Section 78dd-1,
et. seq.) as amended. 
 “FDA” means the United States Food and Drug Administration, and any successor agency
thereto. 
 “FD&C Act” means the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq, as
amended. 
 “Force Majeure Event” has the meaning set forth in Section 14.12. 

“Freight Charges” means [***]. 

“Further Development Work” means the development activities necessary or desirable to support obtaining Regulatory
Approval for [***] which are either described in Exhibit A attached hereto to the extent of the respective amount budgeted for such activities on such Exhibit and any additional activities and costs to the extent approved by each of the
Parties during a meeting of the JSC in writing in the exercise of their respective sole discretion, acting reasonably. 

“GAAP” means generally accepted accounting principles in effect in the United States from time to time, consistently applied.

 “Generic Equivalent” means a pharmaceutical product that has received FDA approval for marketing in the Territory
pursuant to an ANDA as a generic version of the Brand Product. 
 “Government Official” means any (a) officer, employee
of a government or any department, agency or instrument of a government; (b) person acting in an official capacity for or on behalf of a government or any department, agency, or instrument of a government; (c) officer or employee of a
company or business owned in whole or part by a government; (d) officer or employee of a public international organization such as the World Bank or United Nations; (e) officer or employee of a political party or any person acting in an
official capacity on behalf of a political party; and/or (f) candidate or relative of any candidate for political office. 

“Governmental Authority” means any court, tribunal, arbitrator, agency, legislative body, commission, official, authority,
department, regulatory body or other instrumentality of (i) any government in the Territory, or (ii) any national, federal, state, province, region, county, city or other political subdivision of any such government or any supranational
organization of which any such country is a member, which has competent and binding authority to decide, mandate, regulate, enforce, or otherwise control the activities of the Parties or their Affiliates contemplated by this Agreement. 

  
 5 

 “Gross Amount” means the gross amount invoiced for the Product sold by EVL,
its Affiliates or a sublicensee, as the case may be, in the Territory. 
 “Healthcare Professional” means any member of the
medical, pharmacy or nursing professions or any other person who in the course of his or her professional activities may prescribe, purchase, supply or administer a medicinal product. 

“Indemnitee” has the meaning set forth in Section 10.3. 

“Indemnitor” has the meaning set forth in Section 10.3. 

“Insolvency Event” means, with respect to a Party: 

(a)    a voluntary case or proceeding under any applicable bankruptcy, insolvency, or other similar law is commenced by
such Person, or such Person consents to the entry of an order for relief in an involuntary case or proceeding under any such law or against such Person, or such Person consents to the appointment of or taking possession by a receiver, liquidator,
assignee, trustee, custodian, sequestrator, conservator, supervisor, rehabilitator (or other similar official) of such Person or for any material portion of such Person’s assets and properties, or such Person makes a general assignment for the
benefit of creditors, or such Person fails generally to pay, or admits in writing its inability to pay, its debts as they become due or takes any company action in furtherance of the foregoing; 

(b)    the commencement of an involuntary case or proceeding under any applicable bankruptcy, insolvency, or other similar
law against such Person, and such case or proceeding is not dismissed within ninety (90) days; 
 (c)    the entry
by a Governmental Authority having jurisdiction over such Person of a decree or order appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator, conservator, supervisor, rehabilitator (or similar official) for such Person or for
any material portion of such Person’s assets and properties, or ordering the winding-up, supervision, or liquidation of such Person’s affairs; or 

(d)    the taking of any formal action by such Person, its board of directors (or similar governing body) or holders of its
voting securities authorizing any of the foregoing. 
 “Intellectual Property” means all of the following: (i) patent
applications, continuation applications, continuation-in-part applications, divisional applications, and United States patents corresponding to any of the foregoing that
may grant or may have been granted on any of the foregoing, including reissues, re-examinations and extensions and any supplemental protection certificates, or the like; (ii) all Know-How, work product, trade secrets, inventions (whether patentable or otherwise), data, processes, techniques, procedures, compositions, devices, methods, formulas, protocols and information, whether patentable
or not; (iii) copyrightable works, copyrights and applications, registrations and renewals; (iv) logos, trademarks, service marks, and all applications and registrations relating thereto; (v) other proprietary rights; (vi) any
regulatory exclusivities or the like; and (vii) copies and tangible embodiments of any one or more of the foregoing, including the Bioequivalence Studies. For purposes of clarity, data, information and methods related to the Product and its
components developed in connection with this Agreement shall be considered Intellectual Property, whether or not patentable, confidential, or otherwise subject to intellectual property protection laws. 

  
 6 

 “Interfering Event” means any of the following events: (i) pending
litigation concerning [***] or the Product or (ii) any litigation, threatened in writing by a Third Party that the development or manufacture of the Product by any of the Parties or a Third-Party manufacturer infringes any intellectual property
rights of any Third Party; (iii) government restrictions due to safety issues or concerns, including a disruption or halt in operations of the Vigabatrin REMS Program; (iv) inability to manufacture sufficient launch quantities of the
Product due to unavailability of API, materials or components; (v) the receipt of non-saleable product from a contract manufacturing organization; or (vi) an API supplier warning letter. 

“JSC” has the meaning set forth in Section 3.2.1. 

“Know-How” means all of the following: manufacturing protocols and methods, product
specifications, analytical methods and assays, processes, formulations, product designs, plans, trade secrets, ideas, concepts, manufacturing information, engineering and other manuals and drawings, standard operating procedures, flow diagrams,
chemical data, pharmacological data, pharmacokinetic data, toxicological data, pharmaceutical data, physical and analytical data, safety data, quality assurance data, quality control and clinical data, technical information, other data, and research
records. 
 “Label,” “Labeled” or “Labeling” refers to such labels and other written,
printed or graphic matter, (i) upon any container or wrapper utilized with the Product, or (ii) accompanying the Product, including Package inserts. 

“Liabilities” has the meaning set forth in Section 10.1. 

“Milestone Payment” has the meaning set forth in Section 6.2. 

“Negative Amount” has the meaning set forth in Section 6.1.2(c). 

“Net Profit Report” has the meaning set forth in Section 6.1.2(b). 

“Net Profits” means Net Sales, less (i) the Acquisition Cost, (ii) the Sales & Distribution
Expenses, and (iii) the REMS Payments. For the avoidance of doubt, there shall be no deductions for the costs of Further Development Work in determining Net Sales and Net Profits. 

“Net Sales” means the Gross Amount, less the following deductions (provided no such deduction shall be duplicative of
another deduction used to determine Net Sales or Net Profits), to the extent accrued, paid or allowed in accordance with GAAP: 

(a)    [***]; 

(b)    [***]; 

(c)    [***]; 

  
 7 

 (d)    [***]; 

(e)    [***]; 

(f)    [***]; 

(g)    [***]; and 

(h)    [***]. 

“OFAC” has the meaning set forth in Section 9.3.3. 

“Orange Book” means the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations, as may be
amended from time to time. 
 “Package,” “Packaged” or “Packaging” means all primary
containers, including bottles, cartons, shipping cases or any other like matter used in packaging or accompanying a Product. 

“Party” means EVL or Catalyst, as applicable, and “Parties” means both EVL and Catalyst. 

“Person” means an individual, corporation, partnership, limited liability company, firm, association, joint venture, estate,
trust, governmental or administrative body or agency, or any other entity. 
 “Proceedings” means governmental, judicial,
administrative or adversarial proceedings (public or private), litigation, suits, patent oppositions, arbitration, disputes, claims, causes of action or investigations. 

“Product” means the Drug Product [***] that references the Brand Product, including all dosage strengths, and all
packaging configurations thereof. 
 “Product Claim” has the meaning set forth in Section 10.5.

 [***]. 

“Protected Personal Information” has the meaning set forth in Section 9.3.2. 

“Receiving Party” means the Party receiving Confidential Information hereunder from the other Party. 

“Regulatory Approval” means the applicable approval(s) from Regulatory Authorities necessary to market a Drug Product and/or
an active pharmaceutical ingredient, including all applicable product and/or establishment licenses, registrations, permits or other authorizations as may be necessary for the commercial manufacture, commercialization, use, storage, importation,
transport, promotion, pricing, distribution or sale thereof. 

  
 8 

 “Regulatory Authority(ies)” means the Governmental
Authority(ies) in the Territory with authority over the manufacture, market approval, sale, distribution, packaging or use of a Drug Product in the Territory (including the grant of Regulatory Approval by the FDA). 

“Regulatory Documentation” means the following to the extent related to the Product, owned and maintained by or on behalf of
Catalyst and/or its Affiliates or otherwise in the possession of Catalyst or its Affiliates: the [***] and batch records relevant to the Product. 

“REMS” has the meaning set forth in Section 4.4. 

“REMS Payments” means [***]. 

“Representatives” has the meaning set forth in Section 8.1. 

“Royalty” has the meaning set forth in Section 6.1.1. 

“Sales & Distribution Expenses” means [***]. 

“Specifications” means the specifications for the manufacture of the Product as described in [***]. 

“Stable” means a Drug Product that meets FDA requirements for stability for purposes of Regulatory Approval. 

“Tax” or “Taxes” shall mean all taxes, including income, corporation, gross receipts, transfer, excise,
property, sales, harmonized sales, use, value-added, license, payroll, withholding, social insurance, employment insurance, employer health, franchise or other governmental taxes, imposed by any Taxing Authority (including any interest, penalties or
additional tax attributable thereto). 
 “Taxing Authority” shall mean any Governmental Authority, exercising any authority
to impose, regulate or administer the imposition of Taxes. 
 “Term” has the meaning set forth in
Section 12.1. 
 “Territory” means the United States of America, and its commonwealths,
territories, districts and possessions, including the District of Columbia, Commonwealth of Puerto Rico, US Virgin Islands, Guam, American Samoa; and any installation, territory, location or jurisdiction under the purview of the FDA or control of
the United States government; and any United States military bases and installations worldwide. 
 “Therapeutic Equivalent”
has the meaning given to it by the FDA in the current edition of the Orange Book. 
 “Third Party” or “Third
Parties” means any Person other than a Party or its Affiliates. 

  
 9 

 “Third Party Manufacturer” has the meaning set forth in
Section 5.1. 
 “Third Party Supply Agreement” has the meaning set forth in
Section 5.1. 
 ARTICLE 2. LICENSE AND EXCLUSIVITY 

2.1    License Grant. 

2.1.1    Catalyst hereby grants to EVL an exclusive (even as to Catalyst), irrevocable (subject to
Section 12.6), license (with the right to sublicense as set forth in Section 2.1.2 ) under the Catalyst Intellectual Property to manufacture, have manufactured, distribute, have distributed, use,
market, have marketed, sell, have sold, import, and export for the purpose of Commercialization of the Product in the Territory, pursuant to the terms of this Agreement. 

2.1.2    The license granted under Section 2.1.1 is sublicensable by EVL, in whole or in part.
Any such sublicense shall be consistent with the terms of this Agreement, unless any variations thereof are agreed in writing between the Parties, and shall not otherwise diminish EVL’s obligations hereunder. EVL shall cause its sublicensees to
comply with the terms of this Agreement. 
 2.2    Exclusivity;
Non-Competition. 
 2.2.1    Except as expressly set forth in this
Agreement, during the Term, Catalyst, by itself, its Affiliate or through any Third Party, shall not, directly or indirectly, develop, seek Regulatory Approval for, manufacture, import, market, sell, distribute, or otherwise Commercialize any Drug
Product that is a Therapeutic Equivalent of the Product (“Competitive Product”) or otherwise work on the development of, or supply of any Competitive Product (i) in the Territory, or (ii) to any Third Party outside the
Territory which Catalyst knows, or should know, that such Third Party intends to import such Competitive Product in the Territory. 

2.2.2    Except as expressly set forth in this Agreement, during the Term, EVL, by itself, its Affiliate or through any
Third Party, shall not, directly or indirectly, develop, seek Regulatory Approval for, manufacture, import, market, sell, distribute, or otherwise Commercialize any Competitive Product or otherwise work on the development of, or supply of any
Competitive Product (i) in the Territory, or (ii) to any Third Party outside the Territory which EVL knows, or should know, that such Third Party intends to import such Competitive Product in the Territory. 

ARTICLE 3. DEVELOPMENT AND COMMERCIALIZATION 

3.1    Development. 

3.1.1    Catalyst shall exercise Commercially Reasonable Efforts to develop, or cause the development of, a final finished,
Stable dosage form of the Product conforming to the Specifications, except that Catalyst will be excused from the duty to exercise such efforts to the extent that the Third Party
out-of-pocket costs which would be required to be expended for such purpose are not included in the Further Development Work. Notwithstanding the foregoing, the Parties
shall collaborate on any development activities necessary or desirable after the date hereof to support obtaining Regulatory Approval for [***] in the Territory. 

  
 10 

 3.1.2    In connection with the activities of Catalyst under
Section 3.1.1, EVL shall provide reasonable assistance with respect to Further Development Work and the commercial manufacturing process validation for the Product. The Parties shall share equally in the costs and expenses
incurred by EVL and Catalyst after the date hereof in connection with such Further Development Work. Either Party may on a monthly basis until the expiration of the Calendar Quarter following the date of obtaining Regulatory Approval issue
reasonably detailed invoices to the other Party setting forth the costs incurred by such Party as a part of the Further Development Work, half of which amounts shall be reimbursed by the other Party within sixty (60) days following the receipt
of such invoice. 
 3.1.3    In connection with such Further Development Work, each Party shall promptly transfer to the
other Party all data, information and materials generated or obtained in connection with the Product, including with respect to the components thereof, and all associated methods and analytical testing. 

3.2    Joint Steering Committee. 

3.2.1    Promptly following the date hereof, but in no event later than thirty (30) days thereafter, EVL and Catalyst
will form a joint steering committee (the “JSC”) to provide executive oversight and to facilitate information sharing between the Parties with respect to any Further Development Work. 

3.2.2    The JSC will be composed of an equal number of representatives appointed by each of EVL and Catalyst. Each
individual appointed will be an employee or contractor of such Party or such Party’s Affiliate. Each Party may replace any of its JSC representatives at any time upon written notice to the other Party, which notice may be given by e-mail, sent to the other Party. Each JSC representative will be subject to confidentiality obligations no less stringent than those in Article 8. 

3.2.3    The JSC will hold meetings within five (5) Business Days after receiving communications from the FDA
regarding the Product to determine what, if any, Further Development Work is required and the approved costs in connection therewith. The JSC may meet in person or by audio or video conference as its representatives may mutually agree. No action
taken at a meeting will be effective unless at least one representative of each Party is present or participating. Neither Party will unreasonably withhold attendance of at least one representative of such Party at any meeting of the JSC for which
reasonable advance notice was provided. Each Party shall bear the costs and expenses incurred by its own JSC representatives in participating in the JSC meetings. 

3.2.4    The Parties will endeavor in good faith to reach unanimous agreement with respect to all matters within the
JSC’s authority. Should the JSC not be able to reach unanimous agreement with respect to such matter at a duly called meeting of the JSC, either Party may refer such matter for resolution to a Vice-President or other executive officer of each
Party having decision making authority on such matter and designated in writing by such Party to the other 

  
 11 

 
Party within thirty (30) days following the Effective Date, and such executive officers will attempt to resolve the matter in good faith. If the executive officers fail to resolve such
matter within twenty (20) Business Days after the date on which the matter is referred to the executive officers (unless a longer period is agreed to by the Parties), then decisions regarding such matter may be finally determined in accordance
with the procedures set forth in Section 14.10. 
 3.3    Commercial Scale-Up. At EVL’s request, Catalyst shall, at its own cost and expense, provide reasonable assistance with respect to EVL’s preparation for Commercial Launch of the Product by making knowledgeable
Catalyst personnel available for consultation with EVL, it being understood that for the purposes hereof ‘reasonable assistance’ shall mean the provision of assistance consistent with Catalyst’s business, to the best of
Catalyst’s abilities with its then-currently existing and available resources. 
 3.4    Product
Commercialization. 
 3.4.1    EVL shall exercise its Commercially Reasonably Efforts to Commercialize the Product.
Subject to complying with its obligations under the preceding sentence, EVL shall have the sole and exclusive right to make determinations regarding the Commercialization of the Product in the Territory, including the timing of the Commercial Launch
and responsibility for all sales/marketing and promotional activities. 
 3.4.2    Upon the Commercial Launch, EVL (or
its Affiliate) will market and sell the Product, from the EVL Facility or such other facility as EVL may elect in its sole discretion, under EVL’s (or its Affiliate’s) label in a manner consistent with EVL’s normal practices with
respect to its other Drug Products. 
 3.5    Updates. Catalyst shall keep EVL informed and provide
regular updates of the progress on the Regulatory Approval of the [***], communications with Regulatory Authorities related to the Product or Regulatory Approval thereof, and EVL shall keep Catalyst informed and provide regular updates of the
progress on the Commercial Launch. 
 ARTICLE 4. REGULATORY MATTERS 

4.1    Regulatory Approvals and Applications. 

4.1.1    [***]. 

4.1.2    [***]. 

4.1.3    [***]  

4.1.4    [***]. 

4.1.5    [***]. 

4.1.6    [***]. 

  
 12 

 4.2    Product Inserts and Labeling. EVL shall be solely
responsible for the text and regulatory compliance of all package Labels, Product inserts and other Labeling used in connection with obtaining Regulatory Approval in the Territory for the [***]. 

4.3    Product Regulatory Reporting; Compliance With Applicable Laws. From and after
the ANDA Transfer, EVL shall be solely responsible for adverse event reporting to the FDA, investigation and analysis of end-user complaints and otherwise complying with Applicable Laws with respect to the
Commercialization of the Product and ownership of the Regulatory Approval. EVL shall have responsibility for communicating with the end-users to support the complaint handling process. 

4.4    REMS. FDA has determined that a Risk Evaluation and Mitigation Strategy (“REMS”) is
necessary to assure safe use of the Product. The Product is currently subject to the FDA-approved single shared system Vigabatrin REMS Program. EVL will have sole discretion over the evaluation and management
of the Vigabatrin REMS Program. The REMS Payments will not include any historical setup fee for the REMS Program. The Parties shall each bear half of the incremental setup cost that either Party bears that are specific to the Product as a part of
the Further Development Work. 
 ARTICLE 5. MANUFACTURE 

5.1    Third Party Manufacture of Product. During the Term and subject to
Section 5.2, EVL shall engage [***] (or its Affiliate) or a Third Party manufacturer of the Product mutually agreed upon by the Parties (a “Third Party Manufacturer”) pursuant to a manufacture and
supply agreement with such Third Party Manufacturer (the “Third Party Supply Agreement”), which EVL will exercise Commercially Reasonable Efforts to enter into as soon as reasonably practicable after the Effective Date. EVL shall
also collaborate in good faith with Catalyst in connection with the preparation and completion of the Third Party Supply Agreement which collaboration shall include affording Catalyst the opportunity to review and comment upon drafts of the Third
Party Supply Agreement and accommodating to the extent practicable the reasonable comments of Catalyst on such agreement. At any time during the Term, EVL shall be entitled to engage a different manufacturer of the Product mutually agreed upon by
the Parties. 
 5.2    Manufacture by EVL. At any time during the Term, and subject to the terms of
the Third Party Supply Agreement, EVL shall be entitled to become the exclusive manufacturer of the Product in the Territory by providing written notice thereof to Catalyst. Following the ANDA Transfer, EVL shall use commercially reasonable efforts
to transfer the manufacturing of the Product in the Territory to EVL or one of its Affiliates. 
 ARTICLE 6. FINANCIAL PROVISIONS 

6.1    Royalties. 

6.1.1    Royalty Rates. EVL shall pay to Catalyst a royalty (the “Royalty”) equal to [***]
percent ([***]%) of the Net Profits accruing during the Term. 

  
 13 

 6.1.2    Payment of Royalties. 

(a)    Following Commercial Launch, within sixty (60) days of the end of each Calendar Quarter during the Term, EVL
shall pay to Catalyst the Royalties accrued during the preceding Calendar Quarter. 
 (b)    EVL shall, concurrently
with payment of Royalties and in any event within sixty (60) days of the end of each Calendar Quarter during the Term, provide to Catalyst a written report (in the form attached as Exhibit B hereto) outlining the details surrounding the
calculation of Net Profits, Net Sales, deductions from Net Profits and Net Sales and calculation of the Royalties due to Catalyst pursuant to Section 6.1.1 (the “Net Profit Report”). 

(c)    Subject to Section 6.1.2(d), EVL shall pay such amount relating to the share of the Net
Profit payable pursuant to Section 6.1.1 to Catalyst and set forth in the Net Profit Report; provided, however, that in the event that the amount otherwise payable under Section 6.1.1
equals a negative amount (“Negative Amount”), then EVL shall be permitted to carry over such Negative Amount to apply against future Calendar Quarters; provided, further, that if such Negative Amount is not fully
recovered within the following two Calendar Quarters or EVL does not have continuing payment obligations pursuant to Section 6.1.1, then EVL may invoice Catalyst for the unrecovered Negative Amount and Catalyst shall pay
such unrecovered Negative Amount to EVL within thirty (30) days of such invoice, by wire transfer of immediately available funds to a bank account designated in writing by EVL. 

(d)    In the event there is a Negative Amount in two consecutive Calendar Quarters, the JSC shall meet not later than ten
(10) days after issuance of the Net Profit Report for the second consecutive Calendar Quarter to discuss the commercial viability of the Product and endeavor in good faith to reach unanimous agreement with respect to the future
Commercialization of the Product under this Agreement. Should the JSC not be able to reach unanimous agreement with respect to such future Commercialization within such ten (10) day period, either Party may refer such matter for resolution to
the Chief Executive Officer of each Party and such Chief Executive Officers will attempt to resolve the matter in good faith within ten (10) days after the JSC has failed to reach unanimous agreement. In the event that the Chief Executive
Officers cannot resolve such matter within such ten (10) day period, Catalyst may, upon delivery of written notice to EVL, terminate this Agreement effective as of the last day of the calendar month following such written notice. 

(e)    EVL shall make all payments under this Agreement free and clear of all tax deductions and withholdings, unless any
such tax deduction or withholding is required by law in effect at the time of payment. Any Tax required to be withheld on amounts payable under this Agreement by EVL to Catalyst will be paid by EVL on behalf of Catalyst to the appropriate
Governmental Authority, and EVL will furnish Catalyst with official receipts evidencing the payment of such Tax. Any such Tax required to be withheld will be treated as having been paid to Catalyst for all purposes of this Agreement. 

  
 14 

 6.2    Milestone Payment. 

6.2.1    Subject to the terms and conditions of this Agreement, upon achievement of certain milestones, EVL shall make
milestone payments to Catalyst as set forth below (each, a “Milestone Payment”). For the avoidance of doubt, each Milestone Payment shall be payable one-time only upon the first occurrence of
the event triggering the respective milestone set forth below: 
 (a)    [***] ($[***]) upon execution of
this Agreement by both Parties; and 
 (b)    [***] Dollars ($[***]) if upon Commercial Launch no Generic
Equivalent had been commercially sold in the Territory by or on behalf of a Third Party; or 
 (c)    [***]
Dollars ($[***]) if upon Commercial Launch a Generic Equivalent had already been commercially sold in the Territory by or on behalf of a Third Party. 

6.2.2    EVL shall make the applicable Milestone Payments payable to Catalyst under Section 6.2.1
(as applicable) within thirty (30) days following the completion of, and its receipt of an invoice for, the occurrence of the corresponding event, except for the Milestone Payment under Section 6.2.1(a), which shall be
paid by EVL to Catalyst on the date hereof. Upon the occurrence of the applicable event for which a Milestone Payment is due and payable, Catalyst shall provide written notice thereof to EVL, along with an invoice for the corresponding Milestone
Payment; provided, however, that Catalyst shall not be obligated to submit an invoice for the Milestone Payment under Section 6.2.1(a). 

6.3    Payment; Expenses. 

6.3.1    All payments under this Article 6 shall be made by wire transfer of immediately available funds to a bank
account designated in writing by Catalyst. 
 6.3.2    Each Party shall bear its own costs and expenses associated with
its responsibilities under this Agreement, except as expressly set forth in this Agreement. Any amounts payable under this Agreement which are not paid within thirty (30) days of their due date shall bear interest at a rate equal to
[***] percent ([***]%) per annum, which shall be computed on the basis of a 365 day year. 

6.4    Records and Audits. EVL and its Affiliates shall keep and maintain or cause to be maintained books
and records pertaining to the calculation of Cost of Goods Sold, Net Sales and Net Profits during the Term and for two (2) years thereafter. Such books and records shall be maintained in accordance with GAAP and with all records and details
necessary to enable Catalyst to verify the foregoing. All factors included in the determination of the Cost of Goods Sold, Net Sales and Net Profits shall be specific to the Product, reasonably documented, and available for independent audit
purposes. Catalyst shall have the right once per calendar year, at its own expense, during the Term and for two (2) years thereafter, to have an independent public accountant, reasonably acceptable to EVL, audit the relevant financial books and
records of account of EVL for up to the preceding three (3) years during normal business hours, upon reasonable advance notice, to determine or verify the applicable Cost of Goods Sold, Net Sales and Net Profits. If errors are found, any
undisputed deficiency shall be paid within sixty (60) days following delivery of written documentation reasonably substantiating such deficiency. If errors 

  
 15 

 
are discovered as a result of such audit in Catalyst’s favor exceeding ten percent (10%) of Net Profits for the period audited (which shall be no less than one (1) year), EVL shall
reimburse Catalyst for the reasonable expense of such audit. In the event that there is any overpayment by EVL revealed (a) by an examination and review conducted on behalf of Catalyst, or (b) by an examination and review of a Net Profit
Report by EVL’s accountants within one (1) year of delivery of such Net Profit Report, then EVL shall be permitted to carry over such overpayment and apply it against its payment obligations pursuant to
Section 6.1.1 for future Calendar Quarters; provided, however, that if such overpayment is not fully recovered within the following two Calendar Quarters or EVL does not have continuing payment obligations
pursuant to Section 6.1.1, then EVL may invoice Catalyst for the unrecovered overpayment and Catalyst shall pay such unrecovered overpayment to EVL within thirty (30) days of such invoice, by wire transfer of
immediately available funds to a bank account designated in writing by EVL. 
 6.5    Accounting. 

(a)    The Parties acknowledge that any expenses or costs deducted from Net Sales under this Agreement may be based upon
accruals, which accruals will be recognized and adjusted in compliance with GAAP; provided, however, that when the actual results become known relative to any accrued amount, any difference between the actual results and the accrual
shall be accounted for in the subsequent payments due hereunder (subject to customary processing delays). 
 (b)    To
the extent that the difference between such accruals and the actual results has led to an underpayment, EVL shall pay Catalyst the amount of such underpayment on the next date payment is due to Catalyst hereunder. To the extent that the difference
between such accruals and the actual results has led to an overpayment to Catalyst, EVL may, at its option, set-off such overpayments against subsequent payments to be made to Catalyst or issue an invoice for
the amount of such overpayment, which shall be paid by Catalyst within forty-five (45) days after Catalyst’s receipt thereof. 

(c)    After the Term, EVL shall continue to reflect such deductions for accruals, and by the date that is twenty-four
(24) months following the expiration of the Term or termination of this Agreement, as applicable, EVL shall reconcile (and give to Catalyst a report of such reconciliation of) all accrued calculations and deductions used in determining Net
Sales with actual processed credits. If the report shows an underpayment to Catalyst, EVL shall pay Catalyst the amount of the underpayment at the time it gives the report to Catalyst. If the report shows an overpayment to Catalyst, Catalyst shall
pay EVL the amount of the overpayment within thirty (30) days after receipt of such reconciliation. 
 ARTICLE 7. INTELLECTUAL
PROPERTY 
 7.1    General Ownership. 

7.1.1    Except as expressly provided in this Agreement, each Party shall own its own Intellectual Property consistent with
United States or other applicable international patent, trademark, and copyright law. 

  
 16 

 7.1.2    Each Party that owns any particular Intellectual Property
shall, as between the Parties, have the sole and exclusive right to control the filing for, prosecution, maintenance and enforcement of such Intellectual Property in its sole discretion. 

7.2    Product Intellectual Property. 

7.2.1    EVL and Catalyst shall coordinate with each other with respect to Intellectual Property matters, including
strategic decisions relating to potential Intellectual Property litigation and any other litigation arising from or relating to the Product in the Territory. 

7.2.2    Intellectual Property that is jointly invented or jointly conceived during the Term under this Agreement shall be
jointly owned by the Parties, unless otherwise agreed in writing. Employees of Catalyst, whether serving as advisors or consultants to EVL or serving EVL in any other capacity, shall be considered employees of Catalyst for the purpose of determining
ownership of Intellectual Property. 
 7.2.3    For the avoidance of doubt, Intellectual Property covering inventions or
improvements that are created or conceived in the course of developing the Product shall be owned solely by a Party if only its employees create or conceive such invention or improvement. 

7.3    Notification. The Parties shall promptly notify each other of any allegation that any activity
undertaken pursuant to this Agreement infringes or may infringe the Intellectual Property rights of any Third Party. Each Party shall assist and cooperate with the other Party in the defense of any Proceeding relating to the Product (including
consenting to being named as a nominal party thereto). 
 ARTICLE 8. CONFIDENTIALITY AND PUBLIC DISCLOSURE 

8.1    Treatment of Confidential Information. 

A Receiving Party shall retain in strict confidence, and not disclose, divulge or otherwise communicate to any other Person, any Confidential
Information of the Disclosing Party, whether received prior to or after the Effective Date, and shall not use any such Confidential Information for any purpose, except pursuant to the terms of, and as required to carry out such Receiving
Party’s obligations under, this Agreement, except that each Receiving Party may disclose Confidential Information of the Disclosing Party to the officers, directors, employees, agents, accountants, attorneys, consultants, subcontractors or
other representatives of the Receiving Party or its Affiliates (the “Representatives”) who, in each case, (a) need to know such Confidential Information for the limited purposes of the implementation and performance by the
Receiving Party of this Agreement, (b) will use the Confidential Information only for such limited purposes, and (c) are bound by confidentiality obligations no less protective than those set forth in this Agreement. 

8.1.1    A Receiving Party shall use at least the same standard of care in complying with its confidentiality obligations
hereunder as it uses to protect its own Confidential Information of comparable sensitivity and to prevent and restrain the unauthorized disclosure of such Confidential Information by any of its Representatives, but in no event less than a reasonable
standard of care. The Receiving Party shall be liable for any breach by any of its Representatives of the restrictions set forth in this Agreement. 

  
 17 

 8.1.2    Without limiting the generality of any of the foregoing, the
Parties shall not make any disclosure of Confidential Information that would be reasonably likely to preclude the Disclosing Party from obtaining U.S. or foreign patents on any patentable invention or discovery described or otherwise embodied in
such Party’s Confidential Information. 
 8.1.3    The Confidential Information of each Party includes information
from Third Parties subject to confidentiality restrictions and disclosed by one Party to the other Party. 

8.2    Release from Restrictions. 

8.2.1    A Receiving Party may disclose Confidential Information to the extent that such Confidential Information
disclosure is made in response to a valid order or subpoena of a court of competent jurisdiction in the Territory or other Governmental Authority of competent jurisdiction or otherwise required by law, in the reasonable opinion of counsel to the
Receiving Party; provided, however, that, to the extent practicable, the Receiving Party shall first provide written notice to the Disclosing Party reasonably in advance under the circumstances in order to give the Disclosing Party a
reasonable opportunity to quash such order or subpoena or to obtain a protective order requiring that the Confidential Information or documents that are the subject of such order or subpoena to be held in confidence by such court or Governmental
Authority or, if disclosed, be used only for the purposes for which such order or subpoena was issued; and provided further that whether a disclosure order or subpoena is quashed or a protective order is obtained, any Confidential
Information that may be disclosed in response to such court or Governmental Authority order or subpoena shall be limited to information that, in the reasonable opinion of counsel to the Receiving Party, is legally required to be disclosed in such
response to such order or subpoena. 
 8.2.2    A Receiving Party may also disclose Confidential Information to the
extent that such disclosure is made (i) to a Governmental Authority as required in connection with any filing, application or request for Regulatory Approval with respect to the Product, (ii) to comply with the reporting requirements of
any Applicable Laws or any securities exchange on which the securities of the Receiving Party or its Affiliates are traded or (iii) to a Third Party to which a Receiving Party has a contractual obligation related to the Product, but only to the
extent such information is required by such contractual obligation, provided that in each case (clauses (i), (ii) and (iii)), reasonable measures are taken to seek confidential treatment of such Confidential Information. 

8.2.3    A Receiving Party may disclose this Agreement to a Third Party in connection with or in conjunction with
(i) a proposed merger, consolidation, sale of assets that includes those related to this Agreement, (ii) a permitted assignment of this Agreement or (iii) loan financing, raising of capital, or sale of securities; provided,
however, that the disclosing Party obtains an agreement for confidential treatment thereof on terms no less protective than those contained herein. 

  
 18 

 8.2.4    Any Confidential Information disclosed pursuant to this
Section 8.2 shall maintain its confidentiality protection and nonuse restrictions for all purposes other than such disclosure. 

8.3    No Implied Rights. Except as otherwise expressly set forth in this Agreement, nothing herein shall be
construed as granting any Receiving Party any right, title, interest in or ownership of the Confidential Information, proprietary information or Intellectual Property of the Disclosing Party. For the avoidance of doubt, specific information
disclosed as part of Confidential Information shall not be deemed to be in the public domain or in the prior possession of the Receiving Party merely because it is embraced by more general information in the public domain or by more general
information in the prior possession of the Receiving Party. 
 8.4    Survival of Confidentiality
Obligations. The confidentiality obligations of the Parties contained in this Article 8 shall remain binding on both Parties during the Term and for a period of five (5) years after the expiration of the Term or the termination of
this Agreement, regardless of the cause of such expiration or termination. 
 8.5    Disclosure of Terms and
Use of Party’s Name. 
 8.5.1    No press release, public announcement, confirmation or other
communication to the public or Third Parties regarding the existence or terms of this Agreement or related matters shall be made by either Party without the prior written consent of the other Party, including with respect to the form, content and
timing of such press release, public announcement, confirmation or other communication to the public or Third Parties, except as provided Section 8.2 or in the following sentence. The Parties agree that a press release may
be issued by Catalyst at or after the Effective Date in the form included on Exhibit C and that the Parties may make communication of any information specifically included in such press release. 

8.5.2    Except as required by Applicable Laws or as to Labeling activities, no right, express or implied, is granted by
this Agreement to either Party to use in any manner the name of the other Party or its Affiliates or any other trade name or trademark of such other Party or its Affiliates in connection with the performance of this Agreement. For clarity, it is
understood that nothing herein shall prohibit either Party from using the name of the other Party (i) in certain of such Party’s disclosure documents, including those filed or disclosed in order to comply with its obligations under
Applicable Laws or the listing standards or agreements of any national or international securities exchange, The New York Stock Exchange or The NASDAQ Stock Market or other similar laws of a Governmental Authority, (ii) to respond to an inquiry
of a Governmental Authority, or (iii) in a judicial, administrative or arbitration Proceeding, or from disclosing the fact that it has granted or obtained a license to any Intellectual Property of such other Party so long as such use of the
other Party’s name is limited to statements of fact and is not done in a manner to suggest or imply endorsement by such other Party. 

8.6    Third Party Information 

8.6.1     Catalyst has not and shall not (i) violate or misappropriate the trade secrets, know-how, or confidential information, or knowingly violate or misappropriate any other proprietary rights, of any Third Party in developing the Product, and will not communicate any

  
 19 

 
Third Party trade secrets to EVL or its Affiliates in connection with its rights and obligations under this Agreement without receiving permission from such Third Party and informing EVL of
communication of such trade secrets, or (ii) provide or disclose any documents or information to EVL or its Affiliates unless Catalyst is the owner thereof, or otherwise has the full and legal right to do so. 

8.6.2    EVL shall not (i) violate or misappropriate the trade secrets,
know-how, or confidential information, or knowingly violate or misappropriate any other proprietary rights, of any Third Party in connection with its rights and obligations under this Agreement, and will not
communicate any Third Party trade secrets to Catalyst in connection with its rights and obligations under this Agreement without receiving permission from such Third Party and informing Catalyst of communication of such trade secrets, or
(ii) provide or disclose any documents or information to Catalyst unless EVL is the owner thereof, or otherwise has the full and legal right to do so. 

8.7    Remedies. Each Party acknowledges and agrees that: (i) it will be too speculative to measure the
damages that would be suffered by the other Party if such Party fails to comply with the obligations set forth in this Article 8 or in Article 12 and that, in the event of any such failure, such other Party will be irreparably harmed
and will not have an adequate remedy at law, (ii) such other Party shall, therefore, be entitled, in addition to any other rights and remedies, to seek specific performance of such Party’s obligations and to seek immediate injunctive
relief without having to post a bond, and (iii) such non-complying Party shall not assert, as a defense to any proceeding for such specific performance or injunctive relief, that such other Party will not
be irreparably harmed or that such other Party has an adequate remedy at law. 
 ARTICLE 9. REPRESENTATIONS AND WARRANTIES AND COVENANTS

 9.1    By EVL. EVL hereby represents, warrants and covenants that: 

(a)    EVL is a company duly organized and validly existing under the laws of Ireland; 

(b)    EVL has the corporate power and authority to enter into and be bound by the terms and conditions of this Agreement
and to perform its obligations hereunder and the execute this Agreement; 
 (c)    EVL has taken all necessary corporate
action on its part to authorize the execution and delivery of this Agreement and this Agreement has been duly executed and delivered on behalf of EVL and constitutes a legal, valid, binding obligation, enforceable against EVL in accordance with its
terms, subject to bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforceability of creditors’ rights generally and other general equitable principles which may limit the right to obtain certain remedies;

 (d)    EVL is subject to no legal, contractual or other restrictions, limitations or conditions that conflict with
its rights and obligations under this Agreement or that might affect adversely its ability to perform hereunder, including Section 2.2; 

  
 20 

 (e)    EVL has not misappropriated and will not misappropriate trade
secrets of any Third Party in the provision of services and the performance of its obligations under this Agreement or otherwise in connection with the Product; 

(f)    EVL itself or through its Affiliates has maintained and will maintain appropriate skilled personnel and facilities
to carry out its obligations under this Agreement; 
 (g)    No EVL employees or other Persons performing services on
behalf of EVL under this Agreement have been debarred, or are the subject of debarment Proceedings, under Section 306 of the FD&C Act; and if EVL becomes aware that a Person performing on its behalf under this Agreement has been debarred,
or has become the subject of debarment Proceedings, under Section 306 of the FD&C Act, EVL shall promptly notify Catalyst and shall prohibit such Person from performing on its behalf under this Agreement; and 

(h)    EVL and its Affiliates have not and shall not (i) promise, offer, or give anything of value to any government
employee or individual acting in an official capacity for the purpose of securing any improper or undue advantage, (ii) accept or receive any unlawful contributions, payments, expenditures, or gifts, (iii) do business with any person that
is the subject of sanctions imposed or administered by the U.S. Treasury Department’s Office of Foreign Assets Control or the UN Security Council or any governmental agency in a jurisdiction in which EVL and its Affiliates are organized or
doing business, and EVL and its Affiliates are not the subject of any such sanctions, or (iv) violate any applicable export restriction, anti-boycott regulation, or other applicable laws. 

9.2    By Catalyst. Catalyst hereby represents, warrants and covenants that: 

(a)    Catalyst is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction
of its formation; 
 (b)    Catalyst has the corporate power and authority to enter into and be bound by the terms and
conditions of this Agreement and to perform its obligations hereunder; 
 (c)    Catalyst has taken all necessary
corporate action on its part to authorize the execution and delivery of this Agreement and this Agreement has been duly executed and delivered on behalf of Catalyst and constitutes a legal, valid, binding obligation, enforceable against Catalyst in
accordance with its terms, subject to bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforceability of creditors’ rights generally and other general equitable principles which may limit the right to
obtain certain remedies; 
 (d)    Catalyst is subject to no legal, contractual or other restrictions, limitations or
conditions which conflict with either of its rights and obligations under this Agreement or which might affect adversely its ability to perform hereunder, including Section 2.2; 

(e)    Catalyst has not misappropriated and will not misappropriate trade secrets of any Third Party in the provision of
services and the performance of its obligations under this Agreement or otherwise in connection with the Product; 

  
 21 

 (f)    Catalyst has maintained and will maintain appropriate skilled
personnel and facilities to carry out its obligations under this Agreement, consistent with prudent business practices of Catalyst; 

(g)    No Catalyst employees or other Persons performing services on behalf of Catalyst under this Agreement have been
debarred, or are the subject of debarment Proceedings, under Section 306 of the FD&C Act; and if Catalyst becomes aware that a Person performing on its behalf under this Agreement has been debarred, or has become the subject of debarment
Proceedings, under Section 306 of the FD&C Act, Catalyst shall promptly notify EVL and shall prohibit such Person from performing on its behalf under this Agreement; 

(h)    Catalyst and its Affiliates have not and shall not (i) promise, offer, or give anything of value to any
government employee or individual acting in an official capacity for the purpose of securing any improper or undue advantage, (ii) accept or receive any unlawful contributions, payments, expenditures, or gifts, (iii) do business with any
person that is the subject of sanctions imposed or administered by the U.S. Treasury Department’s Office of Foreign Assets Control or the UN Security Council or any governmental agency in a jurisdiction in which Catalyst and its Affiliates are
organized or doing business, and Catalyst and its Affiliates are not the subject of any such sanctions, or (iv) violate any applicable export restriction, anti-boycott regulation, or other Applicable Laws; 

(i)    All Bioequivalence Studies were conducted in accordance with all Applicable Laws (which the Parties acknowledge
does not include the draft FDA guidance otherwise related to such studies); and 
 (j)    [***]. 

9.3    Compliance with Laws. 

9.3.1    Anti-Corruption Laws. Each Party represents and warrants to the other Party that, to the knowledge of such
Party, such Party, with respect to the conduct of its business as of the Effective Date, has been and is in compliance in all material respects with all Applicable Laws. Each Party shall comply, and shall cause its employees and subcontractors to
comply, with all Applicable Laws in its performance of activities contemplated under this Agreement. Without limiting the generality of the foregoing, each Party agrees that it will comply with, and will not take any action that will cause the other
Party or its Affiliates to be in breach of all Applicable Laws for the prevention of fraud, kickbacks, bribery, corruption, racketeering, money laundering or terrorism, including the FCPA, each, as amended from time to time (collectively,
“Anti-Corruption Laws”). Each Party agrees that it has not, and covenants that it will not, in connection with the performance of this Agreement, give, promise, authorize, ratify or offer, or take any act in furtherance of offering
or giving anything of value, directly or indirectly: (i) to any individual, including Government Officials; or (ii) to an intermediary for payment to any individual, including Government Officials; (iii) or to any sick fund, health
insurer or Healthcare Professional or employee or officer of such sick fund, health insurer or Healthcare Professional; or (iv) to any political party. It is the intent of the Parties that no payments or transfers of value shall be made,
promised, authorized, ratified or offered with the purpose or effect of public or commercial bribery, acceptance or acquiescence in extortion, kickbacks or other unlawful or improper means of security an improper advantage or obtaining or retaining
business. 

  
 22 

 9.3.2    Data Protection Laws. From time to time during the Term,
either Party may provide the other Party with personal information that falls under the protection of certain data security and privacy laws (“Protected Personal Information”). Each Party agrees to comply with all Applicable Laws
relating to the use, storage, collection or other processing of such Protected Personal Information, including without implied limitation the General Data Protection Regulation (EU) 2016/679 of the European Parliament and of the Council of
27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (“Data Protection Laws”). The Parties agree to use
good-faith efforts to agree upon and implement any security protocols and information handling guidelines that such Party’s legal advisors recommend in connection with such Party’s compliance with such Data Protection Laws. 

9.3.3    OFAC Compliance. Each Party acknowledges and expressly agrees that certain laws of the United States of
America and other countries, including, without limitation, the United States Export Control Regulations, the United States Anti-Money Laundering laws, the United States Anti-Terrorism laws and the FCPA, and U.S. sanctions programs administered by
the Office of Foreign Assets Control (“OFAC”) and the Bureau of Industry and Security, among others, may result in the imposition of sanctions on the other Party or its Affiliates in the event that, directly or indirectly, products
are exported to or imported from, or payments are sent to or received from various countries or regions, including, without limitation, Iran, North Korea, Syria, Sudan, the Crimea region of Ukraine, or any country embargoed by Executive Order or
otherwise, or to or from certain individuals designated or identified as sanctioned by the U.S. government, including persons in Russia and Ukraine. Each Party warrants that it has searched OFAC’s Consolidated Sanctions List, available at
https://sdnsearch.ofac.treas.gov, in order to ensure compliance with all applicable sanctions regulations. 

9.3.4    Compliance Event Reporting. Each Party agrees that if it learns of any violation of Data Protection Laws,
Applicable Laws, Export Control Laws or Anti-Corruption Laws by an employee or sub-contractor that performs any function under this Agreement (a “Compliance Event”), it will immediately notify
the other Party in writing of such Compliance Event and the measures it has taken and intends to take to remedy such Compliance Event and to prevent its recurrence. 

ARTICLE 10. INDEMNIFICATION 

10.1    Indemnification by Catalyst. Subject to Section 10.3, Catalyst
shall defend, indemnify and hold harmless each of EVL and its Affiliates, and each of their respective directors, officers and employees (each, an “EVL Indemnitee”) from and against any and all liabilities, damages, settlements,
penalties, fines, costs or expenses (including reasonable attorneys’ fees and other expenses of litigation) (collectively, “Liabilities”) arising, directly or indirectly, out of or in connection with Third Party claims, suits,
actions, demands or judgments to the extent arising out of or relating to (i) any breach by Catalyst of any representation, warranty, agreement, undertaking or covenant under this Agreement; (ii) any negligence, gross negligence or willful
misconduct by Catalyst or its Affiliates, past or present employees or agents; (iii) any arrangement entered into 

  
 23 

 
by Catalyst (or its Affiliates) and a Third Party, providing for any royalty or other payment obligation with respect to the Product, or (iv) any patient’s participation in the
Bioequivalence Studies, except, in each case, for those Liabilities for which EVL has an obligation to indemnify the Catalyst Indemnitees pursuant to Section 10.2, as to which Liabilities each Party shall indemnify
the other Party to the extent of its respective liability for such Liabilities. 
 10.2    Indemnification by
EVL. Subject to Section 10.3, EVL shall defend, indemnify and hold harmless each of Catalyst and its Affiliates, and each of their respective directors, officers and employees (each, a “Catalyst
Indemnitee”) from and against any and all Liabilities arising, directly or indirectly, out of or in connection with Third Party claims, suits, actions, demands or judgments to the extent arising out of or relating to (i) any breach by
EVL of any representation, warranty, agreement, undertaking or covenant under this Agreement; (ii) any negligence, gross negligence or willful misconduct by EVL or its Affiliates or sublicensees, past or present employees or agents; or
(iii) product liability claims arising from the manufacture of the Product by EVL or its Affiliates, except, in each case, for those Liabilities for which Catalyst has an obligation to indemnify the EVL Indemnitees pursuant to
Section 10.1, as to which Liabilities each Party shall indemnify the other Party to the extent of its respective liability for such Liabilities. 

10.3    Notice and Procedures. If a Catalyst Indemnitee or an EVL Indemnitee (the
“Indemnitee”) intends to claim indemnification under this Article 10, it shall promptly notify the other Party (the “Indemnitor”) in writing of any such alleged Liabilities. The failure to deliver written
notice to the Indemnitor within a reasonable time after the commencement of any claim or action shall not relieve the Indemnitor of any obligation to the Indemnitee under this Section 10.3 except to the extent that the
Indemnitor is materially prejudiced by such delay. 
 10.3.1    In the event that the Indemnitor does not assume and
pursue in a timely and diligent manner the defense of any Third Party claim (but in no event later than thirty (30) days, or such shorter period as required under Applicable Laws), then the Indemnitor shall be deemed to have ceded control of
such claim and the Indemnitee shall be entitled to appoint counsel of its own choice for such defense, at the cost and expense of the Indemnitor. 

10.3.2    In the event that the Indemnitor assumes such defense, the Indemnitor shall have the right to control the defense
thereof with counsel of its choice, provided that such counsel is reasonably acceptable to Indemnitee; and provided further that any Indemnitee shall have the right to retain its own counsel at its own expense, for any reason,
including if representation of the Indemnitee by the counsel retained by the Indemnitor would be inappropriate due to actual or potential conflicts or differing interests between such Indemnitee and such Indemnitor reasonably represented by such
counsel in such proceeding. The Indemnitee, its employees and agents, shall reasonably cooperate with the Indemnitor and its legal representatives in the investigation of any Liabilities covered by this Article 10. 

10.3.3    The obligations of this Section 10.3 shall not apply to amounts paid in settlement of
any claim, demand, action or other proceeding if such settlement is effected without the consent of the Indemnitor (unless the Indemnitor is deemed to have ceded control of the applicable Third Party claim under this
Section 10.3). 

  
 24 

 10.3.4    Only Catalyst or EVL may claim indemnity under this Article
10 (on its own behalf or on behalf of its Indemnitees), and other Persons may not directly claim indemnity hereunder. 

10.4    Other Product Liability Claims. To the extent either Party incurs any Liabilities arising from or in
connection with any product liability claim with respect to the Product to the extent arising from the actions not subject to the indemnity obligations set forth in Section 10.1 or Section 10.2 (a
“Product Claim”), then each Party shall be liable for such portion of the Liabilities in accordance with such Party’s allocation of the Net Profits pursuant to Section 6.1.1; provided,
however, such Liabilities shall be shared initially by offsetting against the portion of Net Profits otherwise payable or retained pursuant to Section 6.1.1 and in the event of any shortfall thereafter, each
Party’s share thereof shall be paid in accordance with such allocation. EVL shall have sole control in addressing, defending, managing and conducting any negotiations, litigation, threatened litigation or settlement regarding such Product
Claim, using counsel of its choice. In the event that EVL does not respond to the Product Claim against Catalyst within (a) sixty (60) days following the notice of such claim or (b) ten (10) days before the time limit, if any, set forth in
the appropriate laws and regulations for the filing of a response to such Product Claim, whichever comes first, Catalyst shall have the right to control any such Product Claim, using counsel of its own choice. In the event of a Product Claim, the non-controlling Party shall cooperate fully with the controlling Party, including, if a party in such Product Claim, and the controlling Party shall keep the non-controlling
Party and/or the non-controlling Party’s designated legal counsel reasonably informed as to the progress of such action. Neither Party shall enter into any settlement of the Product Claim, without the
prior written consent of the other, such consent not to be unreasonably withheld, delayed or conditioned. Notwithstanding this Section 10.4, (a) Catalyst’s maximum aggregate liability pursuant to this
Section 10.4 shall not exceed an amount equal to $[***], and (b) Catalyst shall have no liability under this Section 10.4 for product liability claims arising from the manufacture of
the Product by any manufacturer other than [***]. 
 10.5    Exclusive Remedy. The rights of the
EVL Indemnitees and the Catalyst Indemnitees under this Article 10 shall be the sole and exclusive remedy of the EVL Indemnitees and the Catalyst Indemnitees, as the case may be, with respect to matters covered hereunder other than as
provided in Article 8 and the termination provisions of Article 12. 
 ARTICLE 11. LIMITATION OF LIABILITY 

NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, EXCEPT WITH RESPECT TO A BREACH OF ARTICLE 8 AND EXCEPT WITH RESPECT TO
AMOUNTS PAYABLE ON LIABILITIES PURSUANT TO THE INDEMNIFICATION OBLIGATIONS SET FORTH IN ARTICLE 10, NO PARTY SHALL BE LIABLE TO THE OTHER FOR ANY CONSEQUENTIAL, INCIDENTAL OR INDIRECT DAMAGES, INCLUDING FOR LOST PROFITS, OR LOSS OF OPPORTUNITY OR
USE OF ANY KIND SUFFERED BY THE A PARTY, WHETHER IN CONTRACT, TORT OR OTHERWISE. 

  
 25 

 ARTICLE 12. TERM AND TERMINATION 

12.1    Term. Unless earlier terminated pursuant to this Article 12, the term of this Agreement shall
continue in force from the Effective Date until the date that is ten (10) years following the Commercial Launch (the “Term”). 

12.2    Termination for Breach. Either Party may terminate this Agreement, or suspend performance under this
Agreement upon written notice to the other Party at any time during the Term, if the other Party is in material breach of this Agreement and such other Party has not cured such material breach within sixty (60) days after notice requesting cure
of such breach; provided, however, that if such breach is not capable of cure within sixty (60) days, but is capable of cure, and the breaching Party has promptly commenced, and is and continues diligently pursuing in good faith
the remedy of any such breach, then such cure period shall be extended for such period as may be reasonably required to effectuate such cure. 

12.3    Termination for Insolvency. Either Party may terminate this Agreement in the event that the other
Party suffers an Insolvency Event, by delivery of written notice thereof by the other Party. 

12.4    Termination for Force Majeure Event. Either Party may terminate this Agreement pursuant to and in
accordance with Section 14.12 in connection a Force Majeure Event. 

12.5    Termination for Other Events. The applicable Party may terminate this Agreement upon delivery of
written notice to the other Party as follows: 
 (a)    EVL may terminate this Agreement if the [***] has not been
approved by the FDA by January 1, 2021; 
 (b)    EVL may terminate this Agreement upon EVL’s reasonable
determination that the Product is not commercially viable; or 
 (c)    Catalyst may terminate this Agreement if the
Commercial Launch has not occurred within 24 months of the [***] having been approved by the FDA, unless the failure to launch arises out of or is related to an Interfering Event. 

12.6    Effect of Expiration or Termination. 

12.6.1    Expiration of the Term or termination of this Agreement for any reason shall be without prejudice to: 

(a)    Each Party’s right to receive all payments due and payable from the other Party as of the effective date of
such termination, if any, pursuant to the terms of this Agreement; 
 (b)    EVL’s right to sell, at its option but
subject to the Commercial Launch, the Product remaining in its inventory at the time of termination (in which event, Net Profits on such sales shall continue to be shared as set forth above in Section 6.1.1) for up to
twelve (12) months following the time of termination (and any remaining unsold inventory shall be destroyed by EVL or its Affiliates) provided that Catalyst or its assigns may elect to purchase from EVL the saleable inventory of the Product at
EVL’s Acquisition Cost; and 

  
 26 

 (c)    any other legal, equitable, or administrative remedies as to
which either Party is or may become entitled. 
 12.6.2    In the event that this Agreement is terminated by Catalyst
pursuant to Section 12.4 or EVL pursuant to Section 12.5(a) or Section 12.5(b), such termination shall automatically result in an offer by EVL to transfer its right,
title, interest, ownership and control of the [***] and any and all other assets owned by EVL or its Affiliates related solely to the Product (other than assets that bear EVL’s or any of its Affiliate’s name or logo) to Catalyst or its
designee free and clear of any adverse claims, liens or payment obligations; and Catalyst or its designee shall have the right, at its sole discretion, to accept such offer by delivering written notice thereof within twenty (20) Business Days
following the date of such notice. In the event of such acceptance, (i) Catalyst shall, subject to Section 12.7 (as applicable), (x) in the event Catalyst elects to continue the Commercialization (at its sole
discretion), be responsible for, at its own expense, all activities in connection with such Commercialization, as well as any Liabilities deriving therefrom, including the obligation to defend, indemnify and hold harmless each EVL Indemnitee from
any Liabilities asserted against EVL for such Commercialization by Catalyst or its designated Affiliate, and (y) make a payment to EVL in an amount equal to [***] Dollars ($[***]) within five (5) days of completion of [***]
from EVL or its Affiliate to Catalyst or its designee; (ii) EVL shall have no further obligation to indemnify a Catalyst Indemnitee pursuant to Section 10.2 for events occurring after the aforementioned [***] pursuant
to this Section 12.6.2 except such indemnification obligations shall remain for Product sold by EVL, its Affiliates or sublicensees; and (iii) the license granted by Catalyst to EVL pursuant to
Section 2.1.1 shall terminate. Each Party shall reasonably cooperate with each other in connection herewith, including (i) negotiating in good faith appropriate documentation addressing the provisions in this
Section 12.6.2, (ii) filing a transfer of ownership letters as required by 21 CFR § 314.72, in forms mutually agreed between Catalyst and EVL, to effectuate the [***] from EVL or its Affiliate to Catalyst or its
designee, and (iii) using commercially reasonable efforts to complete the [***] from EVL or its Affiliate to Catalyst or its designee as soon as practicable, but in any event within forty-five (45) days of Catalyst’s acceptance of
EVL’s offer pursuant to this Section 12.6.2. 
 12.6.3    In the event that the Agreement
is terminated by Catalyst pursuant to Section 12.2, Section 12.3 or Section 12.5(c), (i) EVL shall, for no additional consideration, transfer its right, title, interest,
ownership and control of the [***] and any and all other assets owned by EVL or its Affiliates related solely to the Product (other than assets that bear EVL’s or any of its Affiliate’s name or logo) to Catalyst or its designee,
(ii) in the event Catalyst elects to continue the Commercialization (at its sole discretion), Catalyst shall, subject to Section 12.7 (as applicable), be responsible for, at its own expense, all activities in
connection with such Commercialization, as well as any Liabilities deriving therefrom, including the obligation to defend, indemnify and hold harmless each EVL Indemnitee from any Liabilities asserted against EVL for such Commercialization by
Catalyst or its designated Affiliate, (iii) EVL shall have no further obligation to indemnify a Catalyst Indemnitee pursuant to Section 10.2 for events occurring after the aforementioned [***] pursuant to this
Section 12.6.3, 

  
 27 

 
except such indemnification obligations shall remain for Product sold by EVL, its Affiliates or sublicensees; and (iv) the license granted by Catalyst to EVL pursuant to
Section 2.1.1 shall terminate. Each Party shall reasonably cooperate with each other in connection herewith, including (i) negotiating in good faith appropriate documentation addressing the provisions in this
Section 12.6.3, (ii) filing a transfer of ownership letters as required by 21 CFR § 314.72, in forms mutually agreed between Catalyst and EVL, to effectuate the [***] from EVL or its Affiliate to Catalyst or its
designee, and (iii) using commercially reasonable efforts to complete the [***] a from EVL or its Affiliate to Catalyst or its designee as soon as practicable, but in any event within forty-five (45) days of such termination of this
Agreement. 
 12.6.4    In the event that the Term of the Agreement expires, or EVL wishes to terminate this Agreement
pursuant to Section 12.2 or Section 12.3, then (i) EVL shall retain its right, title, interest, ownership and/or control of the [***], and (ii) the license granted by Catalyst to EVL
pursuant to Section 2.1.1 shall continue in full force and effect. 
 12.6.5    All licenses
and rights to licenses granted under or pursuant to this Agreement are, and shall otherwise be deemed to be, for purposes of Section 365(n) of the United States Bankruptcy Code (the “Code”), licenses of rights to
“intellectual property” as defined under Section 101(35A) of the Code. EVL, as the licensee of such rights under this Agreement, shall retain and may fully exercise all of its rights and elections under the Code, and upon commencement
of a bankruptcy proceeding by or against Catalyst under the Code, shall be entitled to a complete duplicate of, or complete access to (as EVL deems appropriate), any such intellectual property and all embodiments of such intellectual property. Such
intellectual property and all embodiments thereof shall be promptly delivered to EVL (i) upon any such commencement of a bankruptcy proceeding upon written request therefor by EVL, unless Catalyst elects to continue to perform all of its
obligations under this Agreement or (ii) if not delivered under (i) above, upon the rejection of this Agreement by or on behalf of Catalyst, upon written request therefor by EVL, and each Party hereby acknowledges and agrees that the
foregoing shall serve as its consent to such transfer of the intellectual property and all embodiments thereof. The foregoing provisions of this Section 12.6.4 are without prejudice to any rights EVL may have arising under
the Code or other Applicable Law. 
 12.7    Survival. In addition to specific indications throughout this
Agreement that Articles and Sections of this Agreement shall survive expiration and termination of this Agreement, Article 1, Article 8, Article 10, Article 11, Article 12, Article 13, and Article 14,
and Section 4.1.1, Section 6.3, Section 6.4, Section 6.5, and Section 7.1, and any other provisions necessary and proper to
give effect to the intention of the Parties as to the effect of the Agreement after termination shall survive any expiration or termination of this Agreement. In addition, unless otherwise expressly set forth herein, no expiration of the Term or
termination of this Agreement shall have any effect on any payment, obligation accruing or arising prior to such expiration or termination or relieve either Party from obligations that are expressly indicated to survive termination or expiration of
this Agreement. 

  
 28 

 ARTICLE 13. INSURANCE 

13.1    Insurance 

13.1.1    Each Party shall obtain and maintain at all times during the Term, prudent comprehensive general liability
coverage appropriate to its activities with reputable and financially secure insurance carriers to cover its activities related to this Agreement. Additionally such insurance coverage shall include product liability coverage of an appropriate
amount, not less than [***] US dollars ($[***]) per occurrence, for so long as the Product is being sold pursuant to this Agreement. Notwithstanding the foregoing, each Party shall, at its own cost and expense, obtain and maintain in
full force and effect at all times during the Term, and (with respect to claims made insurance) for a period of six (6) years thereafter: 

(a)    commercial general liability insurance covering bodily injury and property damage with limits no less than [***]
Dollars ($[****]) per occurrence and [***] Dollars ($[***]) in the aggregate; and 

(b)    products and completed operations liability insurance (including coverage for all Product used in clinical trials)
with limits no less than [***] Dollars ($[***]) per occurrence and [***] Dollars ($[***]) in the aggregate. 

13.1.2    All of the foregoing insurance policies shall be obtained from an insurance carrier or carriers having a current
A.M. Best rating of at least A- Class VIII. 
 13.1.3    Upon written
request, a Party shall provide the other Party with a certificate of insurance evidencing such coverage. Each Party shall provide the other Party with written notice within thirty (30) days of any material change in the terms or coverage of
such insurance policies or their lapse, cancellation or termination. 
 13.1.4    All insurance policies obtained by
either Party pursuant to this Agreement shall be primary and not contributing to any other insurance, self-insurance or captive insurance maintained by the other party to the extent of such Party’s indemnification obligations hereunder;
provided, however, that notwithstanding the foregoing, (a) EVL may self-insure with respect to its product liability obligations hereunder, and (b) the insurance policies required under
Section 13.1.1 shall not be construed to limit either Party’s liability with respect to its indemnification obligations under this Agreement. 

ARTICLE 14. MISCELLANEOUS 

14.1    Interpretation and Construction. Unless the context of this Agreement otherwise requires,
(i) the terms “include,” “includes,” or “including” shall be deemed to be followed by the words “without limitation” unless otherwise indicated; (ii) words using the
singular or plural number also include the other, (iii) the terms “hereof,” “herein,” “hereby,” and derivative or similar words refer to this entire Agreement; (iv) the terms
“Article,” “Section” and “Exhibit” refer to the specified Article, Section and Exhibit of this Agreement, and (v) words of any gender include each other gender. Whenever this Agreement
refers to a number of days, unless otherwise specified, such number shall refer to calendar days. The headings and paragraph captions in this Agreement are for reference and convenience purposes only and shall not affect the meaning or
interpretation of this Agreement. This Agreement shall not be interpreted or constructed in favor of or against either Party because of its effort in preparing it. 

  
 29 

 14.2    Independent Contractor Status. It is understood
and agreed that nothing in this Agreement nor any agreement related hereto is intended to nor shall create a partnership between the Parties. The Parties are independent contractors and are engaged in the operation of their own respective
businesses, and neither Party is to be considered the agent, partner, joint venturer or employee of the other Party for any purpose whatsoever and neither Party shall have any authority to enter into any contracts or assume any obligations for the
other Party nor make any representations or warranties on behalf of such other Party. 
 14.3    Performance
by Affiliates. 
 14.3.1    Catalyst recognizes that EVL may perform some or all of its obligations under this
Agreement through one (1) or more of its Affiliates; provided, however, that EVL shall remain responsible for such performance by its Affiliates and shall cause its Affiliates to comply with the provisions of this Agreement in
connection with such performance as if it were a party hereto. 
 14.3.2    In connection therewith, EVL may in its
discretion have all or some of EVL’s obligations and duties hereunder, including the commercialization of the Product in the Territory, be fulfilled by one or more of EVL’s Affiliates, without any further action or notice. Without limiting
the foregoing, any obligation or duty of EVL which is performed, satisfied or fulfilled by an Affiliate of EVL shall be deemed to have been performed, satisfied or fulfilled by EVL. EVL shall cause all of its Affiliates involved in any activities in
connection with this Agreement to comply in all respects with all terms and conditions of this Agreement, and any breach by any such Affiliate of any of the terms of this Agreement shall be deemed a breach by EVL. 

14.4    Waiver. The waiver by either Party of a breach of any term or provision contained herein shall not
be effective unless provided in writing and shall in no way be construed as a waiver of any succeeding breach of such term or provision or the waiver of such term or provision itself. 

14.5    Assignment. This Agreement shall be binding upon and inure to the benefit of each of the Parties and
their respective successors and approved assigns; provided, however, that neither Party may assign this Agreement, in whole or in part, without the prior written consent of the other Party, unless such assignment is (i) to an
Affiliate of the assigning Party, or (ii) in connection with a merger or acquisition or sale of all or substantially all of the assets of the assigning Party to which this Agreement relates; provided further, however, that
notwithstanding the foregoing, each Party shall provide written notice (at least ten (10) days in the event of clause (i)) of any assignment of this Agreement in accordance with the terms hereof to the other Party. Any assignment of this
Agreement not in accordance with this provision shall be null and void ab initio. 

14.6    Modification. This Agreement may not be changed, modified, amended or supplemented except by an
express written instrument signed by both Parties. 

  
 30 

 14.7    Severability. If any provision of this Agreement
shall be held illegal or unenforceable, that provision shall be limited or eliminated to the minimum extent necessary so that this Agreement shall otherwise remain in full force and effect and enforceable. 

14.8    Further Assurances. Each Party shall execute, acknowledge and deliver such further instruments and
documents, and to do all such other acts, as may be reasonably necessary or appropriate in order to carry out the purposes and intent of this Agreement. 

14.9    Notices. 

14.9.1    Any notice or other communication to be given under this Agreement by any Party to the other Party shall be in
writing and shall be either (a) personally delivered, (b) mailed by registered or certified mail, postage prepaid with return receipt requested, (c) delivered by overnight express delivery service or
same-day local courier service, or (d) delivered by facsimile transmission (followed by a copy by the preceding methods in clause (a), (b) or (c)), to the email address of the applicable Party as set
forth below, or to such other address as may be designated by the Parties from time to time in accordance with this Section 14.9. 

14.9.2    Notices delivered personally, by overnight express delivery service or by local courier service shall be deemed
given as of actual receipt. Mailed notices shall be deemed given three (3) Business Days after mailing. Notices delivered by facsimile transmission shall be deemed given upon receipt by the sender of the transmission confirmation (in the case
of a facsimile transmission) if transmitted before 5:00 p.m. (recipient’s local time) on a Business Day, and otherwise on the following Business Day. 
  

			
	If to EVL:	    	 Endo Ventures Limited
 First Floor, Minerva
House
 Simmonscourt Road
 Ballsbridge

Dublin 4
 Attention: Senior Vice President, Head of
International
 Pharmaceuticals
 Email:
garella.rahul@endo.com
 Facsimile Number: +353 1 268 2029

		
	With a copy to:	    	 Par Pharmaceutical, Inc.
 6 Ram Ridge Road

Chestnut Ridge, NY 10977
 Attention: Legal

Email: Par.NoticeDept@parpharm.com
 Facsimile Number: (845)
573-5600

		
	If to Catalyst:	    	 Catalyst Pharmaceuticals Inc.
 355 Alhambra
Circle, Suite 1250
 Coral Gables, FL, USA 33134
 Attention:
Brian Elsbernd, Senior Vice President of Legal
 and Compliance

Email: belsbernd@catalystpharma.com
 Facsimile Number: (305) 569-0233

  
 31 

 14.10    Governing Law and Jurisdiction. This Agreement
shall be governed by and construed in accordance with the laws of the State of New York, without reference to the choice of law principles thereof other than those that may permit designation of New York law. The Parties irrevocably agree that the
State and Federal Courts located in the State, City, and County of New York, shall have exclusive jurisdiction to deal with any disputes arising out of or in connection with this Agreement and that venue is proper in such Courts. Each Party hereby
expressly consents and submits to the personal jurisdiction of the Federal and State Courts in the State, City and County of New York. 

14.11    Attorney Fees. In the event that either Party institutes any legal suit, action, or proceeding
against the other Party arising out of this Agreement, the prevailing Party in the suit, action or proceeding shall be entitled to receive, in addition to all other damages to which it may be entitled, the costs incurred by such party in conducting
the suit, action, or proceeding, including reasonable attorneys’ fees and expenses and court costs. 

14.12    Force Majeure. A Party shall not be liable for
non-performance or delay in performance of its obligations hereunder to the extent that and solely for so long as such non-performance or delay in performance is not due
to its negligence or breach of this Agreement and is caused by any event reasonably beyond the control of such Party, including wars, hostilities, revolutions, riots, civil commotion, national emergency, unavailability of supplies, epidemics, fire,
flood, earthquake, force of nature, explosion, terrorist act, embargo, or any other Act of God, or any law, proclamation, regulation, ordinance, or other act or order of any court or Governmental Authority (each, a “Force Majeure
Event”). In the event of any such Force Majeure Event, the delayed Party may defer its performance for the duration of such Force Majeure Event, provided that the delayed Party gives the other Party written notice thereof promptly
and, in any event, within two (2) Business Days of discovery thereof, and uses its good faith efforts to cure the excused breach. If either Party is unable to perform its obligations hereunder as a result of a Force Majeure Event for a period
of ninety (90) days or longer and is not continuously exercising diligent good faith efforts to remedy, overcome or work around the Force Majeure Event, then the other Party shall have the right, upon its issuance of written notice to the other
Party, to terminate this Agreement. 
 14.13    Entire Agreement. This Agreement and any Exhibits attached
hereto constitute the entire agreement between EVL and Catalyst with respect to the Product and supersede all prior representations, understandings and agreements with respect to the Product. In the event of a conflict between this Agreement and any
Exhibits attached hereto, this Agreement shall prevail over any such Exhibit. 
 14.14    Counterparts.
This Agreement may be executed in one or more counterparts, including by transmission of facsimile or PDF copies of signature pages, each of which shall for all purposes are deemed to be an original and all of which shall constitute one instrument.

  
 32 

 14.15    Third Party Beneficiaries. Except as provided in
Section 10.1 and Section 10.2, (i) no term or provision of this Agreement is intended to be, or shall be, for the benefit of any Person (including any
sub-contractor, or any individual member of the control group utilized for the bioequivalence studies) that is not a party hereto, and (ii) no such other Person shall have any right or cause of action
hereunder. 
 14.16    Cumulative Rights. The rights and remedies of each of the Parties under or pursuant
to this Agreement are cumulative, may be exercised as often as such Party considers appropriate and are in addition to its rights and remedies under general law. 

[Signature page follows] 

  
 33 

 IN WITNESS WHEREOF, the Parties hereto have executed this Development, License and
Commercialization Agreement to be effective as of the Effective Date. 
  

					
	ENDO VENTURES LIMITED
		
	By:	 	 /s/ Rahul Garella

		 	Name:	 	Rahul Garella
		 	Title:	 	SVP International Pharmaceuticals

  

					
	CATALYST PHARMACEUTICALS INC.
		
	By:	 	 /s/ Patrick J. McEnany

		 	Name:	 	Patrick J. McEnany
		 	Title:	 	Chief Executive Officer

  
 34 

 Exhibit A 

[***] 

 Exhibit B 

FORM OF 
 NET PROFIT
REPORT 
 [***] 

 Exhibit C 

FORM OF PRESS RELEASE 

CATALYST PHARMACEUTICALS ANNOUNCES DEFINITIVE AGREEMENT WITH 

ENDO FOR VIGABATRIN TABLETS 
 CORAL
GABLES, Fla., December XX, 2018 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare
debilitating, chronic neuromuscular and neurological diseases, today announced that it has signed a Definitive Agreement with Endo International plc’s (NASDAQ: ENDP) subsidiary, Endo Ventures Limited, for the further development and
commercialization of generic Sabril® (vigabatrin) tablets through Endo’s U.S. Generic Pharmaceuticals segment, doing business as Par Pharmaceutical. Pursuant to the agreement, Catalyst
will receive an up-front payment, milestone payments based on achievement of regulatory approvals, and a sharing of defined net profits upon commercialization. 

“We are very happy to work with Endo, to bring generic Sabril® tablets to market. Endo is
an established leader in the generic vigabatrin marketplace,” said Patrick J. McEnany, Chairman and Chief Executive Officer of Catalyst Pharmaceuticals. “Our search for an appropriate partner for this product was long but rewarding with
this result. We look forward to bringing to market this important medication to improve the lives of patients.” 
 “Generic vigabatrin tablets
will complement our current powder vigabatrin offering and will expand the number of patients that can benefit from having access to a high-quality, generic vigabatrin option,” said Brandon Rockwell, Senior Vice President, Business Development
and Strategy of Endo. 
 Vigabatrin comes in two dosage forms – a powder sachet and a tablet. Par Pharmaceutical brought the first generic version of
the powder sachet to market but at this time there is no approved generic version of the tablets. 
 About Catalyst Pharmaceutical 

Catalyst Pharmaceutical is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating,
chronic neuromuscular and neurological diseases, including LEMS, congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis (MuSK-MG), and spinal muscular atrophy (SMA) type 3. Catalyst’s new drug application for Firdapse® (amifampridine) 10 mg tablets for the treatment of adults with Lambert-Eaton Myasthenic Syndrome (LEMS) was recently approved by the U.S. Food & Drug Administration (“FDA”),
and Firdapse® is expected to be commercially available in the United States early in the first quarter of 2019. Prior to its approval, Firdapse for LEMS had received breakthrough therapy
designation and orphan drug designation from the FDA. 
 Firdapse® is currently being evaluated in
clinical trials for the treatment of CMS, MuSK-MG and SMA type 3 and has received Orphan Drug Designation from the FDA for CMS and myasthenia gravis. Firdapse (amifampridine) 10 mg tablets is the first and only approved drug in Europe for the
symptomatic treatment in adults with LEMS. 
  

 About Endo International plc 

Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in
need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com. 

About Par Pharmaceutical 
 Par Pharmaceutical,
headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. Par, among the top leaders in the U.S. generics industry,
possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a research and development (R&D) pipeline of approximately 200 potential new products. Par is an operating
company of Endo International plc. Learn more at www.parpharm.com. 
 Forward-Looking Statements 

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause
Catalyst’s actual results in future periods to differ materially from forecasted results. A number of factors, including (i) whether the milestone payments that are to be paid under Catalyst’s agreement with Endo will ever be earned
and paid; (ii) whether an ANDA for generic vigabatrin tablets will ever be approved by the FDA; (iii) whether Endo, even if vigabatrin tablets are approved for commercialization, will be successful in marketing the product,
(iv) whether Catalyst will earn royalties on sales of generic vigabatrin tablets; (v) whether Catalyst can successfully market Firdapse and become profitable; (vi) whether Firdapse will ever be approved for the treatment of CMS,
MuSK-MG, SMA type 3, or any other disease; and (vii) those other factors described in Catalyst’s Annual Report on Form 10-K for the fiscal year 2017 and its other filings with the U.S. Securities and
Exchange Commission (SEC), could adversely affect Catalyst. Copies of Catalyst’s filings with the SEC are available from the SEC, may be found on Catalyst’s website, or may be obtained upon request from Catalyst. Catalyst does not
undertake any obligation to update the information contained herein, which speaks only as of this date. 
  

			
	 Investor Contact
 Brian Korb

Solebury Trout
 (646)
378-2923
 bkorb@troutgroup.com
	  	 Company Contact
 Patrick J.
McEnany
 Catalyst Pharmaceuticals
 Chief Executive Officer

(305) 420-3200

pmcenany@catalystpharma.com

	 Media Contact
 David Schull

Russo Partners
 (212)
845-4271
 david.schull@russopartnersllc.com
	  	

 ### 

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]